[
  {
    "mutation": "PIK3CD",
    "target_gene": "STK17A",
    "n_mutant_lines": 5,
    "n_wt_lines": 2080,
    "mutant_mean_score": -0.0417,
    "wt_mean_score": -0.0353,
    "effect_size": -0.0064,
    "p_value": 0.8572955337743667,
    "is_significant": true,
    "most_dependent_line": "REH (B-Cell Acute Lymphoblastic Leukemia): -0.0988",
    "mutant_lines_sample": [
      "REH",
      "HT115",
      "HT115",
      "L1236",
      "L1236"
    ],
    "summary": "PIK3CD mutation shows synthetic lethality with STK17A. Effect size: -0.006 (p=0.8573). Tested in 5 mutant lines vs 2080 wild-type lines. Most dependent mutant line: REH (B-Cell Acute Lymphoblastic Leukemia): -0.0988"
  },
  {
    "mutation": "PIK3CD",
    "target_gene": "TBK1",
    "n_mutant_lines": 5,
    "n_wt_lines": 2080,
    "mutant_mean_score": -0.0905,
    "wt_mean_score": -0.0163,
    "effect_size": -0.0742,
    "p_value": 0.2920535465328403,
    "is_significant": true,
    "most_dependent_line": "REH (B-Cell Acute Lymphoblastic Leukemia): -0.2512",
    "mutant_lines_sample": [
      "REH",
      "HT115",
      "HT115",
      "L1236",
      "L1236"
    ],
    "summary": "PIK3CD mutation shows synthetic lethality with TBK1. Effect size: -0.074 (p=0.2921). Tested in 5 mutant lines vs 2080 wild-type lines. Most dependent mutant line: REH (B-Cell Acute Lymphoblastic Leukemia): -0.2512"
  },
  {
    "mutation": "MTOR",
    "target_gene": "MYLK4",
    "n_mutant_lines": 9,
    "n_wt_lines": 2075,
    "mutant_mean_score": 0.0792,
    "wt_mean_score": 0.0803,
    "effect_size": -0.0011,
    "p_value": 0.9641411847350664,
    "is_significant": true,
    "most_dependent_line": "TUHR10TKB (Renal Cell Carcinoma): -0.0108",
    "mutant_lines_sample": [
      "HEC59",
      "HEC59",
      "SNU349",
      "SNU349",
      "HS683"
    ],
    "summary": "MTOR mutation shows synthetic lethality with MYLK4. Effect size: -0.001 (p=0.9641). Tested in 9 mutant lines vs 2075 wild-type lines. Most dependent mutant line: TUHR10TKB (Renal Cell Carcinoma): -0.0108"
  },
  {
    "mutation": "MTOR",
    "target_gene": "TBK1",
    "n_mutant_lines": 9,
    "n_wt_lines": 2075,
    "mutant_mean_score": -0.098,
    "wt_mean_score": -0.0162,
    "effect_size": -0.0818,
    "p_value": 0.3524395052961222,
    "is_significant": true,
    "most_dependent_line": "TUHR10TKB (Renal Cell Carcinoma): -0.6557",
    "mutant_lines_sample": [
      "HEC59",
      "HEC59",
      "SNU349",
      "SNU349",
      "HS683"
    ],
    "summary": "MTOR mutation shows synthetic lethality with TBK1. Effect size: -0.082 (p=0.3524). Tested in 9 mutant lines vs 2075 wild-type lines. Most dependent mutant line: TUHR10TKB (Renal Cell Carcinoma): -0.6557"
  },
  {
    "mutation": "EIF2B3",
    "target_gene": "MYLK4",
    "n_mutant_lines": 6,
    "n_wt_lines": 2079,
    "mutant_mean_score": 0.043,
    "wt_mean_score": 0.0804,
    "effect_size": -0.0374,
    "p_value": 0.0183626923279121,
    "is_significant": true,
    "most_dependent_line": "LS180 (Colorectal Adenocarcinoma): 0.0179",
    "mutant_lines_sample": [
      "LS180",
      "LS180",
      "HOUAI",
      "HOUAI",
      "MGHICC8"
    ],
    "summary": "EIF2B3 mutation shows synthetic lethality with MYLK4. Effect size: -0.037 (p=0.0184). Tested in 6 mutant lines vs 2079 wild-type lines. Most dependent mutant line: LS180 (Colorectal Adenocarcinoma): 0.0179"
  },
  {
    "mutation": "STIL",
    "target_gene": "STK17A",
    "n_mutant_lines": 6,
    "n_wt_lines": 2079,
    "mutant_mean_score": -0.041,
    "wt_mean_score": -0.0353,
    "effect_size": -0.0057,
    "p_value": 0.7594452261275966,
    "is_significant": true,
    "most_dependent_line": "HT115 (Colorectal Adenocarcinoma): -0.0946",
    "mutant_lines_sample": [
      "NZOV9",
      "HT115",
      "HT115",
      "SF268",
      "SF268"
    ],
    "summary": "STIL mutation shows synthetic lethality with STK17A. Effect size: -0.006 (p=0.7594). Tested in 6 mutant lines vs 2079 wild-type lines. Most dependent mutant line: HT115 (Colorectal Adenocarcinoma): -0.0946"
  },
  {
    "mutation": "STIL",
    "target_gene": "TBK1",
    "n_mutant_lines": 6,
    "n_wt_lines": 2079,
    "mutant_mean_score": -0.1205,
    "wt_mean_score": -0.0162,
    "effect_size": -0.1043,
    "p_value": 0.0004627903285096,
    "is_significant": true,
    "most_dependent_line": "HT115 (Colorectal Adenocarcinoma): -0.1534",
    "mutant_lines_sample": [
      "NZOV9",
      "HT115",
      "HT115",
      "SF268",
      "SF268"
    ],
    "summary": "STIL mutation shows synthetic lethality with TBK1. Effect size: -0.104 (p=0.0005). Tested in 6 mutant lines vs 2079 wild-type lines. Most dependent mutant line: HT115 (Colorectal Adenocarcinoma): -0.1534"
  },
  {
    "mutation": "NRAS",
    "target_gene": "MYLK4",
    "n_mutant_lines": 97,
    "n_wt_lines": 1976,
    "mutant_mean_score": 0.0652,
    "wt_mean_score": 0.0814,
    "effect_size": -0.0162,
    "p_value": 0.1637623748634592,
    "is_significant": true,
    "most_dependent_line": "HS852T (Melanoma): -0.2524",
    "mutant_lines_sample": [
      "SNU387",
      "SNU387",
      "SJSA1 (UMF-815H (UMF-815H (UMF-815H (UMF-815H",
      "UMF-815K)",
      "UMF-815K)"
    ],
    "summary": "NRAS mutation shows synthetic lethality with MYLK4. Effect size: -0.016 (p=0.1638). Tested in 97 mutant lines vs 1976 wild-type lines. Most dependent mutant line: HS852T (Melanoma): -0.2524"
  },
  {
    "mutation": "NRAS",
    "target_gene": "CLK4",
    "n_mutant_lines": 97,
    "n_wt_lines": 1976,
    "mutant_mean_score": -0.0558,
    "wt_mean_score": -0.0351,
    "effect_size": -0.0207,
    "p_value": 0.073540235466318,
    "is_significant": true,
    "most_dependent_line": "SKMEL30 (Melanoma): -0.4312",
    "mutant_lines_sample": [
      "SNU387",
      "SNU387",
      "SJSA1 (UMF-815H (UMF-815H (UMF-815H (UMF-815H",
      "UMF-815K)",
      "UMF-815K)"
    ],
    "summary": "NRAS mutation shows synthetic lethality with CLK4. Effect size: -0.021 (p=0.0735). Tested in 97 mutant lines vs 1976 wild-type lines. Most dependent mutant line: SKMEL30 (Melanoma): -0.4312"
  },
  {
    "mutation": "RIT1",
    "target_gene": "TBK1",
    "n_mutant_lines": 3,
    "n_wt_lines": 2082,
    "mutant_mean_score": -0.1097,
    "wt_mean_score": -0.0163,
    "effect_size": -0.0934,
    "p_value": 5.96494369889723e-187,
    "is_significant": true,
    "most_dependent_line": "NCIH2110 (Non-Small Cell Lung Cancer): -0.1097",
    "mutant_lines_sample": [
      "NCIH2110",
      "NCIH2110",
      "NCIH2110"
    ],
    "summary": "RIT1 mutation shows synthetic lethality with TBK1. Effect size: -0.093 (p=0.0000). Tested in 3 mutant lines vs 2082 wild-type lines. Most dependent mutant line: NCIH2110 (Non-Small Cell Lung Cancer): -0.1097"
  },
  {
    "mutation": "ZNF648",
    "target_gene": "STK17A",
    "n_mutant_lines": 7,
    "n_wt_lines": 2078,
    "mutant_mean_score": -0.0502,
    "wt_mean_score": -0.0353,
    "effect_size": -0.0149,
    "p_value": 0.3495267737953684,
    "is_significant": true,
    "most_dependent_line": "LOVO (Colorectal Adenocarcinoma): -0.1106",
    "mutant_lines_sample": [
      "LOVO",
      "CCK81",
      "UMUC1",
      "UMUC1",
      "2313287"
    ],
    "summary": "ZNF648 mutation shows synthetic lethality with STK17A. Effect size: -0.015 (p=0.3495). Tested in 7 mutant lines vs 2078 wild-type lines. Most dependent mutant line: LOVO (Colorectal Adenocarcinoma): -0.1106"
  },
  {
    "mutation": "ZNF648",
    "target_gene": "TBK1",
    "n_mutant_lines": 7,
    "n_wt_lines": 2078,
    "mutant_mean_score": -0.1175,
    "wt_mean_score": -0.0161,
    "effect_size": -0.1014,
    "p_value": 0.0293294097935478,
    "is_significant": true,
    "most_dependent_line": "UMUC1 (Bladder Urothelial Carcinoma): -0.1953",
    "mutant_lines_sample": [
      "LOVO",
      "CCK81",
      "UMUC1",
      "UMUC1",
      "2313287"
    ],
    "summary": "ZNF648 mutation shows synthetic lethality with TBK1. Effect size: -0.101 (p=0.0293). Tested in 7 mutant lines vs 2078 wild-type lines. Most dependent mutant line: UMUC1 (Bladder Urothelial Carcinoma): -0.1953"
  },
  {
    "mutation": "H3-3A",
    "target_gene": "STK17A",
    "n_mutant_lines": 7,
    "n_wt_lines": 2078,
    "mutant_mean_score": -0.0802,
    "wt_mean_score": -0.0352,
    "effect_size": -0.045,
    "p_value": 0.4981021055609909,
    "is_significant": true,
    "most_dependent_line": "CMLT1 (Myeloproliferative Neoplasms): -0.3156",
    "mutant_lines_sample": [
      "NRHGCT1",
      "697",
      "697",
      "CMLT1",
      "CMLT1"
    ],
    "summary": "H3-3A mutation shows synthetic lethality with STK17A. Effect size: -0.045 (p=0.4981). Tested in 7 mutant lines vs 2078 wild-type lines. Most dependent mutant line: CMLT1 (Myeloproliferative Neoplasms): -0.3156"
  },
  {
    "mutation": "H3-3A",
    "target_gene": "MYLK4",
    "n_mutant_lines": 7,
    "n_wt_lines": 2078,
    "mutant_mean_score": 0.0319,
    "wt_mean_score": 0.0805,
    "effect_size": -0.0486,
    "p_value": 0.3836838517915556,
    "is_significant": true,
    "most_dependent_line": "NRHGCT1 (Osteosarcoma): -0.1234",
    "mutant_lines_sample": [
      "NRHGCT1",
      "697",
      "697",
      "CMLT1",
      "CMLT1"
    ],
    "summary": "H3-3A mutation shows synthetic lethality with MYLK4. Effect size: -0.049 (p=0.3837). Tested in 7 mutant lines vs 2078 wild-type lines. Most dependent mutant line: NRHGCT1 (Osteosarcoma): -0.1234"
  },
  {
    "mutation": "H3-3A",
    "target_gene": "TBK1",
    "n_mutant_lines": 7,
    "n_wt_lines": 2078,
    "mutant_mean_score": -0.074,
    "wt_mean_score": -0.0163,
    "effect_size": -0.0577,
    "p_value": 0.3075460061500025,
    "is_significant": true,
    "most_dependent_line": "697 (B-Cell Acute Lymphoblastic Leukemia): -0.2467",
    "mutant_lines_sample": [
      "NRHGCT1",
      "697",
      "697",
      "CMLT1",
      "CMLT1"
    ],
    "summary": "H3-3A mutation shows synthetic lethality with TBK1. Effect size: -0.058 (p=0.3075). Tested in 7 mutant lines vs 2078 wild-type lines. Most dependent mutant line: 697 (B-Cell Acute Lymphoblastic Leukemia): -0.2467"
  },
  {
    "mutation": "H3-3A",
    "target_gene": "CLK4",
    "n_mutant_lines": 7,
    "n_wt_lines": 2078,
    "mutant_mean_score": -0.0874,
    "wt_mean_score": -0.036,
    "effect_size": -0.0514,
    "p_value": 0.1081927808213375,
    "is_significant": true,
    "most_dependent_line": "KNS42 (Diffuse Glioma): -0.1775",
    "mutant_lines_sample": [
      "NRHGCT1",
      "697",
      "697",
      "CMLT1",
      "CMLT1"
    ],
    "summary": "H3-3A mutation shows synthetic lethality with CLK4. Effect size: -0.051 (p=0.1082). Tested in 7 mutant lines vs 2078 wild-type lines. Most dependent mutant line: KNS42 (Diffuse Glioma): -0.1775"
  },
  {
    "mutation": "LYST",
    "target_gene": "TBK1",
    "n_mutant_lines": 3,
    "n_wt_lines": 2082,
    "mutant_mean_score": -0.1296,
    "wt_mean_score": -0.0163,
    "effect_size": -0.1133,
    "p_value": 0.7010524406102242,
    "is_significant": true,
    "most_dependent_line": "SNU81 (Colorectal Adenocarcinoma): -0.6411",
    "mutant_lines_sample": [
      "NTERA2CLD1",
      "NTERA2CLD1",
      "SNU81"
    ],
    "summary": "LYST mutation shows synthetic lethality with TBK1. Effect size: -0.113 (p=0.7011). Tested in 3 mutant lines vs 2082 wild-type lines. Most dependent mutant line: SNU81 (Colorectal Adenocarcinoma): -0.6411"
  },
  {
    "mutation": "GATA3",
    "target_gene": "MYLK4",
    "n_mutant_lines": 10,
    "n_wt_lines": 2071,
    "mutant_mean_score": 0.0684,
    "wt_mean_score": 0.0804,
    "effect_size": -0.012,
    "p_value": 0.7710573916225222,
    "is_significant": true,
    "most_dependent_line": "NH12 (Neuroblastoma): -0.1646",
    "mutant_lines_sample": [
      "KATOIII",
      "KATOIII",
      "HEC59",
      "HEC59",
      "NH12"
    ],
    "summary": "GATA3 mutation shows synthetic lethality with MYLK4. Effect size: -0.012 (p=0.7711). Tested in 10 mutant lines vs 2071 wild-type lines. Most dependent mutant line: NH12 (Neuroblastoma): -0.1646"
  },
  {
    "mutation": "ARID5B",
    "target_gene": "STK17A",
    "n_mutant_lines": 3,
    "n_wt_lines": 2082,
    "mutant_mean_score": -0.1115,
    "wt_mean_score": -0.0353,
    "effect_size": -0.0762,
    "p_value": 0.2238655720026167,
    "is_significant": true,
    "most_dependent_line": "SNUC5 (Colorectal Adenocarcinoma): -0.1992",
    "mutant_lines_sample": [
      "IM95",
      "IM95",
      "SNUC5"
    ],
    "summary": "ARID5B mutation shows synthetic lethality with STK17A. Effect size: -0.076 (p=0.2239). Tested in 3 mutant lines vs 2082 wild-type lines. Most dependent mutant line: SNUC5 (Colorectal Adenocarcinoma): -0.1992"
  },
  {
    "mutation": "PTEN",
    "target_gene": "STK17A",
    "n_mutant_lines": 28,
    "n_wt_lines": 2002,
    "mutant_mean_score": -0.0639,
    "wt_mean_score": -0.0346,
    "effect_size": -0.0293,
    "p_value": 0.1668184400570482,
    "is_significant": true,
    "most_dependent_line": "P31FUJ (Acute Myeloid Leukemia): -0.3004",
    "mutant_lines_sample": [
      "JHUEM1",
      "LS180",
      "HEC59",
      "HEC59",
      "HSC4"
    ],
    "summary": "PTEN mutation shows synthetic lethality with STK17A. Effect size: -0.029 (p=0.1668). Tested in 28 mutant lines vs 2002 wild-type lines. Most dependent mutant line: P31FUJ (Acute Myeloid Leukemia): -0.3004"
  },
  {
    "mutation": "PTEN",
    "target_gene": "TBK1",
    "n_mutant_lines": 28,
    "n_wt_lines": 2002,
    "mutant_mean_score": -0.0209,
    "wt_mean_score": -0.0149,
    "effect_size": -0.006,
    "p_value": 0.8436632307180931,
    "is_significant": true,
    "most_dependent_line": "SNU81 (Colorectal Adenocarcinoma): -0.6411",
    "mutant_lines_sample": [
      "JHUEM1",
      "LS180",
      "HEC59",
      "HEC59",
      "HSC4"
    ],
    "summary": "PTEN mutation shows synthetic lethality with TBK1. Effect size: -0.006 (p=0.8437). Tested in 28 mutant lines vs 2002 wild-type lines. Most dependent mutant line: SNU81 (Colorectal Adenocarcinoma): -0.6411"
  },
  {
    "mutation": "ARMH3",
    "target_gene": "MYLK4",
    "n_mutant_lines": 3,
    "n_wt_lines": 2082,
    "mutant_mean_score": 0.0519,
    "wt_mean_score": 0.0803,
    "effect_size": -0.0284,
    "p_value": 1.1156983890226564e-30,
    "is_significant": true,
    "most_dependent_line": "NMCG1 (Diffuse Glioma): 0.0519",
    "mutant_lines_sample": [
      "NMCG1",
      "NMCG1",
      "NMCG1"
    ],
    "summary": "ARMH3 mutation shows synthetic lethality with MYLK4. Effect size: -0.028 (p=0.0000). Tested in 3 mutant lines vs 2082 wild-type lines. Most dependent mutant line: NMCG1 (Diffuse Glioma): 0.0519"
  },
  {
    "mutation": "ARMH3",
    "target_gene": "TBK1",
    "n_mutant_lines": 3,
    "n_wt_lines": 2082,
    "mutant_mean_score": -0.0657,
    "wt_mean_score": -0.0164,
    "effect_size": -0.0493,
    "p_value": 1.589803519145374e-61,
    "is_significant": true,
    "most_dependent_line": "NMCG1 (Diffuse Glioma): -0.0657",
    "mutant_lines_sample": [
      "NMCG1",
      "NMCG1",
      "NMCG1"
    ],
    "summary": "ARMH3 mutation shows synthetic lethality with TBK1. Effect size: -0.049 (p=0.0000). Tested in 3 mutant lines vs 2082 wild-type lines. Most dependent mutant line: NMCG1 (Diffuse Glioma): -0.0657"
  },
  {
    "mutation": "COL17A1",
    "target_gene": "MYLK4",
    "n_mutant_lines": 3,
    "n_wt_lines": 2082,
    "mutant_mean_score": 0.0379,
    "wt_mean_score": 0.0804,
    "effect_size": -0.0424,
    "p_value": 0.4598601083568269,
    "is_significant": true,
    "most_dependent_line": "HEC251 (Endometrial Carcinoma): -0.0088",
    "mutant_lines_sample": [
      "HEC251",
      "HEC251",
      "JHUEM7"
    ],
    "summary": "COL17A1 mutation shows synthetic lethality with MYLK4. Effect size: -0.042 (p=0.4599). Tested in 3 mutant lines vs 2082 wild-type lines. Most dependent mutant line: HEC251 (Endometrial Carcinoma): -0.0088"
  },
  {
    "mutation": "COL17A1",
    "target_gene": "TBK1",
    "n_mutant_lines": 3,
    "n_wt_lines": 2082,
    "mutant_mean_score": -0.0829,
    "wt_mean_score": -0.0164,
    "effect_size": -0.0665,
    "p_value": 1.0670428005765751e-11,
    "is_significant": true,
    "most_dependent_line": "JHUEM7 (Endometrial Carcinoma): -0.0873",
    "mutant_lines_sample": [
      "HEC251",
      "HEC251",
      "JHUEM7"
    ],
    "summary": "COL17A1 mutation shows synthetic lethality with TBK1. Effect size: -0.067 (p=0.0000). Tested in 3 mutant lines vs 2082 wild-type lines. Most dependent mutant line: JHUEM7 (Endometrial Carcinoma): -0.0873"
  },
  {
    "mutation": "FGFR2",
    "target_gene": "STK17A",
    "n_mutant_lines": 9,
    "n_wt_lines": 2073,
    "mutant_mean_score": -0.0709,
    "wt_mean_score": -0.0349,
    "effect_size": -0.0359,
    "p_value": 0.3329241122176011,
    "is_significant": true,
    "most_dependent_line": "MFE280 (Endometrial Carcinoma): -0.2405",
    "mutant_lines_sample": [
      "U343",
      "U343",
      "MFE280",
      "MFE280",
      "HCC1143"
    ],
    "summary": "FGFR2 mutation shows synthetic lethality with STK17A. Effect size: -0.036 (p=0.3329). Tested in 9 mutant lines vs 2073 wild-type lines. Most dependent mutant line: MFE280 (Endometrial Carcinoma): -0.2405"
  },
  {
    "mutation": "PAOX",
    "target_gene": "TBK1",
    "n_mutant_lines": 4,
    "n_wt_lines": 2081,
    "mutant_mean_score": -0.0239,
    "wt_mean_score": -0.0164,
    "effect_size": -0.0075,
    "p_value": 0.058537389216015,
    "is_significant": true,
    "most_dependent_line": "HOUAI (Endometrial Carcinoma): -0.0280",
    "mutant_lines_sample": [
      "HOUAI",
      "HOUAI",
      "EFO27",
      "EFO27"
    ],
    "summary": "PAOX mutation shows synthetic lethality with TBK1. Effect size: -0.007 (p=0.0585). Tested in 4 mutant lines vs 2081 wild-type lines. Most dependent mutant line: HOUAI (Endometrial Carcinoma): -0.0280"
  },
  {
    "mutation": "PHLDA2",
    "target_gene": "STK17A",
    "n_mutant_lines": 3,
    "n_wt_lines": 2082,
    "mutant_mean_score": -0.0906,
    "wt_mean_score": -0.0353,
    "effect_size": -0.0553,
    "p_value": 0.529878928728823,
    "is_significant": true,
    "most_dependent_line": "SW1463 (Colorectal Adenocarcinoma): -0.2235",
    "mutant_lines_sample": [
      "SW1463",
      "NCIH2087",
      "DMS53"
    ],
    "summary": "PHLDA2 mutation shows synthetic lethality with STK17A. Effect size: -0.055 (p=0.5299). Tested in 3 mutant lines vs 2082 wild-type lines. Most dependent mutant line: SW1463 (Colorectal Adenocarcinoma): -0.2235"
  },
  {
    "mutation": "PHLDA2",
    "target_gene": "TBK1",
    "n_mutant_lines": 3,
    "n_wt_lines": 2082,
    "mutant_mean_score": -0.0926,
    "wt_mean_score": -0.0163,
    "effect_size": -0.0762,
    "p_value": 0.3923784898277843,
    "is_significant": true,
    "most_dependent_line": "DMS53 (Lung Neuroendocrine Tumor): -0.2295",
    "mutant_lines_sample": [
      "SW1463",
      "NCIH2087",
      "DMS53"
    ],
    "summary": "PHLDA2 mutation shows synthetic lethality with TBK1. Effect size: -0.076 (p=0.3924). Tested in 3 mutant lines vs 2082 wild-type lines. Most dependent mutant line: DMS53 (Lung Neuroendocrine Tumor): -0.2295"
  },
  {
    "mutation": "PHLDA2",
    "target_gene": "CLK4",
    "n_mutant_lines": 3,
    "n_wt_lines": 2082,
    "mutant_mean_score": -0.0656,
    "wt_mean_score": -0.0361,
    "effect_size": -0.0295,
    "p_value": 0.726297832773843,
    "is_significant": true,
    "most_dependent_line": "DMS53 (Lung Neuroendocrine Tumor): -0.1509",
    "mutant_lines_sample": [
      "SW1463",
      "NCIH2087",
      "DMS53"
    ],
    "summary": "PHLDA2 mutation shows synthetic lethality with CLK4. Effect size: -0.029 (p=0.7263). Tested in 3 mutant lines vs 2082 wild-type lines. Most dependent mutant line: DMS53 (Lung Neuroendocrine Tumor): -0.1509"
  },
  {
    "mutation": "MYBPC3",
    "target_gene": "MYLK4",
    "n_mutant_lines": 3,
    "n_wt_lines": 2082,
    "mutant_mean_score": 0.0536,
    "wt_mean_score": 0.0803,
    "effect_size": -0.0267,
    "p_value": 0.6410904191241379,
    "is_significant": true,
    "most_dependent_line": "HEC59 (Endometrial Carcinoma): 0.0045",
    "mutant_lines_sample": [
      "HEC59",
      "HEC59",
      "HCC2998"
    ],
    "summary": "MYBPC3 mutation shows synthetic lethality with MYLK4. Effect size: -0.027 (p=0.6411). Tested in 3 mutant lines vs 2082 wild-type lines. Most dependent mutant line: HEC59 (Endometrial Carcinoma): 0.0045"
  },
  {
    "mutation": "CD248",
    "target_gene": "MYLK4",
    "n_mutant_lines": 3,
    "n_wt_lines": 2082,
    "mutant_mean_score": 0.0176,
    "wt_mean_score": 0.0804,
    "effect_size": -0.0628,
    "p_value": 0.1461209936762506,
    "is_significant": true,
    "most_dependent_line": "HUO3N1 (Osteosarcoma): -0.0197",
    "mutant_lines_sample": [
      "EFM19",
      "HUO3N1",
      "CAL51"
    ],
    "summary": "CD248 mutation shows synthetic lethality with MYLK4. Effect size: -0.063 (p=0.1461). Tested in 3 mutant lines vs 2082 wild-type lines. Most dependent mutant line: HUO3N1 (Osteosarcoma): -0.0197"
  },
  {
    "mutation": "CARNS1",
    "target_gene": "STK17A",
    "n_mutant_lines": 4,
    "n_wt_lines": 2081,
    "mutant_mean_score": -0.0674,
    "wt_mean_score": -0.0353,
    "effect_size": -0.0321,
    "p_value": 0.4618586966976259,
    "is_significant": true,
    "most_dependent_line": "RCC10RGB (Renal Cell Carcinoma): -0.1722",
    "mutant_lines_sample": [
      "RCC10RGB",
      "SKMES1",
      "NCIH2009",
      "NCIH1437"
    ],
    "summary": "CARNS1 mutation shows synthetic lethality with STK17A. Effect size: -0.032 (p=0.4619). Tested in 4 mutant lines vs 2081 wild-type lines. Most dependent mutant line: RCC10RGB (Renal Cell Carcinoma): -0.1722"
  },
  {
    "mutation": "CARNS1",
    "target_gene": "MYLK4",
    "n_mutant_lines": 4,
    "n_wt_lines": 2081,
    "mutant_mean_score": 0.0776,
    "wt_mean_score": 0.0803,
    "effect_size": -0.0027,
    "p_value": 0.97319162801185,
    "is_significant": true,
    "most_dependent_line": "RCC10RGB (Renal Cell Carcinoma): -0.1180",
    "mutant_lines_sample": [
      "RCC10RGB",
      "SKMES1",
      "NCIH2009",
      "NCIH1437"
    ],
    "summary": "CARNS1 mutation shows synthetic lethality with MYLK4. Effect size: -0.003 (p=0.9732). Tested in 4 mutant lines vs 2081 wild-type lines. Most dependent mutant line: RCC10RGB (Renal Cell Carcinoma): -0.1180"
  },
  {
    "mutation": "CARNS1",
    "target_gene": "TBK1",
    "n_mutant_lines": 4,
    "n_wt_lines": 2081,
    "mutant_mean_score": -0.0756,
    "wt_mean_score": -0.0163,
    "effect_size": -0.0593,
    "p_value": 0.4125314829790509,
    "is_significant": true,
    "most_dependent_line": "RCC10RGB (Renal Cell Carcinoma): -0.2320",
    "mutant_lines_sample": [
      "RCC10RGB",
      "SKMES1",
      "NCIH2009",
      "NCIH1437"
    ],
    "summary": "CARNS1 mutation shows synthetic lethality with TBK1. Effect size: -0.059 (p=0.4125). Tested in 4 mutant lines vs 2081 wild-type lines. Most dependent mutant line: RCC10RGB (Renal Cell Carcinoma): -0.2320"
  },
  {
    "mutation": "CARNS1",
    "target_gene": "CLK4",
    "n_mutant_lines": 4,
    "n_wt_lines": 2081,
    "mutant_mean_score": -0.0386,
    "wt_mean_score": -0.0361,
    "effect_size": -0.0025,
    "p_value": 0.968265753627368,
    "is_significant": true,
    "most_dependent_line": "RCC10RGB (Renal Cell Carcinoma): -0.2020",
    "mutant_lines_sample": [
      "RCC10RGB",
      "SKMES1",
      "NCIH2009",
      "NCIH1437"
    ],
    "summary": "CARNS1 mutation shows synthetic lethality with CLK4. Effect size: -0.003 (p=0.9683). Tested in 4 mutant lines vs 2081 wild-type lines. Most dependent mutant line: RCC10RGB (Renal Cell Carcinoma): -0.2020"
  },
  {
    "mutation": "CCND1",
    "target_gene": "TBK1",
    "n_mutant_lines": 5,
    "n_wt_lines": 2080,
    "mutant_mean_score": -0.0806,
    "wt_mean_score": -0.0163,
    "effect_size": -0.0643,
    "p_value": 0.2080313021722515,
    "is_significant": true,
    "most_dependent_line": "HEC265 (Endometrial Carcinoma): -0.1831",
    "mutant_lines_sample": [
      "EBC1",
      "OVK18",
      "OVK18",
      "HEC265",
      "HEC265"
    ],
    "summary": "CCND1 mutation shows synthetic lethality with TBK1. Effect size: -0.064 (p=0.2080). Tested in 5 mutant lines vs 2080 wild-type lines. Most dependent mutant line: HEC265 (Endometrial Carcinoma): -0.1831"
  },
  {
    "mutation": "FERRY3",
    "target_gene": "STK17A",
    "n_mutant_lines": 5,
    "n_wt_lines": 2080,
    "mutant_mean_score": -0.0709,
    "wt_mean_score": -0.0353,
    "effect_size": -0.0357,
    "p_value": 0.3539195735982468,
    "is_significant": true,
    "most_dependent_line": "SNU81 (Colorectal Adenocarcinoma): -0.1911",
    "mutant_lines_sample": [
      "MCF7",
      "MCF7",
      "MCF7",
      "SNU81",
      "KPL1"
    ],
    "summary": "FERRY3 mutation shows synthetic lethality with STK17A. Effect size: -0.036 (p=0.3539). Tested in 5 mutant lines vs 2080 wild-type lines. Most dependent mutant line: SNU81 (Colorectal Adenocarcinoma): -0.1911"
  },
  {
    "mutation": "FERRY3",
    "target_gene": "TBK1",
    "n_mutant_lines": 5,
    "n_wt_lines": 2080,
    "mutant_mean_score": -0.022,
    "wt_mean_score": -0.0164,
    "effect_size": -0.0055,
    "p_value": 0.9766155808966456,
    "is_significant": true,
    "most_dependent_line": "SNU81 (Colorectal Adenocarcinoma): -0.6411",
    "mutant_lines_sample": [
      "MCF7",
      "MCF7",
      "MCF7",
      "SNU81",
      "KPL1"
    ],
    "summary": "FERRY3 mutation shows synthetic lethality with TBK1. Effect size: -0.005 (p=0.9766). Tested in 5 mutant lines vs 2080 wild-type lines. Most dependent mutant line: SNU81 (Colorectal Adenocarcinoma): -0.6411"
  },
  {
    "mutation": "DUSP16",
    "target_gene": "STK17A",
    "n_mutant_lines": 4,
    "n_wt_lines": 2081,
    "mutant_mean_score": -0.0646,
    "wt_mean_score": -0.0353,
    "effect_size": -0.0293,
    "p_value": 0.6152963065836984,
    "is_significant": true,
    "most_dependent_line": "SNUC4 (Colorectal Adenocarcinoma): -0.1554",
    "mutant_lines_sample": [
      "FTC133",
      "FTC133",
      "SNUC4",
      "SNUC4"
    ],
    "summary": "DUSP16 mutation shows synthetic lethality with STK17A. Effect size: -0.029 (p=0.6153). Tested in 4 mutant lines vs 2081 wild-type lines. Most dependent mutant line: SNUC4 (Colorectal Adenocarcinoma): -0.1554"
  },
  {
    "mutation": "DUSP16",
    "target_gene": "MYLK4",
    "n_mutant_lines": 4,
    "n_wt_lines": 2081,
    "mutant_mean_score": -0.0324,
    "wt_mean_score": 0.0805,
    "effect_size": -0.1129,
    "p_value": 0.1121425548178913,
    "is_significant": true,
    "most_dependent_line": "SNUC4 (Colorectal Adenocarcinoma): -0.1203",
    "mutant_lines_sample": [
      "FTC133",
      "FTC133",
      "SNUC4",
      "SNUC4"
    ],
    "summary": "DUSP16 mutation shows synthetic lethality with MYLK4. Effect size: -0.113 (p=0.1121). Tested in 4 mutant lines vs 2081 wild-type lines. Most dependent mutant line: SNUC4 (Colorectal Adenocarcinoma): -0.1203"
  },
  {
    "mutation": "DUSP16",
    "target_gene": "TBK1",
    "n_mutant_lines": 4,
    "n_wt_lines": 2081,
    "mutant_mean_score": -0.0208,
    "wt_mean_score": -0.0164,
    "effect_size": -0.0044,
    "p_value": 0.9002671798864166,
    "is_significant": true,
    "most_dependent_line": "SNUC4 (Colorectal Adenocarcinoma): -0.0761",
    "mutant_lines_sample": [
      "FTC133",
      "FTC133",
      "SNUC4",
      "SNUC4"
    ],
    "summary": "DUSP16 mutation shows synthetic lethality with TBK1. Effect size: -0.004 (p=0.9003). Tested in 4 mutant lines vs 2081 wild-type lines. Most dependent mutant line: SNUC4 (Colorectal Adenocarcinoma): -0.0761"
  },
  {
    "mutation": "C2CD5",
    "target_gene": "MYLK4",
    "n_mutant_lines": 4,
    "n_wt_lines": 2081,
    "mutant_mean_score": 0.0568,
    "wt_mean_score": 0.0803,
    "effect_size": -0.0235,
    "p_value": 0.580878821938951,
    "is_significant": true,
    "most_dependent_line": "HEC251 (Endometrial Carcinoma): -0.0088",
    "mutant_lines_sample": [
      "NZOV9",
      "HEC251",
      "HEC251",
      "JHUEM7"
    ],
    "summary": "C2CD5 mutation shows synthetic lethality with MYLK4. Effect size: -0.024 (p=0.5809). Tested in 4 mutant lines vs 2081 wild-type lines. Most dependent mutant line: HEC251 (Endometrial Carcinoma): -0.0088"
  },
  {
    "mutation": "C2CD5",
    "target_gene": "TBK1",
    "n_mutant_lines": 4,
    "n_wt_lines": 2081,
    "mutant_mean_score": -0.0777,
    "wt_mean_score": -0.0163,
    "effect_size": -0.0613,
    "p_value": 0.0001920864393983,
    "is_significant": true,
    "most_dependent_line": "JHUEM7 (Endometrial Carcinoma): -0.0873",
    "mutant_lines_sample": [
      "NZOV9",
      "HEC251",
      "HEC251",
      "JHUEM7"
    ],
    "summary": "C2CD5 mutation shows synthetic lethality with TBK1. Effect size: -0.061 (p=0.0002). Tested in 4 mutant lines vs 2081 wild-type lines. Most dependent mutant line: JHUEM7 (Endometrial Carcinoma): -0.0873"
  },
  {
    "mutation": "KRAS",
    "target_gene": "STK17A",
    "n_mutant_lines": 215,
    "n_wt_lines": 1778,
    "mutant_mean_score": -0.0391,
    "wt_mean_score": -0.0346,
    "effect_size": -0.0045,
    "p_value": 0.5871161107755503,
    "is_significant": true,
    "most_dependent_line": "KCIMOH1 (Pancreatic Adenocarcinoma): -0.4183",
    "mutant_lines_sample": [
      "HPAFII",
      "HUPT4",
      "SNU1033",
      "SNU1033",
      "PSN1"
    ],
    "summary": "KRAS mutation shows synthetic lethality with STK17A. Effect size: -0.004 (p=0.5871). Tested in 215 mutant lines vs 1778 wild-type lines. Most dependent mutant line: KCIMOH1 (Pancreatic Adenocarcinoma): -0.4183"
  },
  {
    "mutation": "ERBB3",
    "target_gene": "STK17A",
    "n_mutant_lines": 23,
    "n_wt_lines": 2062,
    "mutant_mean_score": -0.0387,
    "wt_mean_score": -0.0353,
    "effect_size": -0.0034,
    "p_value": 0.8645106472040329,
    "is_significant": true,
    "most_dependent_line": "OCIC4P (Ovarian Epithelial Tumor): -0.2084",
    "mutant_lines_sample": [
      "SUM190PT",
      "HEC1B",
      "HEC1B",
      "OC316",
      "TGBC18TKB"
    ],
    "summary": "ERBB3 mutation shows synthetic lethality with STK17A. Effect size: -0.003 (p=0.8645). Tested in 23 mutant lines vs 2062 wild-type lines. Most dependent mutant line: OCIC4P (Ovarian Epithelial Tumor): -0.2084"
  },
  {
    "mutation": "ERBB3",
    "target_gene": "TBK1",
    "n_mutant_lines": 23,
    "n_wt_lines": 2062,
    "mutant_mean_score": -0.0397,
    "wt_mean_score": -0.0162,
    "effect_size": -0.0235,
    "p_value": 0.3184767861001951,
    "is_significant": true,
    "most_dependent_line": "HCT15 (Colorectal Adenocarcinoma): -0.3413",
    "mutant_lines_sample": [
      "SUM190PT",
      "HEC1B",
      "HEC1B",
      "OC316",
      "TGBC18TKB"
    ],
    "summary": "ERBB3 mutation shows synthetic lethality with TBK1. Effect size: -0.024 (p=0.3185). Tested in 23 mutant lines vs 2062 wild-type lines. Most dependent mutant line: HCT15 (Colorectal Adenocarcinoma): -0.3413"
  },
  {
    "mutation": "CDK4",
    "target_gene": "MYLK4",
    "n_mutant_lines": 6,
    "n_wt_lines": 2075,
    "mutant_mean_score": 0.0703,
    "wt_mean_score": 0.0802,
    "effect_size": -0.0099,
    "p_value": 0.516109877455805,
    "is_significant": true,
    "most_dependent_line": "LN464 (Melanoma): 0.0338",
    "mutant_lines_sample": [
      "ES2",
      "ES2",
      "LN464",
      "LN464",
      "COLO800"
    ],
    "summary": "CDK4 mutation shows synthetic lethality with MYLK4. Effect size: -0.010 (p=0.5161). Tested in 6 mutant lines vs 2075 wild-type lines. Most dependent mutant line: LN464 (Melanoma): 0.0338"
  },
  {
    "mutation": "CDK4",
    "target_gene": "CLK4",
    "n_mutant_lines": 6,
    "n_wt_lines": 2075,
    "mutant_mean_score": -0.0495,
    "wt_mean_score": -0.036,
    "effect_size": -0.0135,
    "p_value": 0.7752215577458133,
    "is_significant": true,
    "most_dependent_line": "LN464 (Melanoma): -0.1908",
    "mutant_lines_sample": [
      "ES2",
      "ES2",
      "LN464",
      "LN464",
      "COLO800"
    ],
    "summary": "CDK4 mutation shows synthetic lethality with CLK4. Effect size: -0.013 (p=0.7752). Tested in 6 mutant lines vs 2075 wild-type lines. Most dependent mutant line: LN464 (Melanoma): -0.1908"
  },
  {
    "mutation": "PTPN11",
    "target_gene": "STK17A",
    "n_mutant_lines": 8,
    "n_wt_lines": 2077,
    "mutant_mean_score": -0.0871,
    "wt_mean_score": -0.0352,
    "effect_size": -0.0519,
    "p_value": 0.081978289763309,
    "is_significant": true,
    "most_dependent_line": "BICR22 (Head and Neck Squamous Cell Carcinoma): -0.2085",
    "mutant_lines_sample": [
      "NCCMPNST3C1",
      "LN229 (UMF-815H) (UMF-815H)",
      "LN229 (UMF-815H) (UMF-815H)",
      "HT115",
      "HT115"
    ],
    "summary": "PTPN11 mutation shows synthetic lethality with STK17A. Effect size: -0.052 (p=0.0820). Tested in 8 mutant lines vs 2077 wild-type lines. Most dependent mutant line: BICR22 (Head and Neck Squamous Cell Carcinoma): -0.2085"
  },
  {
    "mutation": "PTPN11",
    "target_gene": "TBK1",
    "n_mutant_lines": 8,
    "n_wt_lines": 2077,
    "mutant_mean_score": -0.0316,
    "wt_mean_score": -0.0164,
    "effect_size": -0.0152,
    "p_value": 0.6474916549902104,
    "is_significant": true,
    "most_dependent_line": "HT115 (Colorectal Adenocarcinoma): -0.1534",
    "mutant_lines_sample": [
      "NCCMPNST3C1",
      "LN229 (UMF-815H) (UMF-815H)",
      "LN229 (UMF-815H) (UMF-815H)",
      "HT115",
      "HT115"
    ],
    "summary": "PTPN11 mutation shows synthetic lethality with TBK1. Effect size: -0.015 (p=0.6475). Tested in 8 mutant lines vs 2077 wild-type lines. Most dependent mutant line: HT115 (Colorectal Adenocarcinoma): -0.1534"
  },
  {
    "mutation": "NOS1",
    "target_gene": "MYLK4",
    "n_mutant_lines": 5,
    "n_wt_lines": 2080,
    "mutant_mean_score": -0.0611,
    "wt_mean_score": 0.0806,
    "effect_size": -0.1417,
    "p_value": 0.0565581886822169,
    "is_significant": true,
    "most_dependent_line": "HT144 (Melanoma): -0.1709",
    "mutant_lines_sample": [
      "HKA1",
      "HT144SKINFV2",
      "HT144SKINFV2",
      "HT144",
      "HT144"
    ],
    "summary": "NOS1 mutation shows synthetic lethality with MYLK4. Effect size: -0.142 (p=0.0566). Tested in 5 mutant lines vs 2080 wild-type lines. Most dependent mutant line: HT144 (Melanoma): -0.1709"
  },
  {
    "mutation": "NOS1",
    "target_gene": "CLK4",
    "n_mutant_lines": 5,
    "n_wt_lines": 2080,
    "mutant_mean_score": -0.0743,
    "wt_mean_score": -0.036,
    "effect_size": -0.0383,
    "p_value": 0.356347858341669,
    "is_significant": true,
    "most_dependent_line": "HT144 (Melanoma): -0.1628",
    "mutant_lines_sample": [
      "HKA1",
      "HT144SKINFV2",
      "HT144SKINFV2",
      "HT144",
      "HT144"
    ],
    "summary": "NOS1 mutation shows synthetic lethality with CLK4. Effect size: -0.038 (p=0.3563). Tested in 5 mutant lines vs 2080 wild-type lines. Most dependent mutant line: HT144 (Melanoma): -0.1628"
  },
  {
    "mutation": "POLE",
    "target_gene": "STK17A",
    "n_mutant_lines": 11,
    "n_wt_lines": 2074,
    "mutant_mean_score": -0.0443,
    "wt_mean_score": -0.0353,
    "effect_size": -0.009,
    "p_value": 0.7279218954432516,
    "is_significant": true,
    "most_dependent_line": "SNU81 (Colorectal Adenocarcinoma): -0.1911",
    "mutant_lines_sample": [
      "ESS1",
      "ESS1",
      "ESS1",
      "NZOV9",
      "HCC2998"
    ],
    "summary": "POLE mutation shows synthetic lethality with STK17A. Effect size: -0.009 (p=0.7279). Tested in 11 mutant lines vs 2074 wild-type lines. Most dependent mutant line: SNU81 (Colorectal Adenocarcinoma): -0.1911"
  },
  {
    "mutation": "POLE",
    "target_gene": "TBK1",
    "n_mutant_lines": 11,
    "n_wt_lines": 2074,
    "mutant_mean_score": -0.1598,
    "wt_mean_score": -0.0157,
    "effect_size": -0.1441,
    "p_value": 0.01802955758297,
    "is_significant": true,
    "most_dependent_line": "SNU81 (Colorectal Adenocarcinoma): -0.6411",
    "mutant_lines_sample": [
      "ESS1",
      "ESS1",
      "ESS1",
      "NZOV9",
      "HCC2998"
    ],
    "summary": "POLE mutation shows synthetic lethality with TBK1. Effect size: -0.144 (p=0.0180). Tested in 11 mutant lines vs 2074 wild-type lines. Most dependent mutant line: SNU81 (Colorectal Adenocarcinoma): -0.6411"
  },
  {
    "mutation": "BRCA2",
    "target_gene": "STK17A",
    "n_mutant_lines": 7,
    "n_wt_lines": 2076,
    "mutant_mean_score": -0.1129,
    "wt_mean_score": -0.035,
    "effect_size": -0.0779,
    "p_value": 0.0682976653389714,
    "is_significant": true,
    "most_dependent_line": "CMK115 (Acute Myeloid Leukemia): -0.3025",
    "mutant_lines_sample": [
      "NCIH650",
      "NCIH650",
      "HT115",
      "HT115",
      "CMK115"
    ],
    "summary": "BRCA2 mutation shows synthetic lethality with STK17A. Effect size: -0.078 (p=0.0683). Tested in 7 mutant lines vs 2076 wild-type lines. Most dependent mutant line: CMK115 (Acute Myeloid Leukemia): -0.3025"
  },
  {
    "mutation": "BRCA2",
    "target_gene": "TBK1",
    "n_mutant_lines": 7,
    "n_wt_lines": 2076,
    "mutant_mean_score": -0.1104,
    "wt_mean_score": -0.0159,
    "effect_size": -0.0945,
    "p_value": 0.0001662578639283,
    "is_significant": true,
    "most_dependent_line": "HT115 (Colorectal Adenocarcinoma): -0.1534",
    "mutant_lines_sample": [
      "NCIH650",
      "NCIH650",
      "HT115",
      "HT115",
      "CMK115"
    ],
    "summary": "BRCA2 mutation shows synthetic lethality with TBK1. Effect size: -0.095 (p=0.0002). Tested in 7 mutant lines vs 2076 wild-type lines. Most dependent mutant line: HT115 (Colorectal Adenocarcinoma): -0.1534"
  },
  {
    "mutation": "BRCA2",
    "target_gene": "CLK4",
    "n_mutant_lines": 7,
    "n_wt_lines": 2076,
    "mutant_mean_score": -0.1408,
    "wt_mean_score": -0.0358,
    "effect_size": -0.1049,
    "p_value": 0.1839111140206247,
    "is_significant": true,
    "most_dependent_line": "NCIH650 (Non-Small Cell Lung Cancer): -0.3861",
    "mutant_lines_sample": [
      "NCIH650",
      "NCIH650",
      "HT115",
      "HT115",
      "CMK115"
    ],
    "summary": "BRCA2 mutation shows synthetic lethality with CLK4. Effect size: -0.105 (p=0.1839). Tested in 7 mutant lines vs 2076 wild-type lines. Most dependent mutant line: NCIH650 (Non-Small Cell Lung Cancer): -0.3861"
  },
  {
    "mutation": "FREM2",
    "target_gene": "STK17A",
    "n_mutant_lines": 4,
    "n_wt_lines": 2081,
    "mutant_mean_score": -0.0847,
    "wt_mean_score": -0.0353,
    "effect_size": -0.0494,
    "p_value": 0.1326863391183247,
    "is_significant": true,
    "most_dependent_line": "DLD1 (Colorectal Adenocarcinoma): -0.1266",
    "mutant_lines_sample": [
      "DLD1",
      "DLD1",
      "HCT15 (UMF-815H (UMF-815H (UMF-815H (UMF-815H",
      "UMF-815K)",
      "UMF-815K)"
    ],
    "summary": "FREM2 mutation shows synthetic lethality with STK17A. Effect size: -0.049 (p=0.1327). Tested in 4 mutant lines vs 2081 wild-type lines. Most dependent mutant line: DLD1 (Colorectal Adenocarcinoma): -0.1266"
  },
  {
    "mutation": "FREM2",
    "target_gene": "TBK1",
    "n_mutant_lines": 4,
    "n_wt_lines": 2081,
    "mutant_mean_score": -0.1768,
    "wt_mean_score": -0.0161,
    "effect_size": -0.1607,
    "p_value": 0.1891502582049469,
    "is_significant": true,
    "most_dependent_line": "HCT15 (Colorectal Adenocarcinoma): -0.3413",
    "mutant_lines_sample": [
      "DLD1",
      "DLD1",
      "HCT15 (UMF-815H (UMF-815H (UMF-815H (UMF-815H",
      "UMF-815K)",
      "UMF-815K)"
    ],
    "summary": "FREM2 mutation shows synthetic lethality with TBK1. Effect size: -0.161 (p=0.1892). Tested in 4 mutant lines vs 2081 wild-type lines. Most dependent mutant line: HCT15 (Colorectal Adenocarcinoma): -0.3413"
  },
  {
    "mutation": "RB1",
    "target_gene": "STK17A",
    "n_mutant_lines": 15,
    "n_wt_lines": 2052,
    "mutant_mean_score": -0.0497,
    "wt_mean_score": -0.035,
    "effect_size": -0.0147,
    "p_value": 0.531066949486813,
    "is_significant": true,
    "most_dependent_line": "UMUC7 (Bladder Urothelial Carcinoma): -0.1374",
    "mutant_lines_sample": [
      "NCIH1155",
      "639V",
      "639V",
      "HCC2998",
      "MCC26"
    ],
    "summary": "RB1 mutation shows synthetic lethality with STK17A. Effect size: -0.015 (p=0.5311). Tested in 15 mutant lines vs 2052 wild-type lines. Most dependent mutant line: UMUC7 (Bladder Urothelial Carcinoma): -0.1374"
  },
  {
    "mutation": "RB1",
    "target_gene": "MYLK4",
    "n_mutant_lines": 15,
    "n_wt_lines": 2052,
    "mutant_mean_score": 0.0517,
    "wt_mean_score": 0.0804,
    "effect_size": -0.0287,
    "p_value": 0.220575631706452,
    "is_significant": true,
    "most_dependent_line": "MCC26 (Merkel Cell Carcinoma): -0.0352",
    "mutant_lines_sample": [
      "NCIH1155",
      "639V",
      "639V",
      "HCC2998",
      "MCC26"
    ],
    "summary": "RB1 mutation shows synthetic lethality with MYLK4. Effect size: -0.029 (p=0.2206). Tested in 15 mutant lines vs 2052 wild-type lines. Most dependent mutant line: MCC26 (Merkel Cell Carcinoma): -0.0352"
  },
  {
    "mutation": "DIS3",
    "target_gene": "MYLK4",
    "n_mutant_lines": 8,
    "n_wt_lines": 2077,
    "mutant_mean_score": 0.0393,
    "wt_mean_score": 0.0805,
    "effect_size": -0.0411,
    "p_value": 0.1243013737634241,
    "is_significant": true,
    "most_dependent_line": "KMS27 (Mature B-Cell Neoplasms): -0.0114",
    "mutant_lines_sample": [
      "KMS27",
      "KMS27",
      "HARA",
      "HARA",
      "HCC2998"
    ],
    "summary": "DIS3 mutation shows synthetic lethality with MYLK4. Effect size: -0.041 (p=0.1243). Tested in 8 mutant lines vs 2077 wild-type lines. Most dependent mutant line: KMS27 (Mature B-Cell Neoplasms): -0.0114"
  },
  {
    "mutation": "DIS3",
    "target_gene": "TBK1",
    "n_mutant_lines": 8,
    "n_wt_lines": 2077,
    "mutant_mean_score": -0.1068,
    "wt_mean_score": -0.0161,
    "effect_size": -0.0907,
    "p_value": 0.0068867053333484,
    "is_significant": true,
    "most_dependent_line": "HCC2998 (Colorectal Adenocarcinoma): -0.2532",
    "mutant_lines_sample": [
      "KMS27",
      "KMS27",
      "HARA",
      "HARA",
      "HCC2998"
    ],
    "summary": "DIS3 mutation shows synthetic lethality with TBK1. Effect size: -0.091 (p=0.0069). Tested in 8 mutant lines vs 2077 wild-type lines. Most dependent mutant line: HCC2998 (Colorectal Adenocarcinoma): -0.2532"
  },
  {
    "mutation": "OR4M1",
    "target_gene": "TBK1",
    "n_mutant_lines": 3,
    "n_wt_lines": 2082,
    "mutant_mean_score": -0.0744,
    "wt_mean_score": -0.0164,
    "effect_size": -0.0581,
    "p_value": 0.2455507582330848,
    "is_significant": true,
    "most_dependent_line": "NZM7 (Melanoma): -0.1460",
    "mutant_lines_sample": [
      "NZM7",
      "MELJUSO",
      "MELJUSO"
    ],
    "summary": "OR4M1 mutation shows synthetic lethality with TBK1. Effect size: -0.058 (p=0.2456). Tested in 3 mutant lines vs 2082 wild-type lines. Most dependent mutant line: NZM7 (Melanoma): -0.1460"
  },
  {
    "mutation": "OR4M1",
    "target_gene": "CLK4",
    "n_mutant_lines": 3,
    "n_wt_lines": 2082,
    "mutant_mean_score": -0.1154,
    "wt_mean_score": -0.036,
    "effect_size": -0.0794,
    "p_value": 0.043786622260903,
    "is_significant": true,
    "most_dependent_line": "MELJUSO (Melanoma): -0.1332",
    "mutant_lines_sample": [
      "NZM7",
      "MELJUSO",
      "MELJUSO"
    ],
    "summary": "OR4M1 mutation shows synthetic lethality with CLK4. Effect size: -0.079 (p=0.0438). Tested in 3 mutant lines vs 2082 wild-type lines. Most dependent mutant line: MELJUSO (Melanoma): -0.1332"
  },
  {
    "mutation": "ACTR10",
    "target_gene": "MYLK4",
    "n_mutant_lines": 3,
    "n_wt_lines": 2082,
    "mutant_mean_score": 0.0726,
    "wt_mean_score": 0.0803,
    "effect_size": -0.0077,
    "p_value": 0.932987717185548,
    "is_significant": true,
    "most_dependent_line": "HEC251 (Endometrial Carcinoma): -0.0088",
    "mutant_lines_sample": [
      "SNU81",
      "HEC251",
      "HEC251"
    ],
    "summary": "ACTR10 mutation shows synthetic lethality with MYLK4. Effect size: -0.008 (p=0.9330). Tested in 3 mutant lines vs 2082 wild-type lines. Most dependent mutant line: HEC251 (Endometrial Carcinoma): -0.0088"
  },
  {
    "mutation": "ACTR10",
    "target_gene": "TBK1",
    "n_mutant_lines": 3,
    "n_wt_lines": 2082,
    "mutant_mean_score": -0.2675,
    "wt_mean_score": -0.0161,
    "effect_size": -0.2514,
    "p_value": 0.3105922072239712,
    "is_significant": true,
    "most_dependent_line": "SNU81 (Colorectal Adenocarcinoma): -0.6411",
    "mutant_lines_sample": [
      "SNU81",
      "HEC251",
      "HEC251"
    ],
    "summary": "ACTR10 mutation shows synthetic lethality with TBK1. Effect size: -0.251 (p=0.3106). Tested in 3 mutant lines vs 2082 wild-type lines. Most dependent mutant line: SNU81 (Colorectal Adenocarcinoma): -0.6411"
  },
  {
    "mutation": "SIX4",
    "target_gene": "TBK1",
    "n_mutant_lines": 4,
    "n_wt_lines": 2081,
    "mutant_mean_score": -0.1171,
    "wt_mean_score": -0.0163,
    "effect_size": -0.1008,
    "p_value": 0.0161950987703379,
    "is_significant": true,
    "most_dependent_line": "HT115 (Colorectal Adenocarcinoma): -0.1534",
    "mutant_lines_sample": [
      "HT115",
      "HT115",
      "HEC251",
      "HEC251"
    ],
    "summary": "SIX4 mutation shows synthetic lethality with TBK1. Effect size: -0.101 (p=0.0162). Tested in 4 mutant lines vs 2081 wild-type lines. Most dependent mutant line: HT115 (Colorectal Adenocarcinoma): -0.1534"
  },
  {
    "mutation": "MAX",
    "target_gene": "STK17A",
    "n_mutant_lines": 5,
    "n_wt_lines": 2077,
    "mutant_mean_score": -0.0535,
    "wt_mean_score": -0.0354,
    "effect_size": -0.0181,
    "p_value": 0.768734666330402,
    "is_significant": true,
    "most_dependent_line": "A2780 (Ovarian Epithelial Tumor): -0.1697",
    "mutant_lines_sample": [
      "A2780",
      "A2780",
      "NCIH727",
      "CAL51",
      "CAL51"
    ],
    "summary": "MAX mutation shows synthetic lethality with STK17A. Effect size: -0.018 (p=0.7687). Tested in 5 mutant lines vs 2077 wild-type lines. Most dependent mutant line: A2780 (Ovarian Epithelial Tumor): -0.1697"
  },
  {
    "mutation": "MAX",
    "target_gene": "MYLK4",
    "n_mutant_lines": 5,
    "n_wt_lines": 2077,
    "mutant_mean_score": 0.0746,
    "wt_mean_score": 0.0806,
    "effect_size": -0.006,
    "p_value": 0.9045417811974952,
    "is_significant": true,
    "most_dependent_line": "NCIH727 (Lung Neuroendocrine Tumor): -0.0113",
    "mutant_lines_sample": [
      "A2780",
      "A2780",
      "NCIH727",
      "CAL51",
      "CAL51"
    ],
    "summary": "MAX mutation shows synthetic lethality with MYLK4. Effect size: -0.006 (p=0.9045). Tested in 5 mutant lines vs 2077 wild-type lines. Most dependent mutant line: NCIH727 (Lung Neuroendocrine Tumor): -0.0113"
  },
  {
    "mutation": "MAX",
    "target_gene": "TBK1",
    "n_mutant_lines": 5,
    "n_wt_lines": 2077,
    "mutant_mean_score": -0.043,
    "wt_mean_score": -0.0165,
    "effect_size": -0.0265,
    "p_value": 0.2512811741117716,
    "is_significant": true,
    "most_dependent_line": "A2780 (Ovarian Epithelial Tumor): -0.0716",
    "mutant_lines_sample": [
      "A2780",
      "A2780",
      "NCIH727",
      "CAL51",
      "CAL51"
    ],
    "summary": "MAX mutation shows synthetic lethality with TBK1. Effect size: -0.026 (p=0.2513). Tested in 5 mutant lines vs 2077 wild-type lines. Most dependent mutant line: A2780 (Ovarian Epithelial Tumor): -0.0716"
  },
  {
    "mutation": "B2M",
    "target_gene": "STK17A",
    "n_mutant_lines": 3,
    "n_wt_lines": 2082,
    "mutant_mean_score": -0.1116,
    "wt_mean_score": -0.0353,
    "effect_size": -0.0764,
    "p_value": 0.1946255583692181,
    "is_significant": true,
    "most_dependent_line": "SNU81 (Colorectal Adenocarcinoma): -0.1911",
    "mutant_lines_sample": [
      "HCC2998",
      "NCIH2009",
      "SNU81"
    ],
    "summary": "B2M mutation shows synthetic lethality with STK17A. Effect size: -0.076 (p=0.1946). Tested in 3 mutant lines vs 2082 wild-type lines. Most dependent mutant line: SNU81 (Colorectal Adenocarcinoma): -0.1911"
  },
  {
    "mutation": "B2M",
    "target_gene": "TBK1",
    "n_mutant_lines": 3,
    "n_wt_lines": 2082,
    "mutant_mean_score": -0.2741,
    "wt_mean_score": -0.0161,
    "effect_size": -0.258,
    "p_value": 0.337341471383013,
    "is_significant": true,
    "most_dependent_line": "SNU81 (Colorectal Adenocarcinoma): -0.6411",
    "mutant_lines_sample": [
      "HCC2998",
      "NCIH2009",
      "SNU81"
    ],
    "summary": "B2M mutation shows synthetic lethality with TBK1. Effect size: -0.258 (p=0.3373). Tested in 3 mutant lines vs 2082 wild-type lines. Most dependent mutant line: SNU81 (Colorectal Adenocarcinoma): -0.6411"
  },
  {
    "mutation": "DMXL2",
    "target_gene": "STK17A",
    "n_mutant_lines": 3,
    "n_wt_lines": 2082,
    "mutant_mean_score": -0.07,
    "wt_mean_score": -0.0353,
    "effect_size": -0.0347,
    "p_value": 1.515255507392311e-33,
    "is_significant": true,
    "most_dependent_line": "ESS1 (Uterine Sarcoma/Mesenchymal): -0.0700",
    "mutant_lines_sample": [
      "ESS1",
      "ESS1",
      "ESS1"
    ],
    "summary": "DMXL2 mutation shows synthetic lethality with STK17A. Effect size: -0.035 (p=0.0000). Tested in 3 mutant lines vs 2082 wild-type lines. Most dependent mutant line: ESS1 (Uterine Sarcoma/Mesenchymal): -0.0700"
  },
  {
    "mutation": "DMXL2",
    "target_gene": "TBK1",
    "n_mutant_lines": 3,
    "n_wt_lines": 2082,
    "mutant_mean_score": -0.0819,
    "wt_mean_score": -0.0164,
    "effect_size": -0.0655,
    "p_value": 2.251050739300283e-102,
    "is_significant": true,
    "most_dependent_line": "ESS1 (Uterine Sarcoma/Mesenchymal): -0.0819",
    "mutant_lines_sample": [
      "ESS1",
      "ESS1",
      "ESS1"
    ],
    "summary": "DMXL2 mutation shows synthetic lethality with TBK1. Effect size: -0.066 (p=0.0000). Tested in 3 mutant lines vs 2082 wild-type lines. Most dependent mutant line: ESS1 (Uterine Sarcoma/Mesenchymal): -0.0819"
  },
  {
    "mutation": "DMXL2",
    "target_gene": "CLK4",
    "n_mutant_lines": 3,
    "n_wt_lines": 2082,
    "mutant_mean_score": -0.0577,
    "wt_mean_score": -0.0361,
    "effect_size": -0.0216,
    "p_value": 1.881744827651089e-16,
    "is_significant": true,
    "most_dependent_line": "ESS1 (Uterine Sarcoma/Mesenchymal): -0.0577",
    "mutant_lines_sample": [
      "ESS1",
      "ESS1",
      "ESS1"
    ],
    "summary": "DMXL2 mutation shows synthetic lethality with CLK4. Effect size: -0.022 (p=0.0000). Tested in 3 mutant lines vs 2082 wild-type lines. Most dependent mutant line: ESS1 (Uterine Sarcoma/Mesenchymal): -0.0577"
  },
  {
    "mutation": "MAP2K1",
    "target_gene": "STK17A",
    "n_mutant_lines": 16,
    "n_wt_lines": 2069,
    "mutant_mean_score": -0.1658,
    "wt_mean_score": -0.0344,
    "effect_size": -0.1314,
    "p_value": 0.0038560015450462,
    "is_significant": true,
    "most_dependent_line": "SCC3 (Non-Hodgkin Lymphoma): -0.4580",
    "mutant_lines_sample": [
      "OCUM1",
      "OCUM1",
      "OCUM1",
      "SCC3",
      "SCC3"
    ],
    "summary": "MAP2K1 mutation shows synthetic lethality with STK17A. Effect size: -0.131 (p=0.0039). Tested in 16 mutant lines vs 2069 wild-type lines. Most dependent mutant line: SCC3 (Non-Hodgkin Lymphoma): -0.4580"
  },
  {
    "mutation": "MAP2K1",
    "target_gene": "MYLK4",
    "n_mutant_lines": 16,
    "n_wt_lines": 2069,
    "mutant_mean_score": 0.0124,
    "wt_mean_score": 0.0808,
    "effect_size": -0.0684,
    "p_value": 0.1072020833167187,
    "is_significant": true,
    "most_dependent_line": "OCUM1 (Esophagogastric Adenocarcinoma): -0.2684",
    "mutant_lines_sample": [
      "OCUM1",
      "OCUM1",
      "OCUM1",
      "SCC3",
      "SCC3"
    ],
    "summary": "MAP2K1 mutation shows synthetic lethality with MYLK4. Effect size: -0.068 (p=0.1072). Tested in 16 mutant lines vs 2069 wild-type lines. Most dependent mutant line: OCUM1 (Esophagogastric Adenocarcinoma): -0.2684"
  },
  {
    "mutation": "MAP2K1",
    "target_gene": "CLK4",
    "n_mutant_lines": 16,
    "n_wt_lines": 2069,
    "mutant_mean_score": -0.1282,
    "wt_mean_score": -0.0354,
    "effect_size": -0.0928,
    "p_value": 0.0536865281554843,
    "is_significant": true,
    "most_dependent_line": "SCC3 (Non-Hodgkin Lymphoma): -0.4591",
    "mutant_lines_sample": [
      "OCUM1",
      "OCUM1",
      "OCUM1",
      "SCC3",
      "SCC3"
    ],
    "summary": "MAP2K1 mutation shows synthetic lethality with CLK4. Effect size: -0.093 (p=0.0537). Tested in 16 mutant lines vs 2069 wild-type lines. Most dependent mutant line: SCC3 (Non-Hodgkin Lymphoma): -0.4591"
  },
  {
    "mutation": "BLM",
    "target_gene": "CLK4",
    "n_mutant_lines": 3,
    "n_wt_lines": 2082,
    "mutant_mean_score": -0.1264,
    "wt_mean_score": -0.036,
    "effect_size": -0.0904,
    "p_value": 0.0445447810846919,
    "is_significant": true,
    "most_dependent_line": "PACADD137 (Pancreatic Adenocarcinoma): -0.1669",
    "mutant_lines_sample": [
      "DKMG",
      "DKMG",
      "PACADD137"
    ],
    "summary": "BLM mutation shows synthetic lethality with CLK4. Effect size: -0.090 (p=0.0445). Tested in 3 mutant lines vs 2082 wild-type lines. Most dependent mutant line: PACADD137 (Pancreatic Adenocarcinoma): -0.1669"
  },
  {
    "mutation": "RAB40C",
    "target_gene": "STK17A",
    "n_mutant_lines": 3,
    "n_wt_lines": 2082,
    "mutant_mean_score": -0.1353,
    "wt_mean_score": -0.0352,
    "effect_size": -0.1001,
    "p_value": 0.2463007980616487,
    "is_significant": true,
    "most_dependent_line": "JURKAT (T-Lymphoblastic Leukemia/Lymphoma): -0.1971",
    "mutant_lines_sample": [
      "JURKAT",
      "JURKAT",
      "PACADD137"
    ],
    "summary": "RAB40C mutation shows synthetic lethality with STK17A. Effect size: -0.100 (p=0.2463). Tested in 3 mutant lines vs 2082 wild-type lines. Most dependent mutant line: JURKAT (T-Lymphoblastic Leukemia/Lymphoma): -0.1971"
  },
  {
    "mutation": "RAB40C",
    "target_gene": "CLK4",
    "n_mutant_lines": 3,
    "n_wt_lines": 2082,
    "mutant_mean_score": -0.1135,
    "wt_mean_score": -0.036,
    "effect_size": -0.0775,
    "p_value": 0.0994297410565001,
    "is_significant": true,
    "most_dependent_line": "PACADD137 (Pancreatic Adenocarcinoma): -0.1669",
    "mutant_lines_sample": [
      "JURKAT",
      "JURKAT",
      "PACADD137"
    ],
    "summary": "RAB40C mutation shows synthetic lethality with CLK4. Effect size: -0.077 (p=0.0994). Tested in 3 mutant lines vs 2082 wild-type lines. Most dependent mutant line: PACADD137 (Pancreatic Adenocarcinoma): -0.1669"
  },
  {
    "mutation": "TSC2",
    "target_gene": "TBK1",
    "n_mutant_lines": 4,
    "n_wt_lines": 2079,
    "mutant_mean_score": -0.0244,
    "wt_mean_score": -0.0164,
    "effect_size": -0.008,
    "p_value": 0.8566950237635094,
    "is_significant": true,
    "most_dependent_line": "SKUT1 (Uterine Sarcoma/Mesenchymal): -0.0949",
    "mutant_lines_sample": [
      "SKUT1",
      "SKUT1",
      "MFE319",
      "MFE319"
    ],
    "summary": "TSC2 mutation shows synthetic lethality with TBK1. Effect size: -0.008 (p=0.8567). Tested in 4 mutant lines vs 2079 wild-type lines. Most dependent mutant line: SKUT1 (Uterine Sarcoma/Mesenchymal): -0.0949"
  },
  {
    "mutation": "CREBBP",
    "target_gene": "TBK1",
    "n_mutant_lines": 10,
    "n_wt_lines": 2075,
    "mutant_mean_score": -0.0618,
    "wt_mean_score": -0.0162,
    "effect_size": -0.0456,
    "p_value": 0.5473101766270052,
    "is_significant": true,
    "most_dependent_line": "SNU81 (Colorectal Adenocarcinoma): -0.6411",
    "mutant_lines_sample": [
      "SNGM",
      "RI1",
      "NCIH1703",
      "NCIH1703",
      "TO14"
    ],
    "summary": "CREBBP mutation shows synthetic lethality with TBK1. Effect size: -0.046 (p=0.5473). Tested in 10 mutant lines vs 2075 wild-type lines. Most dependent mutant line: SNU81 (Colorectal Adenocarcinoma): -0.6411"
  },
  {
    "mutation": "DNAH3",
    "target_gene": "TBK1",
    "n_mutant_lines": 5,
    "n_wt_lines": 2080,
    "mutant_mean_score": -0.1035,
    "wt_mean_score": -0.0162,
    "effect_size": -0.0873,
    "p_value": 0.0986781630583737,
    "is_significant": true,
    "most_dependent_line": "HCC2998 (Colorectal Adenocarcinoma): -0.2532",
    "mutant_lines_sample": [
      "HCC2998",
      "INA6",
      "JHUEM7",
      "MDST8",
      "MDST8"
    ],
    "summary": "DNAH3 mutation shows synthetic lethality with TBK1. Effect size: -0.087 (p=0.0987). Tested in 5 mutant lines vs 2080 wild-type lines. Most dependent mutant line: HCC2998 (Colorectal Adenocarcinoma): -0.2532"
  },
  {
    "mutation": "CENPN",
    "target_gene": "MYLK4",
    "n_mutant_lines": 4,
    "n_wt_lines": 2081,
    "mutant_mean_score": 0.0664,
    "wt_mean_score": 0.0803,
    "effect_size": -0.0139,
    "p_value": 0.7707749295194776,
    "is_significant": true,
    "most_dependent_line": "HEC251 (Endometrial Carcinoma): -0.0088",
    "mutant_lines_sample": [
      "HCC2998",
      "HEC251",
      "HEC251",
      "JHUEM7"
    ],
    "summary": "CENPN mutation shows synthetic lethality with MYLK4. Effect size: -0.014 (p=0.7708). Tested in 4 mutant lines vs 2081 wild-type lines. Most dependent mutant line: HEC251 (Endometrial Carcinoma): -0.0088"
  },
  {
    "mutation": "CENPN",
    "target_gene": "TBK1",
    "n_mutant_lines": 4,
    "n_wt_lines": 2081,
    "mutant_mean_score": -0.1255,
    "wt_mean_score": -0.0162,
    "effect_size": -0.1092,
    "p_value": 0.0826210195171068,
    "is_significant": true,
    "most_dependent_line": "HCC2998 (Colorectal Adenocarcinoma): -0.2532",
    "mutant_lines_sample": [
      "HCC2998",
      "HEC251",
      "HEC251",
      "JHUEM7"
    ],
    "summary": "CENPN mutation shows synthetic lethality with TBK1. Effect size: -0.109 (p=0.0826). Tested in 4 mutant lines vs 2081 wild-type lines. Most dependent mutant line: HCC2998 (Colorectal Adenocarcinoma): -0.2532"
  },
  {
    "mutation": "GSE1",
    "target_gene": "MYLK4",
    "n_mutant_lines": 3,
    "n_wt_lines": 2082,
    "mutant_mean_score": 0.0664,
    "wt_mean_score": 0.0803,
    "effect_size": -0.0139,
    "p_value": 0.0737203963635247,
    "is_significant": true,
    "most_dependent_line": "HCC2450 (Non-Small Cell Lung Cancer): 0.0617",
    "mutant_lines_sample": [
      "MDAMB361",
      "HCC2450",
      "HCC2450"
    ],
    "summary": "GSE1 mutation shows synthetic lethality with MYLK4. Effect size: -0.014 (p=0.0737). Tested in 3 mutant lines vs 2082 wild-type lines. Most dependent mutant line: HCC2450 (Non-Small Cell Lung Cancer): 0.0617"
  },
  {
    "mutation": "TP53",
    "target_gene": "STK17A",
    "n_mutant_lines": 161,
    "n_wt_lines": 1048,
    "mutant_mean_score": -0.0413,
    "wt_mean_score": -0.039,
    "effect_size": -0.0023,
    "p_value": 0.8097040260947791,
    "is_significant": true,
    "most_dependent_line": "SET2 (Acute Myeloid Leukemia): -0.3429",
    "mutant_lines_sample": [
      "G401",
      "SNU182",
      "KYSE30",
      "KYSE30",
      "KYSE70"
    ],
    "summary": "TP53 mutation shows synthetic lethality with STK17A. Effect size: -0.002 (p=0.8097). Tested in 161 mutant lines vs 1048 wild-type lines. Most dependent mutant line: SET2 (Acute Myeloid Leukemia): -0.3429"
  },
  {
    "mutation": "NF1",
    "target_gene": "MYLK4",
    "n_mutant_lines": 11,
    "n_wt_lines": 2062,
    "mutant_mean_score": 0.0498,
    "wt_mean_score": 0.08,
    "effect_size": -0.0303,
    "p_value": 0.347899739804781,
    "is_significant": true,
    "most_dependent_line": "HEC151 (Endometrial Carcinoma): -0.0811",
    "mutant_lines_sample": [
      "JHUEM1",
      "GB1",
      "NCCMPNST3C1",
      "KPNYN",
      "SNU81"
    ],
    "summary": "NF1 mutation shows synthetic lethality with MYLK4. Effect size: -0.030 (p=0.3479). Tested in 11 mutant lines vs 2062 wild-type lines. Most dependent mutant line: HEC151 (Endometrial Carcinoma): -0.0811"
  },
  {
    "mutation": "NF1",
    "target_gene": "TBK1",
    "n_mutant_lines": 11,
    "n_wt_lines": 2062,
    "mutant_mean_score": -0.0561,
    "wt_mean_score": -0.0163,
    "effect_size": -0.0399,
    "p_value": 0.5371925539246891,
    "is_significant": true,
    "most_dependent_line": "SNU81 (Colorectal Adenocarcinoma): -0.6411",
    "mutant_lines_sample": [
      "JHUEM1",
      "GB1",
      "NCCMPNST3C1",
      "KPNYN",
      "SNU81"
    ],
    "summary": "NF1 mutation shows synthetic lethality with TBK1. Effect size: -0.040 (p=0.5372). Tested in 11 mutant lines vs 2062 wild-type lines. Most dependent mutant line: SNU81 (Colorectal Adenocarcinoma): -0.6411"
  },
  {
    "mutation": "ERBB2",
    "target_gene": "STK17A",
    "n_mutant_lines": 17,
    "n_wt_lines": 2066,
    "mutant_mean_score": -0.0544,
    "wt_mean_score": -0.0352,
    "effect_size": -0.0192,
    "p_value": 0.4555177609991498,
    "is_significant": true,
    "most_dependent_line": "JVE187 (Colorectal Adenocarcinoma): -0.3675",
    "mutant_lines_sample": [
      "HEC1B",
      "HEC1B",
      "LN229 (UMF-815H) (UMF-815H)",
      "LN229 (UMF-815H) (UMF-815H)",
      "OACM51"
    ],
    "summary": "ERBB2 mutation shows synthetic lethality with STK17A. Effect size: -0.019 (p=0.4555). Tested in 17 mutant lines vs 2066 wild-type lines. Most dependent mutant line: JVE187 (Colorectal Adenocarcinoma): -0.3675"
  },
  {
    "mutation": "ERBB2",
    "target_gene": "CLK4",
    "n_mutant_lines": 17,
    "n_wt_lines": 2066,
    "mutant_mean_score": -0.0372,
    "wt_mean_score": -0.0361,
    "effect_size": -0.001,
    "p_value": 0.9760115852769088,
    "is_significant": true,
    "most_dependent_line": "JVE187 (Colorectal Adenocarcinoma): -0.3310",
    "mutant_lines_sample": [
      "HEC1B",
      "HEC1B",
      "LN229 (UMF-815H) (UMF-815H)",
      "LN229 (UMF-815H) (UMF-815H)",
      "OACM51"
    ],
    "summary": "ERBB2 mutation shows synthetic lethality with CLK4. Effect size: -0.001 (p=0.9760). Tested in 17 mutant lines vs 2066 wild-type lines. Most dependent mutant line: JVE187 (Colorectal Adenocarcinoma): -0.3310"
  },
  {
    "mutation": "BRCA1",
    "target_gene": "STK17A",
    "n_mutant_lines": 4,
    "n_wt_lines": 2078,
    "mutant_mean_score": -0.1332,
    "wt_mean_score": -0.0351,
    "effect_size": -0.0981,
    "p_value": 0.0207684932102426,
    "is_significant": true,
    "most_dependent_line": "SNU668 (Esophagogastric Adenocarcinoma): -0.1718",
    "mutant_lines_sample": [
      "SNU668",
      "SNU668",
      "HT115",
      "HT115"
    ],
    "summary": "BRCA1 mutation shows synthetic lethality with STK17A. Effect size: -0.098 (p=0.0208). Tested in 4 mutant lines vs 2078 wild-type lines. Most dependent mutant line: SNU668 (Esophagogastric Adenocarcinoma): -0.1718"
  },
  {
    "mutation": "BRCA1",
    "target_gene": "MYLK4",
    "n_mutant_lines": 4,
    "n_wt_lines": 2078,
    "mutant_mean_score": 0.0702,
    "wt_mean_score": 0.0803,
    "effect_size": -0.0101,
    "p_value": 0.9403808461187698,
    "is_significant": true,
    "most_dependent_line": "SNU668 (Esophagogastric Adenocarcinoma): -0.1458",
    "mutant_lines_sample": [
      "SNU668",
      "SNU668",
      "HT115",
      "HT115"
    ],
    "summary": "BRCA1 mutation shows synthetic lethality with MYLK4. Effect size: -0.010 (p=0.9404). Tested in 4 mutant lines vs 2078 wild-type lines. Most dependent mutant line: SNU668 (Esophagogastric Adenocarcinoma): -0.1458"
  },
  {
    "mutation": "BRCA1",
    "target_gene": "TBK1",
    "n_mutant_lines": 4,
    "n_wt_lines": 2078,
    "mutant_mean_score": -0.1532,
    "wt_mean_score": -0.0161,
    "effect_size": -0.1371,
    "p_value": 0.0,
    "is_significant": true,
    "most_dependent_line": "HT115 (Colorectal Adenocarcinoma): -0.1534",
    "mutant_lines_sample": [
      "SNU668",
      "SNU668",
      "HT115",
      "HT115"
    ],
    "summary": "BRCA1 mutation shows synthetic lethality with TBK1. Effect size: -0.137 (p=0.0000). Tested in 4 mutant lines vs 2078 wild-type lines. Most dependent mutant line: HT115 (Colorectal Adenocarcinoma): -0.1534"
  },
  {
    "mutation": "SPOP",
    "target_gene": "STK17A",
    "n_mutant_lines": 3,
    "n_wt_lines": 2082,
    "mutant_mean_score": -0.1304,
    "wt_mean_score": -0.0352,
    "effect_size": -0.0952,
    "p_value": 1.1451100251099372e-199,
    "is_significant": true,
    "most_dependent_line": "PATU8902 (Pancreatic Adenocarcinoma): -0.1304",
    "mutant_lines_sample": [
      "PATU8902",
      "PATU8902",
      "PATU8902"
    ],
    "summary": "SPOP mutation shows synthetic lethality with STK17A. Effect size: -0.095 (p=0.0000). Tested in 3 mutant lines vs 2082 wild-type lines. Most dependent mutant line: PATU8902 (Pancreatic Adenocarcinoma): -0.1304"
  },
  {
    "mutation": "ANKRD40",
    "target_gene": "STK17A",
    "n_mutant_lines": 7,
    "n_wt_lines": 2078,
    "mutant_mean_score": -0.0454,
    "wt_mean_score": -0.0353,
    "effect_size": -0.01,
    "p_value": 0.7297521245132796,
    "is_significant": true,
    "most_dependent_line": "SKMEL2 (Melanoma): -0.1245",
    "mutant_lines_sample": [
      "HEYA8",
      "HEYA8",
      "HUNS1",
      "SKMEL2",
      "SKMEL2"
    ],
    "summary": "ANKRD40 mutation shows synthetic lethality with STK17A. Effect size: -0.010 (p=0.7298). Tested in 7 mutant lines vs 2078 wild-type lines. Most dependent mutant line: SKMEL2 (Melanoma): -0.1245"
  },
  {
    "mutation": "ANKRD40",
    "target_gene": "TBK1",
    "n_mutant_lines": 7,
    "n_wt_lines": 2078,
    "mutant_mean_score": -0.0676,
    "wt_mean_score": -0.0163,
    "effect_size": -0.0513,
    "p_value": 0.3597760734761951,
    "is_significant": true,
    "most_dependent_line": "HEY (Ovarian Epithelial Tumor): -0.3258",
    "mutant_lines_sample": [
      "HEYA8",
      "HEYA8",
      "HUNS1",
      "SKMEL2",
      "SKMEL2"
    ],
    "summary": "ANKRD40 mutation shows synthetic lethality with TBK1. Effect size: -0.051 (p=0.3598). Tested in 7 mutant lines vs 2078 wild-type lines. Most dependent mutant line: HEY (Ovarian Epithelial Tumor): -0.3258"
  },
  {
    "mutation": "HEATR6",
    "target_gene": "MYLK4",
    "n_mutant_lines": 3,
    "n_wt_lines": 2082,
    "mutant_mean_score": 0.0379,
    "wt_mean_score": 0.0804,
    "effect_size": -0.0424,
    "p_value": 0.4598601083568269,
    "is_significant": true,
    "most_dependent_line": "HEC251 (Endometrial Carcinoma): -0.0088",
    "mutant_lines_sample": [
      "HEC251",
      "HEC251",
      "JHUEM7"
    ],
    "summary": "HEATR6 mutation shows synthetic lethality with MYLK4. Effect size: -0.042 (p=0.4599). Tested in 3 mutant lines vs 2082 wild-type lines. Most dependent mutant line: HEC251 (Endometrial Carcinoma): -0.0088"
  },
  {
    "mutation": "HEATR6",
    "target_gene": "TBK1",
    "n_mutant_lines": 3,
    "n_wt_lines": 2082,
    "mutant_mean_score": -0.0829,
    "wt_mean_score": -0.0164,
    "effect_size": -0.0665,
    "p_value": 1.0670428005765751e-11,
    "is_significant": true,
    "most_dependent_line": "JHUEM7 (Endometrial Carcinoma): -0.0873",
    "mutant_lines_sample": [
      "HEC251",
      "HEC251",
      "JHUEM7"
    ],
    "summary": "HEATR6 mutation shows synthetic lethality with TBK1. Effect size: -0.067 (p=0.0000). Tested in 3 mutant lines vs 2082 wild-type lines. Most dependent mutant line: JHUEM7 (Endometrial Carcinoma): -0.0873"
  },
  {
    "mutation": "SMAD2",
    "target_gene": "STK17A",
    "n_mutant_lines": 4,
    "n_wt_lines": 2080,
    "mutant_mean_score": -0.112,
    "wt_mean_score": -0.0352,
    "effect_size": -0.0768,
    "p_value": 0.0652783097847126,
    "is_significant": true,
    "most_dependent_line": "SNU81 (Colorectal Adenocarcinoma): -0.1911",
    "mutant_lines_sample": [
      "HCC2998",
      "HT115",
      "HT115",
      "SNU81"
    ],
    "summary": "SMAD2 mutation shows synthetic lethality with STK17A. Effect size: -0.077 (p=0.0653). Tested in 4 mutant lines vs 2080 wild-type lines. Most dependent mutant line: SNU81 (Colorectal Adenocarcinoma): -0.1911"
  },
  {
    "mutation": "SMAD2",
    "target_gene": "TBK1",
    "n_mutant_lines": 4,
    "n_wt_lines": 2080,
    "mutant_mean_score": -0.3003,
    "wt_mean_score": -0.016,
    "effect_size": -0.2843,
    "p_value": 0.0915603921017058,
    "is_significant": true,
    "most_dependent_line": "SNU81 (Colorectal Adenocarcinoma): -0.6411",
    "mutant_lines_sample": [
      "HCC2998",
      "HT115",
      "HT115",
      "SNU81"
    ],
    "summary": "SMAD2 mutation shows synthetic lethality with TBK1. Effect size: -0.284 (p=0.0916). Tested in 4 mutant lines vs 2080 wild-type lines. Most dependent mutant line: SNU81 (Colorectal Adenocarcinoma): -0.6411"
  },
  {
    "mutation": "SMAD4",
    "target_gene": "CLK4",
    "n_mutant_lines": 10,
    "n_wt_lines": 2044,
    "mutant_mean_score": -0.0942,
    "wt_mean_score": -0.0357,
    "effect_size": -0.0585,
    "p_value": 0.115424066180339,
    "is_significant": true,
    "most_dependent_line": "AU565 (Invasive Breast Carcinoma): -0.2372",
    "mutant_lines_sample": [
      "SNU1",
      "SNU1",
      "HUG1N",
      "A253",
      "NZM3"
    ],
    "summary": "SMAD4 mutation shows synthetic lethality with CLK4. Effect size: -0.059 (p=0.1154). Tested in 10 mutant lines vs 2044 wild-type lines. Most dependent mutant line: AU565 (Invasive Breast Carcinoma): -0.2372"
  },
  {
    "mutation": "CIRBP",
    "target_gene": "STK17A",
    "n_mutant_lines": 3,
    "n_wt_lines": 2082,
    "mutant_mean_score": -0.0684,
    "wt_mean_score": -0.0353,
    "effect_size": -0.0331,
    "p_value": 0.8645420880196375,
    "is_significant": true,
    "most_dependent_line": "LS123 (Colorectal Adenocarcinoma): -0.3764",
    "mutant_lines_sample": [
      "LS123",
      "HCT15 (UMF-815H (UMF-815H (UMF-815H (UMF-815H",
      "UMF-815K)",
      "UMF-815K)",
      "UMF-815K)"
    ],
    "summary": "CIRBP mutation shows synthetic lethality with STK17A. Effect size: -0.033 (p=0.8645). Tested in 3 mutant lines vs 2082 wild-type lines. Most dependent mutant line: LS123 (Colorectal Adenocarcinoma): -0.3764"
  },
  {
    "mutation": "CIRBP",
    "target_gene": "MYLK4",
    "n_mutant_lines": 3,
    "n_wt_lines": 2082,
    "mutant_mean_score": 0.0457,
    "wt_mean_score": 0.0803,
    "effect_size": -0.0346,
    "p_value": 0.6018205024442865,
    "is_significant": true,
    "most_dependent_line": "LS1034 (Colorectal Adenocarcinoma): -0.0558",
    "mutant_lines_sample": [
      "LS123",
      "HCT15 (UMF-815H (UMF-815H (UMF-815H (UMF-815H",
      "UMF-815K)",
      "UMF-815K)",
      "UMF-815K)"
    ],
    "summary": "CIRBP mutation shows synthetic lethality with MYLK4. Effect size: -0.035 (p=0.6018). Tested in 3 mutant lines vs 2082 wild-type lines. Most dependent mutant line: LS1034 (Colorectal Adenocarcinoma): -0.0558"
  },
  {
    "mutation": "CIRBP",
    "target_gene": "TBK1",
    "n_mutant_lines": 3,
    "n_wt_lines": 2082,
    "mutant_mean_score": -0.0354,
    "wt_mean_score": -0.0164,
    "effect_size": -0.019,
    "p_value": 0.9125966813328794,
    "is_significant": true,
    "most_dependent_line": "HCT15 (Colorectal Adenocarcinoma): -0.3413",
    "mutant_lines_sample": [
      "LS123",
      "HCT15 (UMF-815H (UMF-815H (UMF-815H (UMF-815H",
      "UMF-815K)",
      "UMF-815K)",
      "UMF-815K)"
    ],
    "summary": "CIRBP mutation shows synthetic lethality with TBK1. Effect size: -0.019 (p=0.9126). Tested in 3 mutant lines vs 2082 wild-type lines. Most dependent mutant line: HCT15 (Colorectal Adenocarcinoma): -0.3413"
  },
  {
    "mutation": "KEAP1",
    "target_gene": "STK17A",
    "n_mutant_lines": 4,
    "n_wt_lines": 2073,
    "mutant_mean_score": -0.04,
    "wt_mean_score": -0.0355,
    "effect_size": -0.0045,
    "p_value": 0.7255218978989981,
    "is_significant": true,
    "most_dependent_line": "LPS853 (Liposarcoma): -0.0592",
    "mutant_lines_sample": [
      "LPS853",
      "LPS853",
      "BICR10",
      "NCIH1944"
    ],
    "summary": "KEAP1 mutation shows synthetic lethality with STK17A. Effect size: -0.004 (p=0.7255). Tested in 4 mutant lines vs 2073 wild-type lines. Most dependent mutant line: LPS853 (Liposarcoma): -0.0592"
  },
  {
    "mutation": "KEAP1",
    "target_gene": "CLK4",
    "n_mutant_lines": 4,
    "n_wt_lines": 2073,
    "mutant_mean_score": -0.0372,
    "wt_mean_score": -0.0363,
    "effect_size": -0.0009,
    "p_value": 0.984300378048792,
    "is_significant": true,
    "most_dependent_line": "BICR10 (Head and Neck Squamous Cell Carcinoma): -0.0866",
    "mutant_lines_sample": [
      "LPS853",
      "LPS853",
      "BICR10",
      "NCIH1944"
    ],
    "summary": "KEAP1 mutation shows synthetic lethality with CLK4. Effect size: -0.001 (p=0.9843). Tested in 4 mutant lines vs 2073 wild-type lines. Most dependent mutant line: BICR10 (Head and Neck Squamous Cell Carcinoma): -0.0866"
  },
  {
    "mutation": "SMARCA4",
    "target_gene": "STK17A",
    "n_mutant_lines": 16,
    "n_wt_lines": 2061,
    "mutant_mean_score": -0.073,
    "wt_mean_score": -0.0341,
    "effect_size": -0.0389,
    "p_value": 0.1006311736818297,
    "is_significant": true,
    "most_dependent_line": "JURKAT (T-Lymphoblastic Leukemia/Lymphoma): -0.1971",
    "mutant_lines_sample": [
      "EOL1",
      "C4II",
      "LPS141",
      "LPS141",
      "LS513"
    ],
    "summary": "SMARCA4 mutation shows synthetic lethality with STK17A. Effect size: -0.039 (p=0.1006). Tested in 16 mutant lines vs 2061 wild-type lines. Most dependent mutant line: JURKAT (T-Lymphoblastic Leukemia/Lymphoma): -0.1971"
  },
  {
    "mutation": "ZNF823",
    "target_gene": "STK17A",
    "n_mutant_lines": 4,
    "n_wt_lines": 2081,
    "mutant_mean_score": -0.0399,
    "wt_mean_score": -0.0354,
    "effect_size": -0.0045,
    "p_value": 0.8907171279855464,
    "is_significant": true,
    "most_dependent_line": "ESS1 (Uterine Sarcoma/Mesenchymal): -0.0700",
    "mutant_lines_sample": [
      "ESS1",
      "ESS1",
      "ESS1",
      "HEC251"
    ],
    "summary": "ZNF823 mutation shows synthetic lethality with STK17A. Effect size: -0.004 (p=0.8907). Tested in 4 mutant lines vs 2081 wild-type lines. Most dependent mutant line: ESS1 (Uterine Sarcoma/Mesenchymal): -0.0700"
  },
  {
    "mutation": "ZNF823",
    "target_gene": "TBK1",
    "n_mutant_lines": 4,
    "n_wt_lines": 2081,
    "mutant_mean_score": -0.0816,
    "wt_mean_score": -0.0163,
    "effect_size": -0.0652,
    "p_value": 2.855504533624858e-100,
    "is_significant": true,
    "most_dependent_line": "ESS1 (Uterine Sarcoma/Mesenchymal): -0.0819",
    "mutant_lines_sample": [
      "ESS1",
      "ESS1",
      "ESS1",
      "HEC251"
    ],
    "summary": "ZNF823 mutation shows synthetic lethality with TBK1. Effect size: -0.065 (p=0.0000). Tested in 4 mutant lines vs 2081 wild-type lines. Most dependent mutant line: ESS1 (Uterine Sarcoma/Mesenchymal): -0.0819"
  },
  {
    "mutation": "NWD1",
    "target_gene": "STK17A",
    "n_mutant_lines": 3,
    "n_wt_lines": 2082,
    "mutant_mean_score": -0.0954,
    "wt_mean_score": -0.0353,
    "effect_size": -0.0602,
    "p_value": 0.2798812479688837,
    "is_significant": true,
    "most_dependent_line": "SH4 (Melanoma): -0.1364",
    "mutant_lines_sample": [
      "SH4",
      "SH4",
      "BICR10"
    ],
    "summary": "NWD1 mutation shows synthetic lethality with STK17A. Effect size: -0.060 (p=0.2799). Tested in 3 mutant lines vs 2082 wild-type lines. Most dependent mutant line: SH4 (Melanoma): -0.1364"
  },
  {
    "mutation": "NWD1",
    "target_gene": "CLK4",
    "n_mutant_lines": 3,
    "n_wt_lines": 2082,
    "mutant_mean_score": -0.0415,
    "wt_mean_score": -0.0361,
    "effect_size": -0.0054,
    "p_value": 0.8333370420221101,
    "is_significant": true,
    "most_dependent_line": "BICR10 (Head and Neck Squamous Cell Carcinoma): -0.0866",
    "mutant_lines_sample": [
      "SH4",
      "SH4",
      "BICR10"
    ],
    "summary": "NWD1 mutation shows synthetic lethality with CLK4. Effect size: -0.005 (p=0.8333). Tested in 3 mutant lines vs 2082 wild-type lines. Most dependent mutant line: BICR10 (Head and Neck Squamous Cell Carcinoma): -0.0866"
  },
  {
    "mutation": "ZNF14",
    "target_gene": "MYLK4",
    "n_mutant_lines": 3,
    "n_wt_lines": 2082,
    "mutant_mean_score": 0.0726,
    "wt_mean_score": 0.0803,
    "effect_size": -0.0077,
    "p_value": 0.932987717185548,
    "is_significant": true,
    "most_dependent_line": "HEC251 (Endometrial Carcinoma): -0.0088",
    "mutant_lines_sample": [
      "SNU81",
      "HEC251",
      "HEC251"
    ],
    "summary": "ZNF14 mutation shows synthetic lethality with MYLK4. Effect size: -0.008 (p=0.9330). Tested in 3 mutant lines vs 2082 wild-type lines. Most dependent mutant line: HEC251 (Endometrial Carcinoma): -0.0088"
  },
  {
    "mutation": "ZNF14",
    "target_gene": "TBK1",
    "n_mutant_lines": 3,
    "n_wt_lines": 2082,
    "mutant_mean_score": -0.2675,
    "wt_mean_score": -0.0161,
    "effect_size": -0.2514,
    "p_value": 0.3105922072239712,
    "is_significant": true,
    "most_dependent_line": "SNU81 (Colorectal Adenocarcinoma): -0.6411",
    "mutant_lines_sample": [
      "SNU81",
      "HEC251",
      "HEC251"
    ],
    "summary": "ZNF14 mutation shows synthetic lethality with TBK1. Effect size: -0.251 (p=0.3106). Tested in 3 mutant lines vs 2082 wild-type lines. Most dependent mutant line: SNU81 (Colorectal Adenocarcinoma): -0.6411"
  },
  {
    "mutation": "ZNF675",
    "target_gene": "TBK1",
    "n_mutant_lines": 4,
    "n_wt_lines": 2081,
    "mutant_mean_score": -0.0832,
    "wt_mean_score": -0.0163,
    "effect_size": -0.0669,
    "p_value": 2.3941294848581073e-36,
    "is_significant": true,
    "most_dependent_line": "JHUEM7 (Endometrial Carcinoma): -0.0873",
    "mutant_lines_sample": [
      "ESS1",
      "ESS1",
      "ESS1",
      "JHUEM7"
    ],
    "summary": "ZNF675 mutation shows synthetic lethality with TBK1. Effect size: -0.067 (p=0.0000). Tested in 4 mutant lines vs 2081 wild-type lines. Most dependent mutant line: JHUEM7 (Endometrial Carcinoma): -0.0873"
  },
  {
    "mutation": "ZNF254",
    "target_gene": "STK17A",
    "n_mutant_lines": 3,
    "n_wt_lines": 2082,
    "mutant_mean_score": -0.07,
    "wt_mean_score": -0.0353,
    "effect_size": -0.0347,
    "p_value": 1.515255507392311e-33,
    "is_significant": true,
    "most_dependent_line": "ESS1 (Uterine Sarcoma/Mesenchymal): -0.0700",
    "mutant_lines_sample": [
      "ESS1",
      "ESS1",
      "ESS1"
    ],
    "summary": "ZNF254 mutation shows synthetic lethality with STK17A. Effect size: -0.035 (p=0.0000). Tested in 3 mutant lines vs 2082 wild-type lines. Most dependent mutant line: ESS1 (Uterine Sarcoma/Mesenchymal): -0.0700"
  },
  {
    "mutation": "ZNF254",
    "target_gene": "TBK1",
    "n_mutant_lines": 3,
    "n_wt_lines": 2082,
    "mutant_mean_score": -0.0819,
    "wt_mean_score": -0.0164,
    "effect_size": -0.0655,
    "p_value": 2.251050739300283e-102,
    "is_significant": true,
    "most_dependent_line": "ESS1 (Uterine Sarcoma/Mesenchymal): -0.0819",
    "mutant_lines_sample": [
      "ESS1",
      "ESS1",
      "ESS1"
    ],
    "summary": "ZNF254 mutation shows synthetic lethality with TBK1. Effect size: -0.066 (p=0.0000). Tested in 3 mutant lines vs 2082 wild-type lines. Most dependent mutant line: ESS1 (Uterine Sarcoma/Mesenchymal): -0.0819"
  },
  {
    "mutation": "ZNF254",
    "target_gene": "CLK4",
    "n_mutant_lines": 3,
    "n_wt_lines": 2082,
    "mutant_mean_score": -0.0577,
    "wt_mean_score": -0.0361,
    "effect_size": -0.0216,
    "p_value": 1.881744827651089e-16,
    "is_significant": true,
    "most_dependent_line": "ESS1 (Uterine Sarcoma/Mesenchymal): -0.0577",
    "mutant_lines_sample": [
      "ESS1",
      "ESS1",
      "ESS1"
    ],
    "summary": "ZNF254 mutation shows synthetic lethality with CLK4. Effect size: -0.022 (p=0.0000). Tested in 3 mutant lines vs 2082 wild-type lines. Most dependent mutant line: ESS1 (Uterine Sarcoma/Mesenchymal): -0.0577"
  },
  {
    "mutation": "ZNF570",
    "target_gene": "TBK1",
    "n_mutant_lines": 5,
    "n_wt_lines": 2080,
    "mutant_mean_score": -0.0227,
    "wt_mean_score": -0.0164,
    "effect_size": -0.0063,
    "p_value": 0.8065207317815777,
    "is_significant": true,
    "most_dependent_line": "KOSC2 (Head and Neck Squamous Cell Carcinoma): -0.0618",
    "mutant_lines_sample": [
      "SUIT2",
      "SUIT2",
      "KOSC2",
      "KOSC2",
      "KOSC2"
    ],
    "summary": "ZNF570 mutation shows synthetic lethality with TBK1. Effect size: -0.006 (p=0.8065). Tested in 5 mutant lines vs 2080 wild-type lines. Most dependent mutant line: KOSC2 (Head and Neck Squamous Cell Carcinoma): -0.0618"
  },
  {
    "mutation": "ZNF570",
    "target_gene": "CLK4",
    "n_mutant_lines": 5,
    "n_wt_lines": 2080,
    "mutant_mean_score": -0.0839,
    "wt_mean_score": -0.036,
    "effect_size": -0.0479,
    "p_value": 0.1597497135246997,
    "is_significant": true,
    "most_dependent_line": "KOSC2 (Head and Neck Squamous Cell Carcinoma): -0.1293",
    "mutant_lines_sample": [
      "SUIT2",
      "SUIT2",
      "KOSC2",
      "KOSC2",
      "KOSC2"
    ],
    "summary": "ZNF570 mutation shows synthetic lethality with CLK4. Effect size: -0.048 (p=0.1597). Tested in 5 mutant lines vs 2080 wild-type lines. Most dependent mutant line: KOSC2 (Head and Neck Squamous Cell Carcinoma): -0.1293"
  },
  {
    "mutation": "ZC3H4",
    "target_gene": "STK17A",
    "n_mutant_lines": 6,
    "n_wt_lines": 2079,
    "mutant_mean_score": -0.0767,
    "wt_mean_score": -0.0352,
    "effect_size": -0.0415,
    "p_value": 0.486517379085938,
    "is_significant": true,
    "most_dependent_line": "JURKAT (T-Lymphoblastic Leukemia/Lymphoma): -0.1971",
    "mutant_lines_sample": [
      "OC316",
      "JURKAT",
      "JURKAT",
      "OC314",
      "HEC1"
    ],
    "summary": "ZC3H4 mutation shows synthetic lethality with STK17A. Effect size: -0.042 (p=0.4865). Tested in 6 mutant lines vs 2079 wild-type lines. Most dependent mutant line: JURKAT (T-Lymphoblastic Leukemia/Lymphoma): -0.1971"
  },
  {
    "mutation": "IRF3",
    "target_gene": "MYLK4",
    "n_mutant_lines": 3,
    "n_wt_lines": 2082,
    "mutant_mean_score": 0.0311,
    "wt_mean_score": 0.0804,
    "effect_size": -0.0493,
    "p_value": 0.4122231724190975,
    "is_significant": true,
    "most_dependent_line": "NO10 (Diffuse Glioma): -0.0625",
    "mutant_lines_sample": [
      "MCC142",
      "NO10",
      "MM576"
    ],
    "summary": "IRF3 mutation shows synthetic lethality with MYLK4. Effect size: -0.049 (p=0.4122). Tested in 3 mutant lines vs 2082 wild-type lines. Most dependent mutant line: NO10 (Diffuse Glioma): -0.0625"
  },
  {
    "mutation": "IRF3",
    "target_gene": "CLK4",
    "n_mutant_lines": 3,
    "n_wt_lines": 2082,
    "mutant_mean_score": -0.1087,
    "wt_mean_score": -0.036,
    "effect_size": -0.0727,
    "p_value": 0.3718200291042302,
    "is_significant": true,
    "most_dependent_line": "MM576 (Melanoma): -0.2212",
    "mutant_lines_sample": [
      "MCC142",
      "NO10",
      "MM576"
    ],
    "summary": "IRF3 mutation shows synthetic lethality with CLK4. Effect size: -0.073 (p=0.3718). Tested in 3 mutant lines vs 2082 wild-type lines. Most dependent mutant line: MM576 (Melanoma): -0.2212"
  },
  {
    "mutation": "PPP2R1A",
    "target_gene": "TBK1",
    "n_mutant_lines": 9,
    "n_wt_lines": 2074,
    "mutant_mean_score": -0.1031,
    "wt_mean_score": -0.0161,
    "effect_size": -0.0869,
    "p_value": 0.0140867987114084,
    "is_significant": true,
    "most_dependent_line": "HCT116 (Colorectal Adenocarcinoma): -0.2235",
    "mutant_lines_sample": [
      "JHUEM1",
      "OVTOKO",
      "OVTOKO",
      "OVTOKO",
      "OVISE"
    ],
    "summary": "PPP2R1A mutation shows synthetic lethality with TBK1. Effect size: -0.087 (p=0.0141). Tested in 9 mutant lines vs 2074 wild-type lines. Most dependent mutant line: HCT116 (Colorectal Adenocarcinoma): -0.2235"
  },
  {
    "mutation": "PPP2R1A",
    "target_gene": "CLK4",
    "n_mutant_lines": 9,
    "n_wt_lines": 2074,
    "mutant_mean_score": -0.0692,
    "wt_mean_score": -0.036,
    "effect_size": -0.0332,
    "p_value": 3.6586759550908856e-32,
    "is_significant": true,
    "most_dependent_line": "JHUEM1 (Endometrial Carcinoma): -0.0747",
    "mutant_lines_sample": [
      "JHUEM1",
      "OVTOKO",
      "OVTOKO",
      "OVTOKO",
      "OVISE"
    ],
    "summary": "PPP2R1A mutation shows synthetic lethality with CLK4. Effect size: -0.033 (p=0.0000). Tested in 9 mutant lines vs 2074 wild-type lines. Most dependent mutant line: JHUEM1 (Endometrial Carcinoma): -0.0747"
  },
  {
    "mutation": "NLRP11",
    "target_gene": "STK17A",
    "n_mutant_lines": 5,
    "n_wt_lines": 2080,
    "mutant_mean_score": -0.0443,
    "wt_mean_score": -0.0353,
    "effect_size": -0.0089,
    "p_value": 0.9143699834430834,
    "is_significant": true,
    "most_dependent_line": "IPC298 (Melanoma): -0.1983",
    "mutant_lines_sample": [
      "MCC13",
      "COLO792",
      "COLO792",
      "IPC298",
      "IPC298"
    ],
    "summary": "NLRP11 mutation shows synthetic lethality with STK17A. Effect size: -0.009 (p=0.9144). Tested in 5 mutant lines vs 2080 wild-type lines. Most dependent mutant line: IPC298 (Melanoma): -0.1983"
  },
  {
    "mutation": "NLRP11",
    "target_gene": "MYLK4",
    "n_mutant_lines": 5,
    "n_wt_lines": 2080,
    "mutant_mean_score": 0.0164,
    "wt_mean_score": 0.0805,
    "effect_size": -0.0641,
    "p_value": 0.0561108040620445,
    "is_significant": true,
    "most_dependent_line": "COLO792 (Melanoma): -0.0101",
    "mutant_lines_sample": [
      "MCC13",
      "COLO792",
      "COLO792",
      "IPC298",
      "IPC298"
    ],
    "summary": "NLRP11 mutation shows synthetic lethality with MYLK4. Effect size: -0.064 (p=0.0561). Tested in 5 mutant lines vs 2080 wild-type lines. Most dependent mutant line: COLO792 (Melanoma): -0.0101"
  },
  {
    "mutation": "NLRP11",
    "target_gene": "CLK4",
    "n_mutant_lines": 5,
    "n_wt_lines": 2080,
    "mutant_mean_score": -0.1005,
    "wt_mean_score": -0.036,
    "effect_size": -0.0645,
    "p_value": 0.2817479402592563,
    "is_significant": true,
    "most_dependent_line": "MCC13 (Merkel Cell Carcinoma): -0.2023",
    "mutant_lines_sample": [
      "MCC13",
      "COLO792",
      "COLO792",
      "IPC298",
      "IPC298"
    ],
    "summary": "NLRP11 mutation shows synthetic lethality with CLK4. Effect size: -0.065 (p=0.2817). Tested in 5 mutant lines vs 2080 wild-type lines. Most dependent mutant line: MCC13 (Merkel Cell Carcinoma): -0.2023"
  },
  {
    "mutation": "MBOAT2",
    "target_gene": "TBK1",
    "n_mutant_lines": 4,
    "n_wt_lines": 2081,
    "mutant_mean_score": -0.1171,
    "wt_mean_score": -0.0163,
    "effect_size": -0.1008,
    "p_value": 0.0161950987703379,
    "is_significant": true,
    "most_dependent_line": "HT115 (Colorectal Adenocarcinoma): -0.1534",
    "mutant_lines_sample": [
      "HT115",
      "HT115",
      "HEC251",
      "HEC251"
    ],
    "summary": "MBOAT2 mutation shows synthetic lethality with TBK1. Effect size: -0.101 (p=0.0162). Tested in 4 mutant lines vs 2081 wild-type lines. Most dependent mutant line: HT115 (Colorectal Adenocarcinoma): -0.1534"
  },
  {
    "mutation": "DNMT3A",
    "target_gene": "MYLK4",
    "n_mutant_lines": 5,
    "n_wt_lines": 2080,
    "mutant_mean_score": -0.091,
    "wt_mean_score": 0.0807,
    "effect_size": -0.1717,
    "p_value": 0.05773362680555,
    "is_significant": true,
    "most_dependent_line": "KO52 (Acute Myeloid Leukemia): -0.2280",
    "mutant_lines_sample": [
      "SET2",
      "OCIAML3",
      "OCIAML3",
      "KO52",
      "KO52"
    ],
    "summary": "DNMT3A mutation shows synthetic lethality with MYLK4. Effect size: -0.172 (p=0.0577). Tested in 5 mutant lines vs 2080 wild-type lines. Most dependent mutant line: KO52 (Acute Myeloid Leukemia): -0.2280"
  },
  {
    "mutation": "DNMT3A",
    "target_gene": "CLK4",
    "n_mutant_lines": 5,
    "n_wt_lines": 2080,
    "mutant_mean_score": -0.0686,
    "wt_mean_score": -0.036,
    "effect_size": -0.0325,
    "p_value": 0.7472770635783481,
    "is_significant": true,
    "most_dependent_line": "OCIAML3 (Acute Myeloid Leukemia): -0.2537",
    "mutant_lines_sample": [
      "SET2",
      "OCIAML3",
      "OCIAML3",
      "KO52",
      "KO52"
    ],
    "summary": "DNMT3A mutation shows synthetic lethality with CLK4. Effect size: -0.033 (p=0.7473). Tested in 5 mutant lines vs 2080 wild-type lines. Most dependent mutant line: OCIAML3 (Acute Myeloid Leukemia): -0.2537"
  },
  {
    "mutation": "ALK",
    "target_gene": "STK17A",
    "n_mutant_lines": 18,
    "n_wt_lines": 2067,
    "mutant_mean_score": -0.0419,
    "wt_mean_score": -0.0353,
    "effect_size": -0.0066,
    "p_value": 0.7645341106724359,
    "is_significant": true,
    "most_dependent_line": "MY (Acute Leukemias of Ambiguous Lineage): -0.1719",
    "mutant_lines_sample": [
      "SNU1",
      "SNU1",
      "TGW",
      "TGW",
      "TGW"
    ],
    "summary": "ALK mutation shows synthetic lethality with STK17A. Effect size: -0.007 (p=0.7645). Tested in 18 mutant lines vs 2067 wild-type lines. Most dependent mutant line: MY (Acute Leukemias of Ambiguous Lineage): -0.1719"
  },
  {
    "mutation": "ALK",
    "target_gene": "CLK4",
    "n_mutant_lines": 18,
    "n_wt_lines": 2067,
    "mutant_mean_score": -0.0607,
    "wt_mean_score": -0.0359,
    "effect_size": -0.0248,
    "p_value": 0.4419086851485541,
    "is_significant": true,
    "most_dependent_line": "NB1643 (Neuroblastoma): -0.2624",
    "mutant_lines_sample": [
      "SNU1",
      "SNU1",
      "TGW",
      "TGW",
      "TGW"
    ],
    "summary": "ALK mutation shows synthetic lethality with CLK4. Effect size: -0.025 (p=0.4419). Tested in 18 mutant lines vs 2067 wild-type lines. Most dependent mutant line: NB1643 (Neuroblastoma): -0.2624"
  },
  {
    "mutation": "MSH2",
    "target_gene": "STK17A",
    "n_mutant_lines": 8,
    "n_wt_lines": 2076,
    "mutant_mean_score": -0.16,
    "wt_mean_score": -0.0348,
    "effect_size": -0.1252,
    "p_value": 8.656155287950836e-05,
    "is_significant": true,
    "most_dependent_line": "HMVII (Mucosal Melanoma of the Vulva/Vagina): -0.2064",
    "mutant_lines_sample": [
      "HMVII",
      "JURKAT",
      "A3KAW",
      "A3KAW",
      "RL952"
    ],
    "summary": "MSH2 mutation shows synthetic lethality with STK17A. Effect size: -0.125 (p=0.0001). Tested in 8 mutant lines vs 2076 wild-type lines. Most dependent mutant line: HMVII (Mucosal Melanoma of the Vulva/Vagina): -0.2064"
  },
  {
    "mutation": "LHCGR",
    "target_gene": "STK17A",
    "n_mutant_lines": 4,
    "n_wt_lines": 2081,
    "mutant_mean_score": -0.1722,
    "wt_mean_score": -0.0351,
    "effect_size": -0.1371,
    "p_value": 0.0307173968299582,
    "is_significant": true,
    "most_dependent_line": "WM115 (Melanoma): -0.2080",
    "mutant_lines_sample": [
      "WM115",
      "WM115",
      "WM115",
      "WM2664"
    ],
    "summary": "LHCGR mutation shows synthetic lethality with STK17A. Effect size: -0.137 (p=0.0307). Tested in 4 mutant lines vs 2081 wild-type lines. Most dependent mutant line: WM115 (Melanoma): -0.2080"
  },
  {
    "mutation": "LHCGR",
    "target_gene": "MYLK4",
    "n_mutant_lines": 4,
    "n_wt_lines": 2081,
    "mutant_mean_score": -0.2133,
    "wt_mean_score": 0.0809,
    "effect_size": -0.2942,
    "p_value": 0.0211229705746316,
    "is_significant": true,
    "most_dependent_line": "WM115 (Melanoma): -0.2796",
    "mutant_lines_sample": [
      "WM115",
      "WM115",
      "WM115",
      "WM2664"
    ],
    "summary": "LHCGR mutation shows synthetic lethality with MYLK4. Effect size: -0.294 (p=0.0211). Tested in 4 mutant lines vs 2081 wild-type lines. Most dependent mutant line: WM115 (Melanoma): -0.2796"
  },
  {
    "mutation": "LHCGR",
    "target_gene": "CLK4",
    "n_mutant_lines": 4,
    "n_wt_lines": 2081,
    "mutant_mean_score": -0.1162,
    "wt_mean_score": -0.036,
    "effect_size": -0.0802,
    "p_value": 0.0956307733006284,
    "is_significant": true,
    "most_dependent_line": "WM115 (Melanoma): -0.1496",
    "mutant_lines_sample": [
      "WM115",
      "WM115",
      "WM115",
      "WM2664"
    ],
    "summary": "LHCGR mutation shows synthetic lethality with CLK4. Effect size: -0.080 (p=0.0956). Tested in 4 mutant lines vs 2081 wild-type lines. Most dependent mutant line: WM115 (Melanoma): -0.1496"
  },
  {
    "mutation": "XPO1",
    "target_gene": "STK17A",
    "n_mutant_lines": 16,
    "n_wt_lines": 2069,
    "mutant_mean_score": -0.0963,
    "wt_mean_score": -0.0349,
    "effect_size": -0.0614,
    "p_value": 0.0399809810373947,
    "is_significant": true,
    "most_dependent_line": "RS411 (B-Cell Acute Lymphoblastic Leukemia): -0.3214",
    "mutant_lines_sample": [
      "ESS1",
      "ESS1",
      "ESS1",
      "HCC2998",
      "HT115"
    ],
    "summary": "XPO1 mutation shows synthetic lethality with STK17A. Effect size: -0.061 (p=0.0400). Tested in 16 mutant lines vs 2069 wild-type lines. Most dependent mutant line: RS411 (B-Cell Acute Lymphoblastic Leukemia): -0.3214"
  },
  {
    "mutation": "XPO1",
    "target_gene": "TBK1",
    "n_mutant_lines": 16,
    "n_wt_lines": 2069,
    "mutant_mean_score": -0.1248,
    "wt_mean_score": -0.0156,
    "effect_size": -0.1091,
    "p_value": 0.0151118708551725,
    "is_significant": true,
    "most_dependent_line": "SNU81 (Colorectal Adenocarcinoma): -0.6411",
    "mutant_lines_sample": [
      "ESS1",
      "ESS1",
      "ESS1",
      "HCC2998",
      "HT115"
    ],
    "summary": "XPO1 mutation shows synthetic lethality with TBK1. Effect size: -0.109 (p=0.0151). Tested in 16 mutant lines vs 2069 wild-type lines. Most dependent mutant line: SNU81 (Colorectal Adenocarcinoma): -0.6411"
  },
  {
    "mutation": "C2orf81",
    "target_gene": "STK17A",
    "n_mutant_lines": 22,
    "n_wt_lines": 2063,
    "mutant_mean_score": -0.0954,
    "wt_mean_score": -0.0347,
    "effect_size": -0.0607,
    "p_value": 0.0156051304895783,
    "is_significant": true,
    "most_dependent_line": "MOGGUVW (Diffuse Glioma): -0.2927",
    "mutant_lines_sample": [
      "PF382",
      "ARH77",
      "MC116",
      "HSC3",
      "JVM2"
    ],
    "summary": "C2orf81 mutation shows synthetic lethality with STK17A. Effect size: -0.061 (p=0.0156). Tested in 22 mutant lines vs 2063 wild-type lines. Most dependent mutant line: MOGGUVW (Diffuse Glioma): -0.2927"
  },
  {
    "mutation": "C2orf81",
    "target_gene": "MYLK4",
    "n_mutant_lines": 22,
    "n_wt_lines": 2063,
    "mutant_mean_score": 0.0622,
    "wt_mean_score": 0.0805,
    "effect_size": -0.0183,
    "p_value": 0.4598030253320331,
    "is_significant": true,
    "most_dependent_line": "DMS273 (Lung Neuroendocrine Tumor): -0.1805",
    "mutant_lines_sample": [
      "PF382",
      "ARH77",
      "MC116",
      "HSC3",
      "JVM2"
    ],
    "summary": "C2orf81 mutation shows synthetic lethality with MYLK4. Effect size: -0.018 (p=0.4598). Tested in 22 mutant lines vs 2063 wild-type lines. Most dependent mutant line: DMS273 (Lung Neuroendocrine Tumor): -0.1805"
  },
  {
    "mutation": "IL37",
    "target_gene": "MYLK4",
    "n_mutant_lines": 3,
    "n_wt_lines": 2082,
    "mutant_mean_score": 0.03,
    "wt_mean_score": 0.0804,
    "effect_size": -0.0503,
    "p_value": 0.3363389240281675,
    "is_significant": true,
    "most_dependent_line": "COLO792 (Melanoma): -0.0101",
    "mutant_lines_sample": [
      "COLO792",
      "COLO792",
      "MDAMB435S"
    ],
    "summary": "IL37 mutation shows synthetic lethality with MYLK4. Effect size: -0.050 (p=0.3363). Tested in 3 mutant lines vs 2082 wild-type lines. Most dependent mutant line: COLO792 (Melanoma): -0.0101"
  },
  {
    "mutation": "IL37",
    "target_gene": "TBK1",
    "n_mutant_lines": 3,
    "n_wt_lines": 2082,
    "mutant_mean_score": -0.0383,
    "wt_mean_score": -0.0164,
    "effect_size": -0.0219,
    "p_value": 0.7324190821016657,
    "is_significant": true,
    "most_dependent_line": "MDAMB435S (Melanoma): -0.1498",
    "mutant_lines_sample": [
      "COLO792",
      "COLO792",
      "MDAMB435S"
    ],
    "summary": "IL37 mutation shows synthetic lethality with TBK1. Effect size: -0.022 (p=0.7324). Tested in 3 mutant lines vs 2082 wild-type lines. Most dependent mutant line: MDAMB435S (Melanoma): -0.1498"
  },
  {
    "mutation": "ERCC3",
    "target_gene": "TBK1",
    "n_mutant_lines": 3,
    "n_wt_lines": 2082,
    "mutant_mean_score": -0.2038,
    "wt_mean_score": -0.0162,
    "effect_size": -0.1876,
    "p_value": 0.1017505857256358,
    "is_significant": true,
    "most_dependent_line": "KP1N (Pancreatic Adenocarcinoma): -0.3337",
    "mutant_lines_sample": [
      "PANC1",
      "HKA1",
      "KP1N"
    ],
    "summary": "ERCC3 mutation shows synthetic lethality with TBK1. Effect size: -0.188 (p=0.1018). Tested in 3 mutant lines vs 2082 wild-type lines. Most dependent mutant line: KP1N (Pancreatic Adenocarcinoma): -0.3337"
  },
  {
    "mutation": "THSD7B",
    "target_gene": "STK17A",
    "n_mutant_lines": 4,
    "n_wt_lines": 2081,
    "mutant_mean_score": -0.1172,
    "wt_mean_score": -0.0352,
    "effect_size": -0.082,
    "p_value": 0.2841119257704134,
    "is_significant": true,
    "most_dependent_line": "IPC298 (Melanoma): -0.1983",
    "mutant_lines_sample": [
      "MM370",
      "MM576",
      "IPC298",
      "IPC298"
    ],
    "summary": "THSD7B mutation shows synthetic lethality with STK17A. Effect size: -0.082 (p=0.2841). Tested in 4 mutant lines vs 2081 wild-type lines. Most dependent mutant line: IPC298 (Melanoma): -0.1983"
  },
  {
    "mutation": "THSD7B",
    "target_gene": "MYLK4",
    "n_mutant_lines": 4,
    "n_wt_lines": 2081,
    "mutant_mean_score": -0.0018,
    "wt_mean_score": 0.0805,
    "effect_size": -0.0823,
    "p_value": 0.0396741394359042,
    "is_significant": true,
    "most_dependent_line": "MM370 (Melanoma): -0.0562",
    "mutant_lines_sample": [
      "MM370",
      "MM576",
      "IPC298",
      "IPC298"
    ],
    "summary": "THSD7B mutation shows synthetic lethality with MYLK4. Effect size: -0.082 (p=0.0397). Tested in 4 mutant lines vs 2081 wild-type lines. Most dependent mutant line: MM370 (Melanoma): -0.0562"
  },
  {
    "mutation": "THSD7B",
    "target_gene": "CLK4",
    "n_mutant_lines": 4,
    "n_wt_lines": 2081,
    "mutant_mean_score": -0.1766,
    "wt_mean_score": -0.0359,
    "effect_size": -0.1407,
    "p_value": 0.0039087826316118,
    "is_significant": true,
    "most_dependent_line": "MM576 (Melanoma): -0.2212",
    "mutant_lines_sample": [
      "MM370",
      "MM576",
      "IPC298",
      "IPC298"
    ],
    "summary": "THSD7B mutation shows synthetic lethality with CLK4. Effect size: -0.141 (p=0.0039). Tested in 4 mutant lines vs 2081 wild-type lines. Most dependent mutant line: MM576 (Melanoma): -0.2212"
  },
  {
    "mutation": "SF3B1",
    "target_gene": "STK17A",
    "n_mutant_lines": 6,
    "n_wt_lines": 2079,
    "mutant_mean_score": -0.0364,
    "wt_mean_score": -0.0354,
    "effect_size": -0.001,
    "p_value": 0.9715757770227136,
    "is_significant": true,
    "most_dependent_line": "CI (Mature B-Cell Neoplasms): -0.0877",
    "mutant_lines_sample": [
      "ESS1",
      "ESS1",
      "ESS1",
      "MEL202",
      "MGHICC2"
    ],
    "summary": "SF3B1 mutation shows synthetic lethality with STK17A. Effect size: -0.001 (p=0.9716). Tested in 6 mutant lines vs 2079 wild-type lines. Most dependent mutant line: CI (Mature B-Cell Neoplasms): -0.0877"
  },
  {
    "mutation": "SF3B1",
    "target_gene": "TBK1",
    "n_mutant_lines": 6,
    "n_wt_lines": 2079,
    "mutant_mean_score": -0.021,
    "wt_mean_score": -0.0164,
    "effect_size": -0.0045,
    "p_value": 0.9311647116956364,
    "is_significant": true,
    "most_dependent_line": "MEL202 (Ocular Melanoma): -0.0890",
    "mutant_lines_sample": [
      "ESS1",
      "ESS1",
      "ESS1",
      "MEL202",
      "MGHICC2"
    ],
    "summary": "SF3B1 mutation shows synthetic lethality with TBK1. Effect size: -0.004 (p=0.9312). Tested in 6 mutant lines vs 2079 wild-type lines. Most dependent mutant line: MEL202 (Ocular Melanoma): -0.0890"
  },
  {
    "mutation": "CASP8",
    "target_gene": "STK17A",
    "n_mutant_lines": 19,
    "n_wt_lines": 2066,
    "mutant_mean_score": -0.0834,
    "wt_mean_score": -0.0349,
    "effect_size": -0.0485,
    "p_value": 0.0063473807608981,
    "is_significant": true,
    "most_dependent_line": "SNUC4 (Colorectal Adenocarcinoma): -0.1554",
    "mutant_lines_sample": [
      "LOVO",
      "LOVO",
      "SUPT1",
      "SUPT1",
      "SIHA"
    ],
    "summary": "CASP8 mutation shows synthetic lethality with STK17A. Effect size: -0.049 (p=0.0063). Tested in 19 mutant lines vs 2066 wild-type lines. Most dependent mutant line: SNUC4 (Colorectal Adenocarcinoma): -0.1554"
  },
  {
    "mutation": "CASP8",
    "target_gene": "TBK1",
    "n_mutant_lines": 19,
    "n_wt_lines": 2066,
    "mutant_mean_score": -0.0537,
    "wt_mean_score": -0.0161,
    "effect_size": -0.0376,
    "p_value": 0.1473756647630238,
    "is_significant": true,
    "most_dependent_line": "KYM1 (Rhabdoid Cancer): -0.2384",
    "mutant_lines_sample": [
      "LOVO",
      "LOVO",
      "SUPT1",
      "SUPT1",
      "SIHA"
    ],
    "summary": "CASP8 mutation shows synthetic lethality with TBK1. Effect size: -0.038 (p=0.1474). Tested in 19 mutant lines vs 2066 wild-type lines. Most dependent mutant line: KYM1 (Rhabdoid Cancer): -0.2384"
  },
  {
    "mutation": "IDH1",
    "target_gene": "MYLK4",
    "n_mutant_lines": 8,
    "n_wt_lines": 2077,
    "mutant_mean_score": 0.0653,
    "wt_mean_score": 0.0804,
    "effect_size": -0.015,
    "p_value": 0.3259263657516458,
    "is_significant": true,
    "most_dependent_line": "MM127 (Melanoma): -0.0086",
    "mutant_lines_sample": [
      "TB096",
      "MM127",
      "CORL105",
      "HT1080",
      "HT1080"
    ],
    "summary": "IDH1 mutation shows synthetic lethality with MYLK4. Effect size: -0.015 (p=0.3259). Tested in 8 mutant lines vs 2077 wild-type lines. Most dependent mutant line: MM127 (Melanoma): -0.0086"
  },
  {
    "mutation": "IDH1",
    "target_gene": "CLK4",
    "n_mutant_lines": 8,
    "n_wt_lines": 2077,
    "mutant_mean_score": -0.0461,
    "wt_mean_score": -0.0361,
    "effect_size": -0.01,
    "p_value": 0.786359607755719,
    "is_significant": true,
    "most_dependent_line": "PACADD165 (Pancreatic Adenocarcinoma): -0.1233",
    "mutant_lines_sample": [
      "TB096",
      "MM127",
      "CORL105",
      "HT1080",
      "HT1080"
    ],
    "summary": "IDH1 mutation shows synthetic lethality with CLK4. Effect size: -0.010 (p=0.7864). Tested in 8 mutant lines vs 2077 wild-type lines. Most dependent mutant line: PACADD165 (Pancreatic Adenocarcinoma): -0.1233"
  },
  {
    "mutation": "XRCC5",
    "target_gene": "STK17A",
    "n_mutant_lines": 3,
    "n_wt_lines": 2082,
    "mutant_mean_score": -0.0857,
    "wt_mean_score": -0.0353,
    "effect_size": -0.0504,
    "p_value": 0.0215737630713435,
    "is_significant": true,
    "most_dependent_line": "HT115 (Colorectal Adenocarcinoma): -0.0946",
    "mutant_lines_sample": [
      "HCC2998",
      "HT115",
      "HT115"
    ],
    "summary": "XRCC5 mutation shows synthetic lethality with STK17A. Effect size: -0.050 (p=0.0216). Tested in 3 mutant lines vs 2082 wild-type lines. Most dependent mutant line: HT115 (Colorectal Adenocarcinoma): -0.0946"
  },
  {
    "mutation": "XRCC5",
    "target_gene": "TBK1",
    "n_mutant_lines": 3,
    "n_wt_lines": 2082,
    "mutant_mean_score": -0.1867,
    "wt_mean_score": -0.0162,
    "effect_size": -0.1705,
    "p_value": 0.0351567712297684,
    "is_significant": true,
    "most_dependent_line": "HCC2998 (Colorectal Adenocarcinoma): -0.2532",
    "mutant_lines_sample": [
      "HCC2998",
      "HT115",
      "HT115"
    ],
    "summary": "XRCC5 mutation shows synthetic lethality with TBK1. Effect size: -0.171 (p=0.0352). Tested in 3 mutant lines vs 2082 wild-type lines. Most dependent mutant line: HCC2998 (Colorectal Adenocarcinoma): -0.2532"
  },
  {
    "mutation": "GIGYF2",
    "target_gene": "STK17A",
    "n_mutant_lines": 4,
    "n_wt_lines": 2081,
    "mutant_mean_score": -0.111,
    "wt_mean_score": -0.0352,
    "effect_size": -0.0758,
    "p_value": 0.0589687170846872,
    "is_significant": true,
    "most_dependent_line": "SNUC4 (Colorectal Adenocarcinoma): -0.1554",
    "mutant_lines_sample": [
      "SNUC4",
      "SNUC4",
      "EFO27",
      "EFO27"
    ],
    "summary": "GIGYF2 mutation shows synthetic lethality with STK17A. Effect size: -0.076 (p=0.0590). Tested in 4 mutant lines vs 2081 wild-type lines. Most dependent mutant line: SNUC4 (Colorectal Adenocarcinoma): -0.1554"
  },
  {
    "mutation": "GIGYF2",
    "target_gene": "MYLK4",
    "n_mutant_lines": 4,
    "n_wt_lines": 2081,
    "mutant_mean_score": 0.0337,
    "wt_mean_score": 0.0804,
    "effect_size": -0.0467,
    "p_value": 0.6359857448865358,
    "is_significant": true,
    "most_dependent_line": "SNUC4 (Colorectal Adenocarcinoma): -0.1203",
    "mutant_lines_sample": [
      "SNUC4",
      "SNUC4",
      "EFO27",
      "EFO27"
    ],
    "summary": "GIGYF2 mutation shows synthetic lethality with MYLK4. Effect size: -0.047 (p=0.6360). Tested in 4 mutant lines vs 2081 wild-type lines. Most dependent mutant line: SNUC4 (Colorectal Adenocarcinoma): -0.1203"
  },
  {
    "mutation": "GIGYF2",
    "target_gene": "TBK1",
    "n_mutant_lines": 4,
    "n_wt_lines": 2081,
    "mutant_mean_score": -0.048,
    "wt_mean_score": -0.0164,
    "effect_size": -0.0316,
    "p_value": 0.1457005675935944,
    "is_significant": true,
    "most_dependent_line": "SNUC4 (Colorectal Adenocarcinoma): -0.0761",
    "mutant_lines_sample": [
      "SNUC4",
      "SNUC4",
      "EFO27",
      "EFO27"
    ],
    "summary": "GIGYF2 mutation shows synthetic lethality with TBK1. Effect size: -0.032 (p=0.1457). Tested in 4 mutant lines vs 2081 wild-type lines. Most dependent mutant line: SNUC4 (Colorectal Adenocarcinoma): -0.0761"
  },
  {
    "mutation": "GNAS",
    "target_gene": "MYLK4",
    "n_mutant_lines": 10,
    "n_wt_lines": 2075,
    "mutant_mean_score": 0.0708,
    "wt_mean_score": 0.0803,
    "effect_size": -0.0095,
    "p_value": 0.6855846306946155,
    "is_significant": true,
    "most_dependent_line": "SNU182 (Hepatocellular Carcinoma): -0.0051",
    "mutant_lines_sample": [
      "SNU182",
      "KM12",
      "KM12",
      "MGHECC4",
      "9505BIK"
    ],
    "summary": "GNAS mutation shows synthetic lethality with MYLK4. Effect size: -0.009 (p=0.6856). Tested in 10 mutant lines vs 2075 wild-type lines. Most dependent mutant line: SNU182 (Hepatocellular Carcinoma): -0.0051"
  },
  {
    "mutation": "TPTE",
    "target_gene": "CLK4",
    "n_mutant_lines": 12,
    "n_wt_lines": 2073,
    "mutant_mean_score": -0.0615,
    "wt_mean_score": -0.036,
    "effect_size": -0.0255,
    "p_value": 0.6448968983354422,
    "is_significant": true,
    "most_dependent_line": "SKMEL30 (Melanoma): -0.4312",
    "mutant_lines_sample": [
      "KATOIII",
      "KATOIII",
      "HCA1",
      "TYKNU",
      "TYKNU"
    ],
    "summary": "TPTE mutation shows synthetic lethality with CLK4. Effect size: -0.025 (p=0.6449). Tested in 12 mutant lines vs 2073 wild-type lines. Most dependent mutant line: SKMEL30 (Melanoma): -0.4312"
  },
  {
    "mutation": "C21orf91",
    "target_gene": "STK17A",
    "n_mutant_lines": 5,
    "n_wt_lines": 2080,
    "mutant_mean_score": -0.0655,
    "wt_mean_score": -0.0353,
    "effect_size": -0.0302,
    "p_value": 0.5455962889236,
    "is_significant": true,
    "most_dependent_line": "COLO824 (Breast Neoplasm, NOS): -0.1736",
    "mutant_lines_sample": [
      "HCC2998",
      "HT115",
      "HT115",
      "JHUEM7",
      "COLO824"
    ],
    "summary": "C21orf91 mutation shows synthetic lethality with STK17A. Effect size: -0.030 (p=0.5456). Tested in 5 mutant lines vs 2080 wild-type lines. Most dependent mutant line: COLO824 (Breast Neoplasm, NOS): -0.1736"
  },
  {
    "mutation": "C21orf91",
    "target_gene": "TBK1",
    "n_mutant_lines": 5,
    "n_wt_lines": 2080,
    "mutant_mean_score": -0.0969,
    "wt_mean_score": -0.0163,
    "effect_size": -0.0807,
    "p_value": 0.3140464370526644,
    "is_significant": true,
    "most_dependent_line": "HCC2998 (Colorectal Adenocarcinoma): -0.2532",
    "mutant_lines_sample": [
      "HCC2998",
      "HT115",
      "HT115",
      "JHUEM7",
      "COLO824"
    ],
    "summary": "C21orf91 mutation shows synthetic lethality with TBK1. Effect size: -0.081 (p=0.3140). Tested in 5 mutant lines vs 2080 wild-type lines. Most dependent mutant line: HCC2998 (Colorectal Adenocarcinoma): -0.2532"
  },
  {
    "mutation": "LTN1",
    "target_gene": "STK17A",
    "n_mutant_lines": 3,
    "n_wt_lines": 2082,
    "mutant_mean_score": -0.0857,
    "wt_mean_score": -0.0353,
    "effect_size": -0.0504,
    "p_value": 0.0215737630713435,
    "is_significant": true,
    "most_dependent_line": "HT115 (Colorectal Adenocarcinoma): -0.0946",
    "mutant_lines_sample": [
      "HCC2998",
      "HT115",
      "HT115"
    ],
    "summary": "LTN1 mutation shows synthetic lethality with STK17A. Effect size: -0.050 (p=0.0216). Tested in 3 mutant lines vs 2082 wild-type lines. Most dependent mutant line: HT115 (Colorectal Adenocarcinoma): -0.0946"
  },
  {
    "mutation": "LTN1",
    "target_gene": "TBK1",
    "n_mutant_lines": 3,
    "n_wt_lines": 2082,
    "mutant_mean_score": -0.1867,
    "wt_mean_score": -0.0162,
    "effect_size": -0.1705,
    "p_value": 0.0351567712297684,
    "is_significant": true,
    "most_dependent_line": "HCC2998 (Colorectal Adenocarcinoma): -0.2532",
    "mutant_lines_sample": [
      "HCC2998",
      "HT115",
      "HT115"
    ],
    "summary": "LTN1 mutation shows synthetic lethality with TBK1. Effect size: -0.171 (p=0.0352). Tested in 3 mutant lines vs 2082 wild-type lines. Most dependent mutant line: HCC2998 (Colorectal Adenocarcinoma): -0.2532"
  },
  {
    "mutation": "OLIG2",
    "target_gene": "STK17A",
    "n_mutant_lines": 5,
    "n_wt_lines": 2080,
    "mutant_mean_score": -0.1131,
    "wt_mean_score": -0.0352,
    "effect_size": -0.0779,
    "p_value": 5.671765186329671e-06,
    "is_significant": true,
    "most_dependent_line": "RKO (Colorectal Adenocarcinoma): -0.1260",
    "mutant_lines_sample": [
      "OCUM1",
      "OCUM1",
      "OCUM1",
      "RKO",
      "RKO"
    ],
    "summary": "OLIG2 mutation shows synthetic lethality with STK17A. Effect size: -0.078 (p=0.0000). Tested in 5 mutant lines vs 2080 wild-type lines. Most dependent mutant line: RKO (Colorectal Adenocarcinoma): -0.1260"
  },
  {
    "mutation": "OLIG2",
    "target_gene": "MYLK4",
    "n_mutant_lines": 5,
    "n_wt_lines": 2080,
    "mutant_mean_score": -0.139,
    "wt_mean_score": 0.0808,
    "effect_size": -0.2198,
    "p_value": 0.0500316583330123,
    "is_significant": true,
    "most_dependent_line": "OCUM1 (Esophagogastric Adenocarcinoma): -0.2684",
    "mutant_lines_sample": [
      "OCUM1",
      "OCUM1",
      "OCUM1",
      "RKO",
      "RKO"
    ],
    "summary": "OLIG2 mutation shows synthetic lethality with MYLK4. Effect size: -0.220 (p=0.0500). Tested in 5 mutant lines vs 2080 wild-type lines. Most dependent mutant line: OCUM1 (Esophagogastric Adenocarcinoma): -0.2684"
  },
  {
    "mutation": "OLIG2",
    "target_gene": "TBK1",
    "n_mutant_lines": 5,
    "n_wt_lines": 2080,
    "mutant_mean_score": -0.0515,
    "wt_mean_score": -0.0164,
    "effect_size": -0.0351,
    "p_value": 0.0925913597409523,
    "is_significant": true,
    "most_dependent_line": "OCUM1 (Esophagogastric Adenocarcinoma): -0.0776",
    "mutant_lines_sample": [
      "OCUM1",
      "OCUM1",
      "OCUM1",
      "RKO",
      "RKO"
    ],
    "summary": "OLIG2 mutation shows synthetic lethality with TBK1. Effect size: -0.035 (p=0.0926). Tested in 5 mutant lines vs 2080 wild-type lines. Most dependent mutant line: OCUM1 (Esophagogastric Adenocarcinoma): -0.0776"
  },
  {
    "mutation": "OLIG2",
    "target_gene": "CLK4",
    "n_mutant_lines": 5,
    "n_wt_lines": 2080,
    "mutant_mean_score": -0.0429,
    "wt_mean_score": -0.0361,
    "effect_size": -0.0068,
    "p_value": 0.550188279737949,
    "is_significant": true,
    "most_dependent_line": "OCUM1 (Esophagogastric Adenocarcinoma): -0.0595",
    "mutant_lines_sample": [
      "OCUM1",
      "OCUM1",
      "OCUM1",
      "RKO",
      "RKO"
    ],
    "summary": "OLIG2 mutation shows synthetic lethality with CLK4. Effect size: -0.007 (p=0.5502). Tested in 5 mutant lines vs 2080 wild-type lines. Most dependent mutant line: OCUM1 (Esophagogastric Adenocarcinoma): -0.0595"
  },
  {
    "mutation": "U2AF1",
    "target_gene": "STK17A",
    "n_mutant_lines": 3,
    "n_wt_lines": 2082,
    "mutant_mean_score": -0.0538,
    "wt_mean_score": -0.0353,
    "effect_size": -0.0185,
    "p_value": 0.7033471336374221,
    "is_significant": true,
    "most_dependent_line": "MONOMAC1 (Acute Myeloid Leukemia): -0.0958",
    "mutant_lines_sample": [
      "MUTZ8",
      "MONOMAC1",
      "MONOMAC1"
    ],
    "summary": "U2AF1 mutation shows synthetic lethality with STK17A. Effect size: -0.018 (p=0.7033). Tested in 3 mutant lines vs 2082 wild-type lines. Most dependent mutant line: MONOMAC1 (Acute Myeloid Leukemia): -0.0958"
  },
  {
    "mutation": "U2AF1",
    "target_gene": "MYLK4",
    "n_mutant_lines": 3,
    "n_wt_lines": 2082,
    "mutant_mean_score": -0.0367,
    "wt_mean_score": 0.0805,
    "effect_size": -0.1171,
    "p_value": 0.0032027838643043,
    "is_significant": true,
    "most_dependent_line": "MONOMAC1 (Acute Myeloid Leukemia): -0.0454",
    "mutant_lines_sample": [
      "MUTZ8",
      "MONOMAC1",
      "MONOMAC1"
    ],
    "summary": "U2AF1 mutation shows synthetic lethality with MYLK4. Effect size: -0.117 (p=0.0032). Tested in 3 mutant lines vs 2082 wild-type lines. Most dependent mutant line: MONOMAC1 (Acute Myeloid Leukemia): -0.0454"
  },
  {
    "mutation": "U2AF1",
    "target_gene": "TBK1",
    "n_mutant_lines": 3,
    "n_wt_lines": 2082,
    "mutant_mean_score": -0.1129,
    "wt_mean_score": -0.0163,
    "effect_size": -0.0965,
    "p_value": 4.126443871123025e-08,
    "is_significant": true,
    "most_dependent_line": "MONOMAC1 (Acute Myeloid Leukemia): -0.1159",
    "mutant_lines_sample": [
      "MUTZ8",
      "MONOMAC1",
      "MONOMAC1"
    ],
    "summary": "U2AF1 mutation shows synthetic lethality with TBK1. Effect size: -0.097 (p=0.0000). Tested in 3 mutant lines vs 2082 wild-type lines. Most dependent mutant line: MONOMAC1 (Acute Myeloid Leukemia): -0.1159"
  },
  {
    "mutation": "U2AF1",
    "target_gene": "CLK4",
    "n_mutant_lines": 3,
    "n_wt_lines": 2082,
    "mutant_mean_score": -0.1269,
    "wt_mean_score": -0.036,
    "effect_size": -0.0909,
    "p_value": 0.1381973972360298,
    "is_significant": true,
    "most_dependent_line": "MUTZ8 (Acute Myeloid Leukemia): -0.2029",
    "mutant_lines_sample": [
      "MUTZ8",
      "MONOMAC1",
      "MONOMAC1"
    ],
    "summary": "U2AF1 mutation shows synthetic lethality with CLK4. Effect size: -0.091 (p=0.1382). Tested in 3 mutant lines vs 2082 wild-type lines. Most dependent mutant line: MUTZ8 (Acute Myeloid Leukemia): -0.2029"
  },
  {
    "mutation": "DRICH1",
    "target_gene": "MYLK4",
    "n_mutant_lines": 3,
    "n_wt_lines": 2082,
    "mutant_mean_score": 0.0339,
    "wt_mean_score": 0.0804,
    "effect_size": -0.0465,
    "p_value": 0.5623166016299702,
    "is_significant": true,
    "most_dependent_line": "CCK81 (Colorectal Adenocarcinoma): -0.0336",
    "mutant_lines_sample": [
      "CCK81",
      "CCK81",
      "PACADD137"
    ],
    "summary": "DRICH1 mutation shows synthetic lethality with MYLK4. Effect size: -0.046 (p=0.5623). Tested in 3 mutant lines vs 2082 wild-type lines. Most dependent mutant line: CCK81 (Colorectal Adenocarcinoma): -0.0336"
  },
  {
    "mutation": "DRICH1",
    "target_gene": "CLK4",
    "n_mutant_lines": 3,
    "n_wt_lines": 2082,
    "mutant_mean_score": -0.0703,
    "wt_mean_score": -0.0361,
    "effect_size": -0.0343,
    "p_value": 0.5516788650675861,
    "is_significant": true,
    "most_dependent_line": "PACADD137 (Pancreatic Adenocarcinoma): -0.1669",
    "mutant_lines_sample": [
      "CCK81",
      "CCK81",
      "PACADD137"
    ],
    "summary": "DRICH1 mutation shows synthetic lethality with CLK4. Effect size: -0.034 (p=0.5517). Tested in 3 mutant lines vs 2082 wild-type lines. Most dependent mutant line: PACADD137 (Pancreatic Adenocarcinoma): -0.1669"
  },
  {
    "mutation": "EP300",
    "target_gene": "STK17A",
    "n_mutant_lines": 11,
    "n_wt_lines": 2069,
    "mutant_mean_score": -0.0663,
    "wt_mean_score": -0.0351,
    "effect_size": -0.0312,
    "p_value": 0.5150881101884028,
    "is_significant": true,
    "most_dependent_line": "CAL33 (Head and Neck Squamous Cell Carcinoma): -0.3636",
    "mutant_lines_sample": [
      "SKOV3",
      "SKOV3",
      "RL",
      "RL",
      "MCF7"
    ],
    "summary": "EP300 mutation shows synthetic lethality with STK17A. Effect size: -0.031 (p=0.5151). Tested in 11 mutant lines vs 2069 wild-type lines. Most dependent mutant line: CAL33 (Head and Neck Squamous Cell Carcinoma): -0.3636"
  },
  {
    "mutation": "EP300",
    "target_gene": "MYLK4",
    "n_mutant_lines": 11,
    "n_wt_lines": 2069,
    "mutant_mean_score": 0.066,
    "wt_mean_score": 0.0805,
    "effect_size": -0.0145,
    "p_value": 0.5095682691864839,
    "is_significant": true,
    "most_dependent_line": "SKOV3 (Ovarian Epithelial Tumor): -0.0030",
    "mutant_lines_sample": [
      "SKOV3",
      "SKOV3",
      "RL",
      "RL",
      "MCF7"
    ],
    "summary": "EP300 mutation shows synthetic lethality with MYLK4. Effect size: -0.015 (p=0.5096). Tested in 11 mutant lines vs 2069 wild-type lines. Most dependent mutant line: SKOV3 (Ovarian Epithelial Tumor): -0.0030"
  },
  {
    "mutation": "VHL",
    "target_gene": "MYLK4",
    "n_mutant_lines": 6,
    "n_wt_lines": 2065,
    "mutant_mean_score": -0.0597,
    "wt_mean_score": 0.0806,
    "effect_size": -0.1403,
    "p_value": 0.0508399701770463,
    "is_significant": true,
    "most_dependent_line": "NP5 (Diffuse Glioma): -0.3130",
    "mutant_lines_sample": [
      "EKVX",
      "EKVX",
      "EKVX",
      "NP5",
      "SLR23"
    ],
    "summary": "VHL mutation shows synthetic lethality with MYLK4. Effect size: -0.140 (p=0.0508). Tested in 6 mutant lines vs 2065 wild-type lines. Most dependent mutant line: NP5 (Diffuse Glioma): -0.3130"
  },
  {
    "mutation": "VHL",
    "target_gene": "TBK1",
    "n_mutant_lines": 6,
    "n_wt_lines": 2065,
    "mutant_mean_score": -0.0738,
    "wt_mean_score": -0.0165,
    "effect_size": -0.0574,
    "p_value": 0.1058541506318084,
    "is_significant": true,
    "most_dependent_line": "EKVX (Non-Small Cell Lung Cancer): -0.1196",
    "mutant_lines_sample": [
      "EKVX",
      "EKVX",
      "EKVX",
      "NP5",
      "SLR23"
    ],
    "summary": "VHL mutation shows synthetic lethality with TBK1. Effect size: -0.057 (p=0.1059). Tested in 6 mutant lines vs 2065 wild-type lines. Most dependent mutant line: EKVX (Non-Small Cell Lung Cancer): -0.1196"
  },
  {
    "mutation": "RAF1",
    "target_gene": "STK17A",
    "n_mutant_lines": 5,
    "n_wt_lines": 2080,
    "mutant_mean_score": -0.059,
    "wt_mean_score": -0.0353,
    "effect_size": -0.0237,
    "p_value": 0.4895458219472116,
    "is_significant": true,
    "most_dependent_line": "UPCISCC090 (Head and Neck Squamous Cell Carcinoma): -0.1377",
    "mutant_lines_sample": [
      "UPCISCC152",
      "UPCISCC152",
      "HCC2998",
      "NO10",
      "UPCISCC090"
    ],
    "summary": "RAF1 mutation shows synthetic lethality with STK17A. Effect size: -0.024 (p=0.4895). Tested in 5 mutant lines vs 2080 wild-type lines. Most dependent mutant line: UPCISCC090 (Head and Neck Squamous Cell Carcinoma): -0.1377"
  },
  {
    "mutation": "RAF1",
    "target_gene": "TBK1",
    "n_mutant_lines": 5,
    "n_wt_lines": 2080,
    "mutant_mean_score": -0.1862,
    "wt_mean_score": -0.016,
    "effect_size": -0.1701,
    "p_value": 0.0788870549871725,
    "is_significant": true,
    "most_dependent_line": "UPCISCC090 (Head and Neck Squamous Cell Carcinoma): -0.4225",
    "mutant_lines_sample": [
      "UPCISCC152",
      "UPCISCC152",
      "HCC2998",
      "NO10",
      "UPCISCC090"
    ],
    "summary": "RAF1 mutation shows synthetic lethality with TBK1. Effect size: -0.170 (p=0.0789). Tested in 5 mutant lines vs 2080 wild-type lines. Most dependent mutant line: UPCISCC090 (Head and Neck Squamous Cell Carcinoma): -0.4225"
  },
  {
    "mutation": "RAF1",
    "target_gene": "CLK4",
    "n_mutant_lines": 5,
    "n_wt_lines": 2080,
    "mutant_mean_score": -0.0447,
    "wt_mean_score": -0.0361,
    "effect_size": -0.0086,
    "p_value": 0.8276962916233168,
    "is_significant": true,
    "most_dependent_line": "UPCISCC152 (Head and Neck Squamous Cell Carcinoma): -0.1237",
    "mutant_lines_sample": [
      "UPCISCC152",
      "UPCISCC152",
      "HCC2998",
      "NO10",
      "UPCISCC090"
    ],
    "summary": "RAF1 mutation shows synthetic lethality with CLK4. Effect size: -0.009 (p=0.8277). Tested in 5 mutant lines vs 2080 wild-type lines. Most dependent mutant line: UPCISCC152 (Head and Neck Squamous Cell Carcinoma): -0.1237"
  },
  {
    "mutation": "TOP2B",
    "target_gene": "TBK1",
    "n_mutant_lines": 3,
    "n_wt_lines": 2082,
    "mutant_mean_score": -0.1439,
    "wt_mean_score": -0.0163,
    "effect_size": -0.1277,
    "p_value": 0.2494920143874215,
    "is_significant": true,
    "most_dependent_line": "HCT116 (Colorectal Adenocarcinoma): -0.2235",
    "mutant_lines_sample": [
      "SNGM",
      "HCT116",
      "HCT116"
    ],
    "summary": "TOP2B mutation shows synthetic lethality with TBK1. Effect size: -0.128 (p=0.2495). Tested in 3 mutant lines vs 2082 wild-type lines. Most dependent mutant line: HCT116 (Colorectal Adenocarcinoma): -0.2235"
  },
  {
    "mutation": "CTNNB1",
    "target_gene": "STK17A",
    "n_mutant_lines": 39,
    "n_wt_lines": 2031,
    "mutant_mean_score": -0.0398,
    "wt_mean_score": -0.0357,
    "effect_size": -0.0041,
    "p_value": 0.8404209142964654,
    "is_significant": true,
    "most_dependent_line": "MORCPR (Non-Small Cell Lung Cancer): -0.2997",
    "mutant_lines_sample": [
      "SNGM",
      "SNGM",
      "SNGM",
      "MGHECC4",
      "SNU869"
    ],
    "summary": "CTNNB1 mutation shows synthetic lethality with STK17A. Effect size: -0.004 (p=0.8404). Tested in 39 mutant lines vs 2031 wild-type lines. Most dependent mutant line: MORCPR (Non-Small Cell Lung Cancer): -0.2997"
  },
  {
    "mutation": "CTNNB1",
    "target_gene": "TBK1",
    "n_mutant_lines": 39,
    "n_wt_lines": 2031,
    "mutant_mean_score": -0.0325,
    "wt_mean_score": -0.0165,
    "effect_size": -0.016,
    "p_value": 0.4440858047058987,
    "is_significant": true,
    "most_dependent_line": "SCS214 (Synovial Sarcoma): -0.3699",
    "mutant_lines_sample": [
      "SNGM",
      "SNGM",
      "SNGM",
      "MGHECC4",
      "SNU869"
    ],
    "summary": "CTNNB1 mutation shows synthetic lethality with TBK1. Effect size: -0.016 (p=0.4441). Tested in 39 mutant lines vs 2031 wild-type lines. Most dependent mutant line: SCS214 (Synovial Sarcoma): -0.3699"
  },
  {
    "mutation": "CTNNB1",
    "target_gene": "CLK4",
    "n_mutant_lines": 39,
    "n_wt_lines": 2031,
    "mutant_mean_score": -0.037,
    "wt_mean_score": -0.0366,
    "effect_size": -0.0004,
    "p_value": 0.984868605248734,
    "is_significant": true,
    "most_dependent_line": "OVMIU (Ovarian Epithelial Tumor): -0.4359",
    "mutant_lines_sample": [
      "SNGM",
      "SNGM",
      "SNGM",
      "MGHECC4",
      "SNU869"
    ],
    "summary": "CTNNB1 mutation shows synthetic lethality with CLK4. Effect size: -0.000 (p=0.9849). Tested in 39 mutant lines vs 2031 wild-type lines. Most dependent mutant line: OVMIU (Ovarian Epithelial Tumor): -0.4359"
  },
  {
    "mutation": "ZNF502",
    "target_gene": "TBK1",
    "n_mutant_lines": 3,
    "n_wt_lines": 2082,
    "mutant_mean_score": -0.0178,
    "wt_mean_score": -0.0165,
    "effect_size": -0.0014,
    "p_value": 0.9760724598409132,
    "is_significant": true,
    "most_dependent_line": "HCC461 (Non-Small Cell Lung Cancer): -0.1000",
    "mutant_lines_sample": [
      "HCC461",
      "JHH7",
      "JHH7"
    ],
    "summary": "ZNF502 mutation shows synthetic lethality with TBK1. Effect size: -0.001 (p=0.9761). Tested in 3 mutant lines vs 2082 wild-type lines. Most dependent mutant line: HCC461 (Non-Small Cell Lung Cancer): -0.1000"
  },
  {
    "mutation": "CDC25A",
    "target_gene": "TBK1",
    "n_mutant_lines": 3,
    "n_wt_lines": 2082,
    "mutant_mean_score": -0.0878,
    "wt_mean_score": -0.0164,
    "effect_size": -0.0715,
    "p_value": 2.6704481925566606e-119,
    "is_significant": true,
    "most_dependent_line": "22RV1 (Prostate Adenocarcinoma): -0.0878",
    "mutant_lines_sample": [
      "22RV1",
      "22RV1",
      "22RV1"
    ],
    "summary": "CDC25A mutation shows synthetic lethality with TBK1. Effect size: -0.071 (p=0.0000). Tested in 3 mutant lines vs 2082 wild-type lines. Most dependent mutant line: 22RV1 (Prostate Adenocarcinoma): -0.0878"
  },
  {
    "mutation": "CDC25A",
    "target_gene": "CLK4",
    "n_mutant_lines": 3,
    "n_wt_lines": 2082,
    "mutant_mean_score": -0.4313,
    "wt_mean_score": -0.0356,
    "effect_size": -0.3957,
    "p_value": 0.0,
    "is_significant": true,
    "most_dependent_line": "22RV1 (Prostate Adenocarcinoma): -0.4313",
    "mutant_lines_sample": [
      "22RV1",
      "22RV1",
      "22RV1"
    ],
    "summary": "CDC25A mutation shows synthetic lethality with CLK4. Effect size: -0.396 (p=0.0000). Tested in 3 mutant lines vs 2082 wild-type lines. Most dependent mutant line: 22RV1 (Prostate Adenocarcinoma): -0.4313"
  },
  {
    "mutation": "RHOA",
    "target_gene": "MYLK4",
    "n_mutant_lines": 27,
    "n_wt_lines": 2056,
    "mutant_mean_score": 0.0636,
    "wt_mean_score": 0.0805,
    "effect_size": -0.0169,
    "p_value": 0.3618277967783238,
    "is_significant": true,
    "most_dependent_line": "PCI6A (Head and Neck Squamous Cell Carcinoma): -0.1336",
    "mutant_lines_sample": [
      "CCK81",
      "CCK81",
      "JAR",
      "JAR",
      "PCI6A"
    ],
    "summary": "RHOA mutation shows synthetic lethality with MYLK4. Effect size: -0.017 (p=0.3618). Tested in 27 mutant lines vs 2056 wild-type lines. Most dependent mutant line: PCI6A (Head and Neck Squamous Cell Carcinoma): -0.1336"
  },
  {
    "mutation": "RHOA",
    "target_gene": "TBK1",
    "n_mutant_lines": 27,
    "n_wt_lines": 2056,
    "mutant_mean_score": -0.0418,
    "wt_mean_score": -0.0161,
    "effect_size": -0.0257,
    "p_value": 0.3157254882806654,
    "is_significant": true,
    "most_dependent_line": "SNU16 (Esophagogastric Adenocarcinoma): -0.4520",
    "mutant_lines_sample": [
      "CCK81",
      "CCK81",
      "JAR",
      "JAR",
      "PCI6A"
    ],
    "summary": "RHOA mutation shows synthetic lethality with TBK1. Effect size: -0.026 (p=0.3157). Tested in 27 mutant lines vs 2056 wild-type lines. Most dependent mutant line: SNU16 (Esophagogastric Adenocarcinoma): -0.4520"
  },
  {
    "mutation": "RHOA",
    "target_gene": "CLK4",
    "n_mutant_lines": 27,
    "n_wt_lines": 2056,
    "mutant_mean_score": -0.0379,
    "wt_mean_score": -0.036,
    "effect_size": -0.0019,
    "p_value": 0.9445771996050564,
    "is_significant": true,
    "most_dependent_line": "SUSA (Non-Seminomatous Germ Cell Tumor): -0.3623",
    "mutant_lines_sample": [
      "CCK81",
      "CCK81",
      "JAR",
      "JAR",
      "PCI6A"
    ],
    "summary": "RHOA mutation shows synthetic lethality with CLK4. Effect size: -0.002 (p=0.9446). Tested in 27 mutant lines vs 2056 wild-type lines. Most dependent mutant line: SUSA (Non-Seminomatous Germ Cell Tumor): -0.3623"
  },
  {
    "mutation": "PBRM1",
    "target_gene": "STK17A",
    "n_mutant_lines": 4,
    "n_wt_lines": 2078,
    "mutant_mean_score": -0.0694,
    "wt_mean_score": -0.0353,
    "effect_size": -0.0341,
    "p_value": 1.3316038783328052e-30,
    "is_significant": true,
    "most_dependent_line": "ESS1 (Uterine Sarcoma/Mesenchymal): -0.0700",
    "mutant_lines_sample": [
      "ESS1",
      "ESS1",
      "ESS1",
      "HCC2998"
    ],
    "summary": "PBRM1 mutation shows synthetic lethality with STK17A. Effect size: -0.034 (p=0.0000). Tested in 4 mutant lines vs 2078 wild-type lines. Most dependent mutant line: ESS1 (Uterine Sarcoma/Mesenchymal): -0.0700"
  },
  {
    "mutation": "PBRM1",
    "target_gene": "TBK1",
    "n_mutant_lines": 4,
    "n_wt_lines": 2078,
    "mutant_mean_score": -0.1247,
    "wt_mean_score": -0.0161,
    "effect_size": -0.1086,
    "p_value": 0.0847447099351862,
    "is_significant": true,
    "most_dependent_line": "HCC2998 (Colorectal Adenocarcinoma): -0.2532",
    "mutant_lines_sample": [
      "ESS1",
      "ESS1",
      "ESS1",
      "HCC2998"
    ],
    "summary": "PBRM1 mutation shows synthetic lethality with TBK1. Effect size: -0.109 (p=0.0847). Tested in 4 mutant lines vs 2078 wild-type lines. Most dependent mutant line: HCC2998 (Colorectal Adenocarcinoma): -0.2532"
  },
  {
    "mutation": "PIK3CB",
    "target_gene": "TBK1",
    "n_mutant_lines": 6,
    "n_wt_lines": 2077,
    "mutant_mean_score": -0.0756,
    "wt_mean_score": -0.0164,
    "effect_size": -0.0593,
    "p_value": 0.0249263288558355,
    "is_significant": true,
    "most_dependent_line": "RCCFG2 (Renal Cell Carcinoma): -0.1603",
    "mutant_lines_sample": [
      "LOVO",
      "LOVO",
      "EOL1",
      "EOL1",
      "EOL1"
    ],
    "summary": "PIK3CB mutation shows synthetic lethality with TBK1. Effect size: -0.059 (p=0.0249). Tested in 6 mutant lines vs 2077 wild-type lines. Most dependent mutant line: RCCFG2 (Renal Cell Carcinoma): -0.1603"
  },
  {
    "mutation": "PRKCI",
    "target_gene": "STK17A",
    "n_mutant_lines": 6,
    "n_wt_lines": 2079,
    "mutant_mean_score": -0.0778,
    "wt_mean_score": -0.0352,
    "effect_size": -0.0426,
    "p_value": 9.368258170680842e-05,
    "is_significant": true,
    "most_dependent_line": "HT115 (Colorectal Adenocarcinoma): -0.0946",
    "mutant_lines_sample": [
      "ESS1",
      "ESS1",
      "ESS1",
      "HCC2998",
      "HT115"
    ],
    "summary": "PRKCI mutation shows synthetic lethality with STK17A. Effect size: -0.043 (p=0.0001). Tested in 6 mutant lines vs 2079 wild-type lines. Most dependent mutant line: HT115 (Colorectal Adenocarcinoma): -0.0946"
  },
  {
    "mutation": "PRKCI",
    "target_gene": "TBK1",
    "n_mutant_lines": 6,
    "n_wt_lines": 2079,
    "mutant_mean_score": -0.1343,
    "wt_mean_score": -0.0161,
    "effect_size": -0.1182,
    "p_value": 0.0078440603074901,
    "is_significant": true,
    "most_dependent_line": "HCC2998 (Colorectal Adenocarcinoma): -0.2532",
    "mutant_lines_sample": [
      "ESS1",
      "ESS1",
      "ESS1",
      "HCC2998",
      "HT115"
    ],
    "summary": "PRKCI mutation shows synthetic lethality with TBK1. Effect size: -0.118 (p=0.0078). Tested in 6 mutant lines vs 2079 wild-type lines. Most dependent mutant line: HCC2998 (Colorectal Adenocarcinoma): -0.2532"
  },
  {
    "mutation": "PIK3CA",
    "target_gene": "MYLK4",
    "n_mutant_lines": 201,
    "n_wt_lines": 1874,
    "mutant_mean_score": 0.0799,
    "wt_mean_score": 0.0804,
    "effect_size": -0.0005,
    "p_value": 0.952258659755148,
    "is_significant": true,
    "most_dependent_line": "NP5 (Diffuse Glioma): -0.3130",
    "mutant_lines_sample": [
      "SW403",
      "SW403",
      "ESS1",
      "ESS1",
      "ESS1"
    ],
    "summary": "PIK3CA mutation shows synthetic lethality with MYLK4. Effect size: -0.001 (p=0.9523). Tested in 201 mutant lines vs 1874 wild-type lines. Most dependent mutant line: NP5 (Diffuse Glioma): -0.3130"
  },
  {
    "mutation": "PIK3CA",
    "target_gene": "TBK1",
    "n_mutant_lines": 201,
    "n_wt_lines": 1874,
    "mutant_mean_score": -0.0201,
    "wt_mean_score": -0.0163,
    "effect_size": -0.0039,
    "p_value": 0.6968388300663595,
    "is_significant": true,
    "most_dependent_line": "MFE296 (Endometrial Carcinoma): -0.5710",
    "mutant_lines_sample": [
      "SW403",
      "SW403",
      "ESS1",
      "ESS1",
      "ESS1"
    ],
    "summary": "PIK3CA mutation shows synthetic lethality with TBK1. Effect size: -0.004 (p=0.6968). Tested in 201 mutant lines vs 1874 wild-type lines. Most dependent mutant line: MFE296 (Endometrial Carcinoma): -0.5710"
  },
  {
    "mutation": "C3orf70",
    "target_gene": "STK17A",
    "n_mutant_lines": 3,
    "n_wt_lines": 2082,
    "mutant_mean_score": -0.0427,
    "wt_mean_score": -0.0353,
    "effect_size": -0.0074,
    "p_value": 0.9173821933546822,
    "is_significant": true,
    "most_dependent_line": "647V (Bladder Urothelial Carcinoma): -0.1673",
    "mutant_lines_sample": [
      "647V",
      "SW756",
      "MDAMB453"
    ],
    "summary": "C3orf70 mutation shows synthetic lethality with STK17A. Effect size: -0.007 (p=0.9174). Tested in 3 mutant lines vs 2082 wild-type lines. Most dependent mutant line: 647V (Bladder Urothelial Carcinoma): -0.1673"
  },
  {
    "mutation": "C3orf70",
    "target_gene": "MYLK4",
    "n_mutant_lines": 3,
    "n_wt_lines": 2082,
    "mutant_mean_score": 0.0336,
    "wt_mean_score": 0.0804,
    "effect_size": -0.0467,
    "p_value": 0.0690254378679416,
    "is_significant": true,
    "most_dependent_line": "SW756 (Cervical Squamous Cell Carcinoma): 0.0069",
    "mutant_lines_sample": [
      "647V",
      "SW756",
      "MDAMB453"
    ],
    "summary": "C3orf70 mutation shows synthetic lethality with MYLK4. Effect size: -0.047 (p=0.0690). Tested in 3 mutant lines vs 2082 wild-type lines. Most dependent mutant line: SW756 (Cervical Squamous Cell Carcinoma): 0.0069"
  },
  {
    "mutation": "C3orf70",
    "target_gene": "CLK4",
    "n_mutant_lines": 3,
    "n_wt_lines": 2082,
    "mutant_mean_score": -0.0953,
    "wt_mean_score": -0.036,
    "effect_size": -0.0593,
    "p_value": 0.3137660267545685,
    "is_significant": true,
    "most_dependent_line": "SW756 (Cervical Squamous Cell Carcinoma): -0.1427",
    "mutant_lines_sample": [
      "647V",
      "SW756",
      "MDAMB453"
    ],
    "summary": "C3orf70 mutation shows synthetic lethality with CLK4. Effect size: -0.059 (p=0.3138). Tested in 3 mutant lines vs 2082 wild-type lines. Most dependent mutant line: SW756 (Cervical Squamous Cell Carcinoma): -0.1427"
  },
  {
    "mutation": "TP63",
    "target_gene": "STK17A",
    "n_mutant_lines": 3,
    "n_wt_lines": 2082,
    "mutant_mean_score": -0.1173,
    "wt_mean_score": -0.0352,
    "effect_size": -0.0821,
    "p_value": 2.412479397942091e-25,
    "is_significant": true,
    "most_dependent_line": "MM485 (Melanoma): -0.1204",
    "mutant_lines_sample": [
      "A2058",
      "A2058",
      "MM485"
    ],
    "summary": "TP63 mutation shows synthetic lethality with STK17A. Effect size: -0.082 (p=0.0000). Tested in 3 mutant lines vs 2082 wild-type lines. Most dependent mutant line: MM485 (Melanoma): -0.1204"
  },
  {
    "mutation": "TP63",
    "target_gene": "MYLK4",
    "n_mutant_lines": 3,
    "n_wt_lines": 2082,
    "mutant_mean_score": 0.0696,
    "wt_mean_score": 0.0803,
    "effect_size": -0.0107,
    "p_value": 0.9021728418260584,
    "is_significant": true,
    "most_dependent_line": "A2058 (Melanoma): -0.0073",
    "mutant_lines_sample": [
      "A2058",
      "A2058",
      "MM485"
    ],
    "summary": "TP63 mutation shows synthetic lethality with MYLK4. Effect size: -0.011 (p=0.9022). Tested in 3 mutant lines vs 2082 wild-type lines. Most dependent mutant line: A2058 (Melanoma): -0.0073"
  },
  {
    "mutation": "TP63",
    "target_gene": "CLK4",
    "n_mutant_lines": 3,
    "n_wt_lines": 2082,
    "mutant_mean_score": -0.059,
    "wt_mean_score": -0.0361,
    "effect_size": -0.0229,
    "p_value": 0.6972117251883153,
    "is_significant": true,
    "most_dependent_line": "MM485 (Melanoma): -0.1606",
    "mutant_lines_sample": [
      "A2058",
      "A2058",
      "MM485"
    ],
    "summary": "TP63 mutation shows synthetic lethality with CLK4. Effect size: -0.023 (p=0.6972). Tested in 3 mutant lines vs 2082 wild-type lines. Most dependent mutant line: MM485 (Melanoma): -0.1606"
  },
  {
    "mutation": "MB21D2",
    "target_gene": "STK17A",
    "n_mutant_lines": 3,
    "n_wt_lines": 2082,
    "mutant_mean_score": -0.0429,
    "wt_mean_score": -0.0353,
    "effect_size": -0.0076,
    "p_value": 0.6925565886932976,
    "is_significant": true,
    "most_dependent_line": "NCIH2009 (Non-Small Cell Lung Cancer): -0.0760",
    "mutant_lines_sample": [
      "NCIH2009",
      "NCIH650",
      "NCIH650"
    ],
    "summary": "MB21D2 mutation shows synthetic lethality with STK17A. Effect size: -0.008 (p=0.6926). Tested in 3 mutant lines vs 2082 wild-type lines. Most dependent mutant line: NCIH2009 (Non-Small Cell Lung Cancer): -0.0760"
  },
  {
    "mutation": "MB21D2",
    "target_gene": "TBK1",
    "n_mutant_lines": 3,
    "n_wt_lines": 2082,
    "mutant_mean_score": -0.0434,
    "wt_mean_score": -0.0164,
    "effect_size": -0.027,
    "p_value": 0.6866742659398432,
    "is_significant": true,
    "most_dependent_line": "NCIH650 (Non-Small Cell Lung Cancer): -0.1012",
    "mutant_lines_sample": [
      "NCIH2009",
      "NCIH650",
      "NCIH650"
    ],
    "summary": "MB21D2 mutation shows synthetic lethality with TBK1. Effect size: -0.027 (p=0.6867). Tested in 3 mutant lines vs 2082 wild-type lines. Most dependent mutant line: NCIH650 (Non-Small Cell Lung Cancer): -0.1012"
  },
  {
    "mutation": "MB21D2",
    "target_gene": "CLK4",
    "n_mutant_lines": 3,
    "n_wt_lines": 2082,
    "mutant_mean_score": -0.2709,
    "wt_mean_score": -0.0358,
    "effect_size": -0.2351,
    "p_value": 0.1779591279045606,
    "is_significant": true,
    "most_dependent_line": "NCIH650 (Non-Small Cell Lung Cancer): -0.3861",
    "mutant_lines_sample": [
      "NCIH2009",
      "NCIH650",
      "NCIH650"
    ],
    "summary": "MB21D2 mutation shows synthetic lethality with CLK4. Effect size: -0.235 (p=0.1780). Tested in 3 mutant lines vs 2082 wild-type lines. Most dependent mutant line: NCIH650 (Non-Small Cell Lung Cancer): -0.3861"
  },
  {
    "mutation": "ZNF732",
    "target_gene": "MYLK4",
    "n_mutant_lines": 5,
    "n_wt_lines": 2080,
    "mutant_mean_score": 0.0392,
    "wt_mean_score": 0.0804,
    "effect_size": -0.0412,
    "p_value": 0.235967695676252,
    "is_significant": true,
    "most_dependent_line": "HEC251 (Endometrial Carcinoma): -0.0088",
    "mutant_lines_sample": [
      "HCC2998",
      "SCMCRM2",
      "SCMCRM2",
      "HEC251",
      "HEC251"
    ],
    "summary": "ZNF732 mutation shows synthetic lethality with MYLK4. Effect size: -0.041 (p=0.2360). Tested in 5 mutant lines vs 2080 wild-type lines. Most dependent mutant line: HEC251 (Endometrial Carcinoma): -0.0088"
  },
  {
    "mutation": "ZNF732",
    "target_gene": "TBK1",
    "n_mutant_lines": 5,
    "n_wt_lines": 2080,
    "mutant_mean_score": -0.1398,
    "wt_mean_score": -0.0162,
    "effect_size": -0.1237,
    "p_value": 0.0168745948112559,
    "is_significant": true,
    "most_dependent_line": "HCC2998 (Colorectal Adenocarcinoma): -0.2532",
    "mutant_lines_sample": [
      "HCC2998",
      "SCMCRM2",
      "SCMCRM2",
      "HEC251",
      "HEC251"
    ],
    "summary": "ZNF732 mutation shows synthetic lethality with TBK1. Effect size: -0.124 (p=0.0169). Tested in 5 mutant lines vs 2080 wild-type lines. Most dependent mutant line: HCC2998 (Colorectal Adenocarcinoma): -0.2532"
  },
  {
    "mutation": "FGFR3",
    "target_gene": "STK17A",
    "n_mutant_lines": 10,
    "n_wt_lines": 2072,
    "mutant_mean_score": -0.1178,
    "wt_mean_score": -0.0349,
    "effect_size": -0.0829,
    "p_value": 0.0053391001991102,
    "is_significant": true,
    "most_dependent_line": "UMUC16 (Bladder Urothelial Carcinoma): -0.1970",
    "mutant_lines_sample": [
      "UMUC16",
      "NB4",
      "NB4",
      "OPM2 (UMF-815H (UMF-815H (UMF-815H (UMF-815H",
      "UMF-815K)"
    ],
    "summary": "FGFR3 mutation shows synthetic lethality with STK17A. Effect size: -0.083 (p=0.0053). Tested in 10 mutant lines vs 2072 wild-type lines. Most dependent mutant line: UMUC16 (Bladder Urothelial Carcinoma): -0.1970"
  },
  {
    "mutation": "FGFR3",
    "target_gene": "MYLK4",
    "n_mutant_lines": 10,
    "n_wt_lines": 2072,
    "mutant_mean_score": 0.0124,
    "wt_mean_score": 0.0808,
    "effect_size": -0.0684,
    "p_value": 0.0241774594900631,
    "is_significant": true,
    "most_dependent_line": "J82 (Bladder Urothelial Carcinoma): -0.1041",
    "mutant_lines_sample": [
      "UMUC16",
      "NB4",
      "NB4",
      "OPM2 (UMF-815H (UMF-815H (UMF-815H (UMF-815H",
      "UMF-815K)"
    ],
    "summary": "FGFR3 mutation shows synthetic lethality with MYLK4. Effect size: -0.068 (p=0.0242). Tested in 10 mutant lines vs 2072 wild-type lines. Most dependent mutant line: J82 (Bladder Urothelial Carcinoma): -0.1041"
  },
  {
    "mutation": "FGFR3",
    "target_gene": "TBK1",
    "n_mutant_lines": 10,
    "n_wt_lines": 2072,
    "mutant_mean_score": -0.1099,
    "wt_mean_score": -0.016,
    "effect_size": -0.0938,
    "p_value": 0.0238528051991728,
    "is_significant": true,
    "most_dependent_line": "KMS11 (Mature B-Cell Neoplasms): -0.2586",
    "mutant_lines_sample": [
      "UMUC16",
      "NB4",
      "NB4",
      "OPM2 (UMF-815H (UMF-815H (UMF-815H (UMF-815H",
      "UMF-815K)"
    ],
    "summary": "FGFR3 mutation shows synthetic lethality with TBK1. Effect size: -0.094 (p=0.0239). Tested in 10 mutant lines vs 2072 wild-type lines. Most dependent mutant line: KMS11 (Mature B-Cell Neoplasms): -0.2586"
  },
  {
    "mutation": "FGFR3",
    "target_gene": "CLK4",
    "n_mutant_lines": 10,
    "n_wt_lines": 2072,
    "mutant_mean_score": -0.0417,
    "wt_mean_score": -0.036,
    "effect_size": -0.0057,
    "p_value": 0.758680506982133,
    "is_significant": true,
    "most_dependent_line": "J82 (Bladder Urothelial Carcinoma): -0.1644",
    "mutant_lines_sample": [
      "UMUC16",
      "NB4",
      "NB4",
      "OPM2 (UMF-815H (UMF-815H (UMF-815H (UMF-815H",
      "UMF-815K)"
    ],
    "summary": "FGFR3 mutation shows synthetic lethality with CLK4. Effect size: -0.006 (p=0.7587). Tested in 10 mutant lines vs 2072 wild-type lines. Most dependent mutant line: J82 (Bladder Urothelial Carcinoma): -0.1644"
  },
  {
    "mutation": "KIT",
    "target_gene": "STK17A",
    "n_mutant_lines": 3,
    "n_wt_lines": 2078,
    "mutant_mean_score": -0.2179,
    "wt_mean_score": -0.0351,
    "effect_size": -0.1828,
    "p_value": 0.1219318978861894,
    "is_significant": true,
    "most_dependent_line": "KASUMI1 (Acute Myeloid Leukemia): -0.2884",
    "mutant_lines_sample": [
      "MM100511",
      "KASUMI1",
      "KASUMI1"
    ],
    "summary": "KIT mutation shows synthetic lethality with STK17A. Effect size: -0.183 (p=0.1219). Tested in 3 mutant lines vs 2078 wild-type lines. Most dependent mutant line: KASUMI1 (Acute Myeloid Leukemia): -0.2884"
  },
  {
    "mutation": "KIT",
    "target_gene": "MYLK4",
    "n_mutant_lines": 3,
    "n_wt_lines": 2078,
    "mutant_mean_score": -0.1205,
    "wt_mean_score": 0.0808,
    "effect_size": -0.2013,
    "p_value": 0.0636615621022357,
    "is_significant": true,
    "most_dependent_line": "MM100511 (Melanoma): -0.2276",
    "mutant_lines_sample": [
      "MM100511",
      "KASUMI1",
      "KASUMI1"
    ],
    "summary": "KIT mutation shows synthetic lethality with MYLK4. Effect size: -0.201 (p=0.0637). Tested in 3 mutant lines vs 2078 wild-type lines. Most dependent mutant line: MM100511 (Melanoma): -0.2276"
  },
  {
    "mutation": "KIT",
    "target_gene": "TBK1",
    "n_mutant_lines": 3,
    "n_wt_lines": 2078,
    "mutant_mean_score": -0.07,
    "wt_mean_score": -0.0162,
    "effect_size": -0.0538,
    "p_value": 0.2760987644306305,
    "is_significant": true,
    "most_dependent_line": "KASUMI1 (Acute Myeloid Leukemia): -0.1063",
    "mutant_lines_sample": [
      "MM100511",
      "KASUMI1",
      "KASUMI1"
    ],
    "summary": "KIT mutation shows synthetic lethality with TBK1. Effect size: -0.054 (p=0.2761). Tested in 3 mutant lines vs 2078 wild-type lines. Most dependent mutant line: KASUMI1 (Acute Myeloid Leukemia): -0.1063"
  },
  {
    "mutation": "KDR",
    "target_gene": "MYLK4",
    "n_mutant_lines": 6,
    "n_wt_lines": 2078,
    "mutant_mean_score": 0.008,
    "wt_mean_score": 0.0805,
    "effect_size": -0.0725,
    "p_value": 0.0003012087846171,
    "is_significant": true,
    "most_dependent_line": "COLO792 (Melanoma): -0.0101",
    "mutant_lines_sample": [
      "COLO792",
      "COLO792",
      "NZM3",
      "MDST8",
      "KMRC1"
    ],
    "summary": "KDR mutation shows synthetic lethality with MYLK4. Effect size: -0.072 (p=0.0003). Tested in 6 mutant lines vs 2078 wild-type lines. Most dependent mutant line: COLO792 (Melanoma): -0.0101"
  },
  {
    "mutation": "KDR",
    "target_gene": "TBK1",
    "n_mutant_lines": 6,
    "n_wt_lines": 2078,
    "mutant_mean_score": -0.0205,
    "wt_mean_score": -0.0164,
    "effect_size": -0.004,
    "p_value": 0.8392095825223942,
    "is_significant": true,
    "most_dependent_line": "MDST8 (Colorectal Adenocarcinoma): -0.0867",
    "mutant_lines_sample": [
      "COLO792",
      "COLO792",
      "NZM3",
      "MDST8",
      "KMRC1"
    ],
    "summary": "KDR mutation shows synthetic lethality with TBK1. Effect size: -0.004 (p=0.8392). Tested in 6 mutant lines vs 2078 wild-type lines. Most dependent mutant line: MDST8 (Colorectal Adenocarcinoma): -0.0867"
  },
  {
    "mutation": "KDR",
    "target_gene": "CLK4",
    "n_mutant_lines": 6,
    "n_wt_lines": 2078,
    "mutant_mean_score": -0.0824,
    "wt_mean_score": -0.036,
    "effect_size": -0.0464,
    "p_value": 0.2784603964480762,
    "is_significant": true,
    "most_dependent_line": "MDST8 (Colorectal Adenocarcinoma): -0.2028",
    "mutant_lines_sample": [
      "COLO792",
      "COLO792",
      "NZM3",
      "MDST8",
      "KMRC1"
    ],
    "summary": "KDR mutation shows synthetic lethality with CLK4. Effect size: -0.046 (p=0.2785). Tested in 6 mutant lines vs 2078 wild-type lines. Most dependent mutant line: MDST8 (Colorectal Adenocarcinoma): -0.2028"
  },
  {
    "mutation": "FBXW7",
    "target_gene": "STK17A",
    "n_mutant_lines": 53,
    "n_wt_lines": 2023,
    "mutant_mean_score": -0.0609,
    "wt_mean_score": -0.0347,
    "effect_size": -0.0262,
    "p_value": 0.1455913923927372,
    "is_significant": true,
    "most_dependent_line": "CMLT1 (Myeloproliferative Neoplasms): -0.3156",
    "mutant_lines_sample": [
      "ESS1",
      "ESS1",
      "ESS1",
      "JHUEM1",
      "LOVO"
    ],
    "summary": "FBXW7 mutation shows synthetic lethality with STK17A. Effect size: -0.026 (p=0.1456). Tested in 53 mutant lines vs 2023 wild-type lines. Most dependent mutant line: CMLT1 (Myeloproliferative Neoplasms): -0.3156"
  },
  {
    "mutation": "FBXW7",
    "target_gene": "TBK1",
    "n_mutant_lines": 53,
    "n_wt_lines": 2023,
    "mutant_mean_score": -0.0442,
    "wt_mean_score": -0.0159,
    "effect_size": -0.0283,
    "p_value": 0.1252389942691064,
    "is_significant": true,
    "most_dependent_line": "SNU81 (Colorectal Adenocarcinoma): -0.6411",
    "mutant_lines_sample": [
      "ESS1",
      "ESS1",
      "ESS1",
      "JHUEM1",
      "LOVO"
    ],
    "summary": "FBXW7 mutation shows synthetic lethality with TBK1. Effect size: -0.028 (p=0.1252). Tested in 53 mutant lines vs 2023 wild-type lines. Most dependent mutant line: SNU81 (Colorectal Adenocarcinoma): -0.6411"
  },
  {
    "mutation": "SDHA",
    "target_gene": "MYLK4",
    "n_mutant_lines": 4,
    "n_wt_lines": 2081,
    "mutant_mean_score": 0.0722,
    "wt_mean_score": 0.0803,
    "effect_size": -0.0081,
    "p_value": 0.8010440880969958,
    "is_significant": true,
    "most_dependent_line": "OACM51 (Esophagogastric Adenocarcinoma): 0.0215",
    "mutant_lines_sample": [
      "OACM51",
      "OACM51",
      "SKUT1",
      "SKUT1"
    ],
    "summary": "SDHA mutation shows synthetic lethality with MYLK4. Effect size: -0.008 (p=0.8010). Tested in 4 mutant lines vs 2081 wild-type lines. Most dependent mutant line: OACM51 (Esophagogastric Adenocarcinoma): 0.0215"
  },
  {
    "mutation": "SDHA",
    "target_gene": "TBK1",
    "n_mutant_lines": 4,
    "n_wt_lines": 2081,
    "mutant_mean_score": -0.0856,
    "wt_mean_score": -0.0163,
    "effect_size": -0.0693,
    "p_value": 9.57757716456118e-05,
    "is_significant": true,
    "most_dependent_line": "SKUT1 (Uterine Sarcoma/Mesenchymal): -0.0949",
    "mutant_lines_sample": [
      "OACM51",
      "OACM51",
      "SKUT1",
      "SKUT1"
    ],
    "summary": "SDHA mutation shows synthetic lethality with TBK1. Effect size: -0.069 (p=0.0001). Tested in 4 mutant lines vs 2081 wild-type lines. Most dependent mutant line: SKUT1 (Uterine Sarcoma/Mesenchymal): -0.0949"
  },
  {
    "mutation": "PIK3R1",
    "target_gene": "STK17A",
    "n_mutant_lines": 10,
    "n_wt_lines": 2075,
    "mutant_mean_score": -0.0759,
    "wt_mean_score": -0.0352,
    "effect_size": -0.0407,
    "p_value": 0.1495812033981384,
    "is_significant": true,
    "most_dependent_line": "SNU81 (Colorectal Adenocarcinoma): -0.1911",
    "mutant_lines_sample": [
      "BL70",
      "BL70",
      "REH",
      "HEC59",
      "HEC59"
    ],
    "summary": "PIK3R1 mutation shows synthetic lethality with STK17A. Effect size: -0.041 (p=0.1496). Tested in 10 mutant lines vs 2075 wild-type lines. Most dependent mutant line: SNU81 (Colorectal Adenocarcinoma): -0.1911"
  },
  {
    "mutation": "PIK3R1",
    "target_gene": "TBK1",
    "n_mutant_lines": 10,
    "n_wt_lines": 2075,
    "mutant_mean_score": -0.1092,
    "wt_mean_score": -0.016,
    "effect_size": -0.0932,
    "p_value": 0.2307384556729761,
    "is_significant": true,
    "most_dependent_line": "SNU81 (Colorectal Adenocarcinoma): -0.6411",
    "mutant_lines_sample": [
      "BL70",
      "BL70",
      "REH",
      "HEC59",
      "HEC59"
    ],
    "summary": "PIK3R1 mutation shows synthetic lethality with TBK1. Effect size: -0.093 (p=0.2307). Tested in 10 mutant lines vs 2075 wild-type lines. Most dependent mutant line: SNU81 (Colorectal Adenocarcinoma): -0.6411"
  },
  {
    "mutation": "AP3B1",
    "target_gene": "MYLK4",
    "n_mutant_lines": 3,
    "n_wt_lines": 2082,
    "mutant_mean_score": -0.017,
    "wt_mean_score": 0.0804,
    "effect_size": -0.0975,
    "p_value": 0.2774700897585224,
    "is_significant": true,
    "most_dependent_line": "BC2 (Mature B-Cell Neoplasms): -0.1489",
    "mutant_lines_sample": [
      "BC2",
      "MDAMB453",
      "MDAMB453"
    ],
    "summary": "AP3B1 mutation shows synthetic lethality with MYLK4. Effect size: -0.098 (p=0.2775). Tested in 3 mutant lines vs 2082 wild-type lines. Most dependent mutant line: BC2 (Mature B-Cell Neoplasms): -0.1489"
  },
  {
    "mutation": "AP3B1",
    "target_gene": "CLK4",
    "n_mutant_lines": 3,
    "n_wt_lines": 2082,
    "mutant_mean_score": -0.0803,
    "wt_mean_score": -0.0361,
    "effect_size": -0.0442,
    "p_value": 0.5158597441734732,
    "is_significant": true,
    "most_dependent_line": "MDAMB453 (Invasive Breast Carcinoma): -0.1367",
    "mutant_lines_sample": [
      "BC2",
      "MDAMB453",
      "MDAMB453"
    ],
    "summary": "AP3B1 mutation shows synthetic lethality with CLK4. Effect size: -0.044 (p=0.5159). Tested in 3 mutant lines vs 2082 wild-type lines. Most dependent mutant line: MDAMB453 (Invasive Breast Carcinoma): -0.1367"
  },
  {
    "mutation": "APC",
    "target_gene": "CLK4",
    "n_mutant_lines": 31,
    "n_wt_lines": 2028,
    "mutant_mean_score": -0.0608,
    "wt_mean_score": -0.0362,
    "effect_size": -0.0246,
    "p_value": 0.386606423055682,
    "is_significant": true,
    "most_dependent_line": "SKMEL30 (Melanoma): -0.4312",
    "mutant_lines_sample": [
      "CL40",
      "CL40",
      "LOVO",
      "LOVO",
      "JVE015"
    ],
    "summary": "APC mutation shows synthetic lethality with CLK4. Effect size: -0.025 (p=0.3866). Tested in 31 mutant lines vs 2028 wild-type lines. Most dependent mutant line: SKMEL30 (Melanoma): -0.4312"
  },
  {
    "mutation": "PCDHGA1",
    "target_gene": "TBK1",
    "n_mutant_lines": 4,
    "n_wt_lines": 2081,
    "mutant_mean_score": -0.1171,
    "wt_mean_score": -0.0163,
    "effect_size": -0.1008,
    "p_value": 0.0161950987703379,
    "is_significant": true,
    "most_dependent_line": "HT115 (Colorectal Adenocarcinoma): -0.1534",
    "mutant_lines_sample": [
      "HT115",
      "HT115",
      "HEC251",
      "HEC251"
    ],
    "summary": "PCDHGA1 mutation shows synthetic lethality with TBK1. Effect size: -0.101 (p=0.0162). Tested in 4 mutant lines vs 2081 wild-type lines. Most dependent mutant line: HT115 (Colorectal Adenocarcinoma): -0.1534"
  },
  {
    "mutation": "PPP2R2B",
    "target_gene": "STK17A",
    "n_mutant_lines": 3,
    "n_wt_lines": 2082,
    "mutant_mean_score": -0.0827,
    "wt_mean_score": -0.0353,
    "effect_size": -0.0474,
    "p_value": 0.4714173942607926,
    "is_significant": true,
    "most_dependent_line": "SH4 (Melanoma): -0.1364",
    "mutant_lines_sample": [
      "SH4",
      "SH4",
      "H314"
    ],
    "summary": "PPP2R2B mutation shows synthetic lethality with STK17A. Effect size: -0.047 (p=0.4714). Tested in 3 mutant lines vs 2082 wild-type lines. Most dependent mutant line: SH4 (Melanoma): -0.1364"
  },
  {
    "mutation": "PPP2R2B",
    "target_gene": "MYLK4",
    "n_mutant_lines": 3,
    "n_wt_lines": 2082,
    "mutant_mean_score": 0.0346,
    "wt_mean_score": 0.0804,
    "effect_size": -0.0457,
    "p_value": 8.042957637346589e-14,
    "is_significant": true,
    "most_dependent_line": "H314 (Head and Neck Squamous Cell Carcinoma): 0.0315",
    "mutant_lines_sample": [
      "SH4",
      "SH4",
      "H314"
    ],
    "summary": "PPP2R2B mutation shows synthetic lethality with MYLK4. Effect size: -0.046 (p=0.0000). Tested in 3 mutant lines vs 2082 wild-type lines. Most dependent mutant line: H314 (Head and Neck Squamous Cell Carcinoma): 0.0315"
  },
  {
    "mutation": "PPP2R2B",
    "target_gene": "CLK4",
    "n_mutant_lines": 3,
    "n_wt_lines": 2082,
    "mutant_mean_score": -0.0997,
    "wt_mean_score": -0.036,
    "effect_size": -0.0636,
    "p_value": 0.5129593193438694,
    "is_significant": true,
    "most_dependent_line": "H314 (Head and Neck Squamous Cell Carcinoma): -0.2610",
    "mutant_lines_sample": [
      "SH4",
      "SH4",
      "H314"
    ],
    "summary": "PPP2R2B mutation shows synthetic lethality with CLK4. Effect size: -0.064 (p=0.5130). Tested in 3 mutant lines vs 2082 wild-type lines. Most dependent mutant line: H314 (Head and Neck Squamous Cell Carcinoma): -0.2610"
  },
  {
    "mutation": "TENM2",
    "target_gene": "STK17A",
    "n_mutant_lines": 3,
    "n_wt_lines": 2082,
    "mutant_mean_score": -0.1015,
    "wt_mean_score": -0.0353,
    "effect_size": -0.0662,
    "p_value": 2.03368671427774e-108,
    "is_significant": true,
    "most_dependent_line": "HUH1 (Hepatocellular Carcinoma): -0.1015",
    "mutant_lines_sample": [
      "HUH1",
      "HUH1",
      "HUH1"
    ],
    "summary": "TENM2 mutation shows synthetic lethality with STK17A. Effect size: -0.066 (p=0.0000). Tested in 3 mutant lines vs 2082 wild-type lines. Most dependent mutant line: HUH1 (Hepatocellular Carcinoma): -0.1015"
  },
  {
    "mutation": "TENM2",
    "target_gene": "TBK1",
    "n_mutant_lines": 3,
    "n_wt_lines": 2082,
    "mutant_mean_score": -0.0338,
    "wt_mean_score": -0.0164,
    "effect_size": -0.0174,
    "p_value": 2.0046165387120516e-09,
    "is_significant": true,
    "most_dependent_line": "HUH1 (Hepatocellular Carcinoma): -0.0338",
    "mutant_lines_sample": [
      "HUH1",
      "HUH1",
      "HUH1"
    ],
    "summary": "TENM2 mutation shows synthetic lethality with TBK1. Effect size: -0.017 (p=0.0000). Tested in 3 mutant lines vs 2082 wild-type lines. Most dependent mutant line: HUH1 (Hepatocellular Carcinoma): -0.0338"
  },
  {
    "mutation": "TENM2",
    "target_gene": "CLK4",
    "n_mutant_lines": 3,
    "n_wt_lines": 2082,
    "mutant_mean_score": -0.0987,
    "wt_mean_score": -0.036,
    "effect_size": -0.0627,
    "p_value": 1.0608751872182258e-113,
    "is_significant": true,
    "most_dependent_line": "HUH1 (Hepatocellular Carcinoma): -0.0987",
    "mutant_lines_sample": [
      "HUH1",
      "HUH1",
      "HUH1"
    ],
    "summary": "TENM2 mutation shows synthetic lethality with CLK4. Effect size: -0.063 (p=0.0000). Tested in 3 mutant lines vs 2082 wild-type lines. Most dependent mutant line: HUH1 (Hepatocellular Carcinoma): -0.0987"
  },
  {
    "mutation": "IRF4",
    "target_gene": "STK17A",
    "n_mutant_lines": 4,
    "n_wt_lines": 2081,
    "mutant_mean_score": -0.1023,
    "wt_mean_score": -0.0352,
    "effect_size": -0.067,
    "p_value": 0.1579056416023507,
    "is_significant": true,
    "most_dependent_line": "L428 (Hodgkin Lymphoma): -0.1644",
    "mutant_lines_sample": [
      "L428",
      "L428",
      "UHO1",
      "UHO1"
    ],
    "summary": "IRF4 mutation shows synthetic lethality with STK17A. Effect size: -0.067 (p=0.1579). Tested in 4 mutant lines vs 2081 wild-type lines. Most dependent mutant line: L428 (Hodgkin Lymphoma): -0.1644"
  },
  {
    "mutation": "IRF4",
    "target_gene": "TBK1",
    "n_mutant_lines": 4,
    "n_wt_lines": 2081,
    "mutant_mean_score": -0.0897,
    "wt_mean_score": -0.0163,
    "effect_size": -0.0733,
    "p_value": 0.1108556542700957,
    "is_significant": true,
    "most_dependent_line": "L428 (Hodgkin Lymphoma): -0.1465",
    "mutant_lines_sample": [
      "L428",
      "L428",
      "UHO1",
      "UHO1"
    ],
    "summary": "IRF4 mutation shows synthetic lethality with TBK1. Effect size: -0.073 (p=0.1109). Tested in 4 mutant lines vs 2081 wild-type lines. Most dependent mutant line: L428 (Hodgkin Lymphoma): -0.1465"
  },
  {
    "mutation": "HLA-A",
    "target_gene": "STK17A",
    "n_mutant_lines": 460,
    "n_wt_lines": 1512,
    "mutant_mean_score": -0.0382,
    "wt_mean_score": -0.0365,
    "effect_size": -0.0018,
    "p_value": 0.792971472222099,
    "is_significant": true,
    "most_dependent_line": "SCC3 (Non-Hodgkin Lymphoma): -0.4580",
    "mutant_lines_sample": [
      "NCIH1581",
      "G401",
      "G401",
      "SIMA",
      "KE97"
    ],
    "summary": "HLA-A mutation shows synthetic lethality with STK17A. Effect size: -0.002 (p=0.7930). Tested in 460 mutant lines vs 1512 wild-type lines. Most dependent mutant line: SCC3 (Non-Hodgkin Lymphoma): -0.4580"
  },
  {
    "mutation": "HLA-A",
    "target_gene": "TBK1",
    "n_mutant_lines": 460,
    "n_wt_lines": 1512,
    "mutant_mean_score": -0.0242,
    "wt_mean_score": -0.0145,
    "effect_size": -0.0097,
    "p_value": 0.1751544755694347,
    "is_significant": true,
    "most_dependent_line": "BECKER (Diffuse Glioma): -0.6361",
    "mutant_lines_sample": [
      "NCIH1581",
      "G401",
      "G401",
      "SIMA",
      "KE97"
    ],
    "summary": "HLA-A mutation shows synthetic lethality with TBK1. Effect size: -0.010 (p=0.1752). Tested in 460 mutant lines vs 1512 wild-type lines. Most dependent mutant line: BECKER (Diffuse Glioma): -0.6361"
  },
  {
    "mutation": "HLA-A",
    "target_gene": "CLK4",
    "n_mutant_lines": 460,
    "n_wt_lines": 1512,
    "mutant_mean_score": -0.0491,
    "wt_mean_score": -0.0326,
    "effect_size": -0.0165,
    "p_value": 0.0114802022630617,
    "is_significant": true,
    "most_dependent_line": "LAN2 (Neuroblastoma): -0.5263",
    "mutant_lines_sample": [
      "NCIH1581",
      "G401",
      "G401",
      "SIMA",
      "KE97"
    ],
    "summary": "HLA-A mutation shows synthetic lethality with CLK4. Effect size: -0.017 (p=0.0115). Tested in 460 mutant lines vs 1512 wild-type lines. Most dependent mutant line: LAN2 (Neuroblastoma): -0.5263"
  },
  {
    "mutation": "HLA-B",
    "target_gene": "STK17A",
    "n_mutant_lines": 104,
    "n_wt_lines": 1925,
    "mutant_mean_score": -0.0406,
    "wt_mean_score": -0.0363,
    "effect_size": -0.0043,
    "p_value": 0.7286261689285916,
    "is_significant": true,
    "most_dependent_line": "CMLT1 (Myeloproliferative Neoplasms): -0.3156",
    "mutant_lines_sample": [
      "HCC1937",
      "SKM1",
      "RMGI",
      "ES2",
      "HEC59"
    ],
    "summary": "HLA-B mutation shows synthetic lethality with STK17A. Effect size: -0.004 (p=0.7286). Tested in 104 mutant lines vs 1925 wild-type lines. Most dependent mutant line: CMLT1 (Myeloproliferative Neoplasms): -0.3156"
  },
  {
    "mutation": "COL21A1",
    "target_gene": "STK17A",
    "n_mutant_lines": 4,
    "n_wt_lines": 2081,
    "mutant_mean_score": -0.0894,
    "wt_mean_score": -0.0353,
    "effect_size": -0.0542,
    "p_value": 1.68308747785728e-08,
    "is_significant": true,
    "most_dependent_line": "NCIH2126 (Non-Small Cell Lung Cancer): -0.0944",
    "mutant_lines_sample": [
      "NCIH2126",
      "NCIH2126",
      "HS936T",
      "HS936T"
    ],
    "summary": "COL21A1 mutation shows synthetic lethality with STK17A. Effect size: -0.054 (p=0.0000). Tested in 4 mutant lines vs 2081 wild-type lines. Most dependent mutant line: NCIH2126 (Non-Small Cell Lung Cancer): -0.0944"
  },
  {
    "mutation": "COL21A1",
    "target_gene": "MYLK4",
    "n_mutant_lines": 4,
    "n_wt_lines": 2081,
    "mutant_mean_score": 0.0701,
    "wt_mean_score": 0.0803,
    "effect_size": -0.0102,
    "p_value": 0.8054015557881935,
    "is_significant": true,
    "most_dependent_line": "NCIH2126 (Non-Small Cell Lung Cancer): 0.0047",
    "mutant_lines_sample": [
      "NCIH2126",
      "NCIH2126",
      "HS936T",
      "HS936T"
    ],
    "summary": "COL21A1 mutation shows synthetic lethality with MYLK4. Effect size: -0.010 (p=0.8054). Tested in 4 mutant lines vs 2081 wild-type lines. Most dependent mutant line: NCIH2126 (Non-Small Cell Lung Cancer): 0.0047"
  },
  {
    "mutation": "COL21A1",
    "target_gene": "TBK1",
    "n_mutant_lines": 4,
    "n_wt_lines": 2081,
    "mutant_mean_score": -0.0209,
    "wt_mean_score": -0.0164,
    "effect_size": -0.0045,
    "p_value": 0.9106349372736984,
    "is_significant": true,
    "most_dependent_line": "HS936T (Melanoma): -0.0842",
    "mutant_lines_sample": [
      "NCIH2126",
      "NCIH2126",
      "HS936T",
      "HS936T"
    ],
    "summary": "COL21A1 mutation shows synthetic lethality with TBK1. Effect size: -0.004 (p=0.9106). Tested in 4 mutant lines vs 2081 wild-type lines. Most dependent mutant line: HS936T (Melanoma): -0.0842"
  },
  {
    "mutation": "DST",
    "target_gene": "STK17A",
    "n_mutant_lines": 3,
    "n_wt_lines": 2082,
    "mutant_mean_score": -0.0743,
    "wt_mean_score": -0.0353,
    "effect_size": -0.039,
    "p_value": 0.1937123151249676,
    "is_significant": true,
    "most_dependent_line": "HT115 (Colorectal Adenocarcinoma): -0.0946",
    "mutant_lines_sample": [
      "NZOV9",
      "HT115",
      "HT115"
    ],
    "summary": "DST mutation shows synthetic lethality with STK17A. Effect size: -0.039 (p=0.1937). Tested in 3 mutant lines vs 2082 wild-type lines. Most dependent mutant line: HT115 (Colorectal Adenocarcinoma): -0.0946"
  },
  {
    "mutation": "DST",
    "target_gene": "TBK1",
    "n_mutant_lines": 3,
    "n_wt_lines": 2082,
    "mutant_mean_score": -0.123,
    "wt_mean_score": -0.0163,
    "effect_size": -0.1067,
    "p_value": 0.0715715128012253,
    "is_significant": true,
    "most_dependent_line": "HT115 (Colorectal Adenocarcinoma): -0.1534",
    "mutant_lines_sample": [
      "NZOV9",
      "HT115",
      "HT115"
    ],
    "summary": "DST mutation shows synthetic lethality with TBK1. Effect size: -0.107 (p=0.0716). Tested in 3 mutant lines vs 2082 wild-type lines. Most dependent mutant line: HT115 (Colorectal Adenocarcinoma): -0.1534"
  },
  {
    "mutation": "KCNQ5",
    "target_gene": "STK17A",
    "n_mutant_lines": 3,
    "n_wt_lines": 2082,
    "mutant_mean_score": -0.1,
    "wt_mean_score": -0.0353,
    "effect_size": -0.0647,
    "p_value": 0.0011853025463152,
    "is_significant": true,
    "most_dependent_line": "MCC13 (Merkel Cell Carcinoma): -0.1107",
    "mutant_lines_sample": [
      "HT115",
      "HT115",
      "MCC13"
    ],
    "summary": "KCNQ5 mutation shows synthetic lethality with STK17A. Effect size: -0.065 (p=0.0012). Tested in 3 mutant lines vs 2082 wild-type lines. Most dependent mutant line: MCC13 (Merkel Cell Carcinoma): -0.1107"
  },
  {
    "mutation": "KCNQ5",
    "target_gene": "TBK1",
    "n_mutant_lines": 3,
    "n_wt_lines": 2082,
    "mutant_mean_score": -0.068,
    "wt_mean_score": -0.0164,
    "effect_size": -0.0516,
    "p_value": 0.6073976870007872,
    "is_significant": true,
    "most_dependent_line": "HT115 (Colorectal Adenocarcinoma): -0.1534",
    "mutant_lines_sample": [
      "HT115",
      "HT115",
      "MCC13"
    ],
    "summary": "KCNQ5 mutation shows synthetic lethality with TBK1. Effect size: -0.052 (p=0.6074). Tested in 3 mutant lines vs 2082 wild-type lines. Most dependent mutant line: HT115 (Colorectal Adenocarcinoma): -0.1534"
  },
  {
    "mutation": "KCNQ5",
    "target_gene": "CLK4",
    "n_mutant_lines": 3,
    "n_wt_lines": 2082,
    "mutant_mean_score": -0.056,
    "wt_mean_score": -0.0361,
    "effect_size": -0.0199,
    "p_value": 0.8112048513031261,
    "is_significant": true,
    "most_dependent_line": "MCC13 (Merkel Cell Carcinoma): -0.2023",
    "mutant_lines_sample": [
      "HT115",
      "HT115",
      "MCC13"
    ],
    "summary": "KCNQ5 mutation shows synthetic lethality with CLK4. Effect size: -0.020 (p=0.8112). Tested in 3 mutant lines vs 2082 wild-type lines. Most dependent mutant line: MCC13 (Merkel Cell Carcinoma): -0.2023"
  },
  {
    "mutation": "CGAS",
    "target_gene": "STK17A",
    "n_mutant_lines": 5,
    "n_wt_lines": 2080,
    "mutant_mean_score": -0.1081,
    "wt_mean_score": -0.0352,
    "effect_size": -0.0729,
    "p_value": 0.0629292411904589,
    "is_significant": true,
    "most_dependent_line": "OCIC4P (Ovarian Epithelial Tumor): -0.2084",
    "mutant_lines_sample": [
      "UBLC1",
      "P30OHK",
      "P30OHK",
      "P30OHK",
      "OCIC4P"
    ],
    "summary": "CGAS mutation shows synthetic lethality with STK17A. Effect size: -0.073 (p=0.0629). Tested in 5 mutant lines vs 2080 wild-type lines. Most dependent mutant line: OCIC4P (Ovarian Epithelial Tumor): -0.2084"
  },
  {
    "mutation": "CGAS",
    "target_gene": "CLK4",
    "n_mutant_lines": 5,
    "n_wt_lines": 2080,
    "mutant_mean_score": -0.0645,
    "wt_mean_score": -0.0361,
    "effect_size": -0.0284,
    "p_value": 0.1103155314157609,
    "is_significant": true,
    "most_dependent_line": "P30OHK (B-Cell Acute Lymphoblastic Leukemia): -0.0865",
    "mutant_lines_sample": [
      "UBLC1",
      "P30OHK",
      "P30OHK",
      "P30OHK",
      "OCIC4P"
    ],
    "summary": "CGAS mutation shows synthetic lethality with CLK4. Effect size: -0.028 (p=0.1103). Tested in 5 mutant lines vs 2080 wild-type lines. Most dependent mutant line: P30OHK (B-Cell Acute Lymphoblastic Leukemia): -0.0865"
  },
  {
    "mutation": "SYNE1",
    "target_gene": "STK17A",
    "n_mutant_lines": 4,
    "n_wt_lines": 2081,
    "mutant_mean_score": -0.0495,
    "wt_mean_score": -0.0353,
    "effect_size": -0.0141,
    "p_value": 0.656604950690344,
    "is_significant": true,
    "most_dependent_line": "HT115 (Colorectal Adenocarcinoma): -0.0946",
    "mutant_lines_sample": [
      "NZOV9",
      "HT115",
      "HT115",
      "H314"
    ],
    "summary": "SYNE1 mutation shows synthetic lethality with STK17A. Effect size: -0.014 (p=0.6566). Tested in 4 mutant lines vs 2081 wild-type lines. Most dependent mutant line: HT115 (Colorectal Adenocarcinoma): -0.0946"
  },
  {
    "mutation": "SYNE1",
    "target_gene": "TBK1",
    "n_mutant_lines": 4,
    "n_wt_lines": 2081,
    "mutant_mean_score": -0.0493,
    "wt_mean_score": -0.0164,
    "effect_size": -0.0329,
    "p_value": 0.6970605867116209,
    "is_significant": true,
    "most_dependent_line": "HT115 (Colorectal Adenocarcinoma): -0.1534",
    "mutant_lines_sample": [
      "NZOV9",
      "HT115",
      "HT115",
      "H314"
    ],
    "summary": "SYNE1 mutation shows synthetic lethality with TBK1. Effect size: -0.033 (p=0.6971). Tested in 4 mutant lines vs 2081 wild-type lines. Most dependent mutant line: HT115 (Colorectal Adenocarcinoma): -0.1534"
  },
  {
    "mutation": "SYNE1",
    "target_gene": "CLK4",
    "n_mutant_lines": 4,
    "n_wt_lines": 2081,
    "mutant_mean_score": -0.0677,
    "wt_mean_score": -0.0361,
    "effect_size": -0.0316,
    "p_value": 0.6646320244031014,
    "is_significant": true,
    "most_dependent_line": "H314 (Head and Neck Squamous Cell Carcinoma): -0.2610",
    "mutant_lines_sample": [
      "NZOV9",
      "HT115",
      "HT115",
      "H314"
    ],
    "summary": "SYNE1 mutation shows synthetic lethality with CLK4. Effect size: -0.032 (p=0.6646). Tested in 4 mutant lines vs 2081 wild-type lines. Most dependent mutant line: H314 (Head and Neck Squamous Cell Carcinoma): -0.2610"
  },
  {
    "mutation": "CARD11",
    "target_gene": "STK17A",
    "n_mutant_lines": 3,
    "n_wt_lines": 2082,
    "mutant_mean_score": -0.1561,
    "wt_mean_score": -0.0352,
    "effect_size": -0.1209,
    "p_value": 0.1025117805396004,
    "is_significant": true,
    "most_dependent_line": "IPC298 (Melanoma): -0.1983",
    "mutant_lines_sample": [
      "HEC6",
      "IPC298",
      "IPC298"
    ],
    "summary": "CARD11 mutation shows synthetic lethality with STK17A. Effect size: -0.121 (p=0.1025). Tested in 3 mutant lines vs 2082 wild-type lines. Most dependent mutant line: IPC298 (Melanoma): -0.1983"
  },
  {
    "mutation": "CARD11",
    "target_gene": "MYLK4",
    "n_mutant_lines": 3,
    "n_wt_lines": 2082,
    "mutant_mean_score": 0.0125,
    "wt_mean_score": 0.0804,
    "effect_size": -0.0679,
    "p_value": 0.0597727783224266,
    "is_significant": true,
    "most_dependent_line": "IPC298 (Melanoma): -0.0053",
    "mutant_lines_sample": [
      "HEC6",
      "IPC298",
      "IPC298"
    ],
    "summary": "CARD11 mutation shows synthetic lethality with MYLK4. Effect size: -0.068 (p=0.0598). Tested in 3 mutant lines vs 2082 wild-type lines. Most dependent mutant line: IPC298 (Melanoma): -0.0053"
  },
  {
    "mutation": "CARD11",
    "target_gene": "CLK4",
    "n_mutant_lines": 3,
    "n_wt_lines": 2082,
    "mutant_mean_score": -0.1003,
    "wt_mean_score": -0.036,
    "effect_size": -0.0642,
    "p_value": 0.4862777400420754,
    "is_significant": true,
    "most_dependent_line": "IPC298 (Melanoma): -0.1761",
    "mutant_lines_sample": [
      "HEC6",
      "IPC298",
      "IPC298"
    ],
    "summary": "CARD11 mutation shows synthetic lethality with CLK4. Effect size: -0.064 (p=0.4863). Tested in 3 mutant lines vs 2082 wild-type lines. Most dependent mutant line: IPC298 (Melanoma): -0.1761"
  },
  {
    "mutation": "RAC1",
    "target_gene": "STK17A",
    "n_mutant_lines": 19,
    "n_wt_lines": 2066,
    "mutant_mean_score": -0.0494,
    "wt_mean_score": -0.0352,
    "effect_size": -0.0142,
    "p_value": 0.4571937849683232,
    "is_significant": true,
    "most_dependent_line": "JURKAT (T-Lymphoblastic Leukemia/Lymphoma): -0.1971",
    "mutant_lines_sample": [
      "UOK101",
      "UOK101",
      "TGW",
      "TGW",
      "TGW"
    ],
    "summary": "RAC1 mutation shows synthetic lethality with STK17A. Effect size: -0.014 (p=0.4572). Tested in 19 mutant lines vs 2066 wild-type lines. Most dependent mutant line: JURKAT (T-Lymphoblastic Leukemia/Lymphoma): -0.1971"
  },
  {
    "mutation": "EGFR",
    "target_gene": "STK17A",
    "n_mutant_lines": 17,
    "n_wt_lines": 2062,
    "mutant_mean_score": -0.0678,
    "wt_mean_score": -0.0353,
    "effect_size": -0.0325,
    "p_value": 0.1729130303893789,
    "is_significant": true,
    "most_dependent_line": "BC3 (Mature B-Cell Neoplasms): -0.2158",
    "mutant_lines_sample": [
      "KYSE450",
      "KYSE450",
      "HS683",
      "NCIH1650",
      "NCIH1650"
    ],
    "summary": "EGFR mutation shows synthetic lethality with STK17A. Effect size: -0.033 (p=0.1729). Tested in 17 mutant lines vs 2062 wild-type lines. Most dependent mutant line: BC3 (Mature B-Cell Neoplasms): -0.2158"
  },
  {
    "mutation": "EGFR",
    "target_gene": "TBK1",
    "n_mutant_lines": 17,
    "n_wt_lines": 2062,
    "mutant_mean_score": -0.0482,
    "wt_mean_score": -0.016,
    "effect_size": -0.0322,
    "p_value": 0.2630671007655142,
    "is_significant": true,
    "most_dependent_line": "HS683 (Diffuse Glioma): -0.2240",
    "mutant_lines_sample": [
      "KYSE450",
      "KYSE450",
      "HS683",
      "NCIH1650",
      "NCIH1650"
    ],
    "summary": "EGFR mutation shows synthetic lethality with TBK1. Effect size: -0.032 (p=0.2631). Tested in 17 mutant lines vs 2062 wild-type lines. Most dependent mutant line: HS683 (Diffuse Glioma): -0.2240"
  },
  {
    "mutation": "PON1",
    "target_gene": "MYLK4",
    "n_mutant_lines": 6,
    "n_wt_lines": 2079,
    "mutant_mean_score": -0.0119,
    "wt_mean_score": 0.0806,
    "effect_size": -0.0925,
    "p_value": 0.4367089522472633,
    "is_significant": true,
    "most_dependent_line": "NP5 (Diffuse Glioma): -0.3130",
    "mutant_lines_sample": [
      "HT115",
      "HT115",
      "HEC251",
      "HEC251",
      "NP5"
    ],
    "summary": "PON1 mutation shows synthetic lethality with MYLK4. Effect size: -0.092 (p=0.4367). Tested in 6 mutant lines vs 2079 wild-type lines. Most dependent mutant line: NP5 (Diffuse Glioma): -0.3130"
  },
  {
    "mutation": "PON1",
    "target_gene": "TBK1",
    "n_mutant_lines": 6,
    "n_wt_lines": 2079,
    "mutant_mean_score": -0.0566,
    "wt_mean_score": -0.0163,
    "effect_size": -0.0402,
    "p_value": 0.3666145423344312,
    "is_significant": true,
    "most_dependent_line": "HT115 (Colorectal Adenocarcinoma): -0.1534",
    "mutant_lines_sample": [
      "HT115",
      "HT115",
      "HEC251",
      "HEC251",
      "NP5"
    ],
    "summary": "PON1 mutation shows synthetic lethality with TBK1. Effect size: -0.040 (p=0.3666). Tested in 6 mutant lines vs 2079 wild-type lines. Most dependent mutant line: HT115 (Colorectal Adenocarcinoma): -0.1534"
  },
  {
    "mutation": "TRRAP",
    "target_gene": "STK17A",
    "n_mutant_lines": 5,
    "n_wt_lines": 2080,
    "mutant_mean_score": -0.1343,
    "wt_mean_score": -0.0351,
    "effect_size": -0.0992,
    "p_value": 0.4618750487127628,
    "is_significant": true,
    "most_dependent_line": "UACC62SKINCJ1 (Melanoma): -0.4282",
    "mutant_lines_sample": [
      "SEM",
      "TE11",
      "UACC62",
      "UACC62SKINCJ1",
      "UACC62SKINCJ1"
    ],
    "summary": "TRRAP mutation shows synthetic lethality with STK17A. Effect size: -0.099 (p=0.4619). Tested in 5 mutant lines vs 2080 wild-type lines. Most dependent mutant line: UACC62SKINCJ1 (Melanoma): -0.4282"
  },
  {
    "mutation": "TRRAP",
    "target_gene": "TBK1",
    "n_mutant_lines": 5,
    "n_wt_lines": 2080,
    "mutant_mean_score": -0.0256,
    "wt_mean_score": -0.0164,
    "effect_size": -0.0092,
    "p_value": 0.8128760508733969,
    "is_significant": true,
    "most_dependent_line": "UACC62 (Melanoma): -0.0919",
    "mutant_lines_sample": [
      "SEM",
      "TE11",
      "UACC62",
      "UACC62SKINCJ1",
      "UACC62SKINCJ1"
    ],
    "summary": "TRRAP mutation shows synthetic lethality with TBK1. Effect size: -0.009 (p=0.8129). Tested in 5 mutant lines vs 2080 wild-type lines. Most dependent mutant line: UACC62 (Melanoma): -0.0919"
  },
  {
    "mutation": "TRRAP",
    "target_gene": "CLK4",
    "n_mutant_lines": 5,
    "n_wt_lines": 2080,
    "mutant_mean_score": -0.0966,
    "wt_mean_score": -0.036,
    "effect_size": -0.0606,
    "p_value": 0.5444837697911256,
    "is_significant": true,
    "most_dependent_line": "UACC62SKINCJ1 (Melanoma): -0.3184",
    "mutant_lines_sample": [
      "SEM",
      "TE11",
      "UACC62",
      "UACC62SKINCJ1",
      "UACC62SKINCJ1"
    ],
    "summary": "TRRAP mutation shows synthetic lethality with CLK4. Effect size: -0.061 (p=0.5445). Tested in 5 mutant lines vs 2080 wild-type lines. Most dependent mutant line: UACC62SKINCJ1 (Melanoma): -0.3184"
  },
  {
    "mutation": "MET",
    "target_gene": "STK17A",
    "n_mutant_lines": 4,
    "n_wt_lines": 2081,
    "mutant_mean_score": -0.1997,
    "wt_mean_score": -0.035,
    "effect_size": -0.1647,
    "p_value": 0.038515168765327,
    "is_significant": true,
    "most_dependent_line": "M040416 (Melanoma): -0.2806",
    "mutant_lines_sample": [
      "F5",
      "M040416",
      "M040416",
      "SNU1544"
    ],
    "summary": "MET mutation shows synthetic lethality with STK17A. Effect size: -0.165 (p=0.0385). Tested in 4 mutant lines vs 2081 wild-type lines. Most dependent mutant line: M040416 (Melanoma): -0.2806"
  },
  {
    "mutation": "MET",
    "target_gene": "MYLK4",
    "n_mutant_lines": 4,
    "n_wt_lines": 2081,
    "mutant_mean_score": 0.0682,
    "wt_mean_score": 0.0803,
    "effect_size": -0.0121,
    "p_value": 0.8918710443342512,
    "is_significant": true,
    "most_dependent_line": "F5 (Meningothelial Tumor): -0.1710",
    "mutant_lines_sample": [
      "F5",
      "M040416",
      "M040416",
      "SNU1544"
    ],
    "summary": "MET mutation shows synthetic lethality with MYLK4. Effect size: -0.012 (p=0.8919). Tested in 4 mutant lines vs 2081 wild-type lines. Most dependent mutant line: F5 (Meningothelial Tumor): -0.1710"
  },
  {
    "mutation": "MET",
    "target_gene": "TBK1",
    "n_mutant_lines": 4,
    "n_wt_lines": 2081,
    "mutant_mean_score": -0.0782,
    "wt_mean_score": -0.0163,
    "effect_size": -0.0618,
    "p_value": 0.1235697907398079,
    "is_significant": true,
    "most_dependent_line": "SNU1544 (Colorectal Adenocarcinoma): -0.1517",
    "mutant_lines_sample": [
      "F5",
      "M040416",
      "M040416",
      "SNU1544"
    ],
    "summary": "MET mutation shows synthetic lethality with TBK1. Effect size: -0.062 (p=0.1236). Tested in 4 mutant lines vs 2081 wild-type lines. Most dependent mutant line: SNU1544 (Colorectal Adenocarcinoma): -0.1517"
  },
  {
    "mutation": "MET",
    "target_gene": "CLK4",
    "n_mutant_lines": 4,
    "n_wt_lines": 2081,
    "mutant_mean_score": -0.0802,
    "wt_mean_score": -0.036,
    "effect_size": -0.0442,
    "p_value": 0.5656847710129674,
    "is_significant": true,
    "most_dependent_line": "F5 (Meningothelial Tumor): -0.2014",
    "mutant_lines_sample": [
      "F5",
      "M040416",
      "M040416",
      "SNU1544"
    ],
    "summary": "MET mutation shows synthetic lethality with CLK4. Effect size: -0.044 (p=0.5657). Tested in 4 mutant lines vs 2081 wild-type lines. Most dependent mutant line: F5 (Meningothelial Tumor): -0.2014"
  },
  {
    "mutation": "CADPS2",
    "target_gene": "MYLK4",
    "n_mutant_lines": 3,
    "n_wt_lines": 2082,
    "mutant_mean_score": 0.0447,
    "wt_mean_score": 0.0803,
    "effect_size": -0.0356,
    "p_value": 0.5745290839586752,
    "is_significant": true,
    "most_dependent_line": "HEC251 (Endometrial Carcinoma): -0.0088",
    "mutant_lines_sample": [
      "HCC2998",
      "HEC251",
      "HEC251"
    ],
    "summary": "CADPS2 mutation shows synthetic lethality with MYLK4. Effect size: -0.036 (p=0.5745). Tested in 3 mutant lines vs 2082 wild-type lines. Most dependent mutant line: HEC251 (Endometrial Carcinoma): -0.0088"
  },
  {
    "mutation": "CADPS2",
    "target_gene": "TBK1",
    "n_mutant_lines": 3,
    "n_wt_lines": 2082,
    "mutant_mean_score": -0.1382,
    "wt_mean_score": -0.0163,
    "effect_size": -0.1219,
    "p_value": 0.1677266767979561,
    "is_significant": true,
    "most_dependent_line": "HCC2998 (Colorectal Adenocarcinoma): -0.2532",
    "mutant_lines_sample": [
      "HCC2998",
      "HEC251",
      "HEC251"
    ],
    "summary": "CADPS2 mutation shows synthetic lethality with TBK1. Effect size: -0.122 (p=0.1677). Tested in 3 mutant lines vs 2082 wild-type lines. Most dependent mutant line: HCC2998 (Colorectal Adenocarcinoma): -0.2532"
  },
  {
    "mutation": "BRAF",
    "target_gene": "MYLK4",
    "n_mutant_lines": 117,
    "n_wt_lines": 1935,
    "mutant_mean_score": 0.0785,
    "wt_mean_score": 0.0804,
    "effect_size": -0.0019,
    "p_value": 0.8332354254130006,
    "is_significant": true,
    "most_dependent_line": "WM115 (Melanoma): -0.2796",
    "mutant_lines_sample": [
      "MELHO",
      "MELHO",
      "RVH421",
      "ES2",
      "ES2"
    ],
    "summary": "BRAF mutation shows synthetic lethality with MYLK4. Effect size: -0.002 (p=0.8332). Tested in 117 mutant lines vs 1935 wild-type lines. Most dependent mutant line: WM115 (Melanoma): -0.2796"
  },
  {
    "mutation": "BRAF",
    "target_gene": "TBK1",
    "n_mutant_lines": 117,
    "n_wt_lines": 1935,
    "mutant_mean_score": -0.0173,
    "wt_mean_score": -0.0156,
    "effect_size": -0.0017,
    "p_value": 0.8963048954921113,
    "is_significant": true,
    "most_dependent_line": "MMAC (Melanoma): -0.2499",
    "mutant_lines_sample": [
      "MELHO",
      "MELHO",
      "RVH421",
      "ES2",
      "ES2"
    ],
    "summary": "BRAF mutation shows synthetic lethality with TBK1. Effect size: -0.002 (p=0.8963). Tested in 117 mutant lines vs 1935 wild-type lines. Most dependent mutant line: MMAC (Melanoma): -0.2499"
  },
  {
    "mutation": "BRAF",
    "target_gene": "CLK4",
    "n_mutant_lines": 117,
    "n_wt_lines": 1935,
    "mutant_mean_score": -0.0363,
    "wt_mean_score": -0.0359,
    "effect_size": -0.0005,
    "p_value": 0.969846306809079,
    "is_significant": true,
    "most_dependent_line": "22RV1 (Prostate Adenocarcinoma): -0.4313",
    "mutant_lines_sample": [
      "MELHO",
      "MELHO",
      "RVH421",
      "ES2",
      "ES2"
    ],
    "summary": "BRAF mutation shows synthetic lethality with CLK4. Effect size: -0.001 (p=0.9698). Tested in 117 mutant lines vs 1935 wild-type lines. Most dependent mutant line: 22RV1 (Prostate Adenocarcinoma): -0.4313"
  },
  {
    "mutation": "EZH2",
    "target_gene": "MYLK4",
    "n_mutant_lines": 18,
    "n_wt_lines": 2066,
    "mutant_mean_score": 0.0334,
    "wt_mean_score": 0.0807,
    "effect_size": -0.0473,
    "p_value": 0.1168821689700703,
    "is_significant": true,
    "most_dependent_line": "ROS50 (Mature B-Cell Neoplasms): -0.4179",
    "mutant_lines_sample": [
      "SKM1",
      "RL",
      "RL",
      "IGR1",
      "IGR1"
    ],
    "summary": "EZH2 mutation shows synthetic lethality with MYLK4. Effect size: -0.047 (p=0.1169). Tested in 18 mutant lines vs 2066 wild-type lines. Most dependent mutant line: ROS50 (Mature B-Cell Neoplasms): -0.4179"
  },
  {
    "mutation": "NEFM",
    "target_gene": "STK17A",
    "n_mutant_lines": 7,
    "n_wt_lines": 2078,
    "mutant_mean_score": -0.0916,
    "wt_mean_score": -0.0352,
    "effect_size": -0.0565,
    "p_value": 0.0049943273293827,
    "is_significant": true,
    "most_dependent_line": "DLD1 (Colorectal Adenocarcinoma): -0.1266",
    "mutant_lines_sample": [
      "DLD1",
      "DLD1",
      "HCT15 (UMF-815H (UMF-815H (UMF-815H (UMF-815H",
      "UMF-815K)",
      "UMF-815K)"
    ],
    "summary": "NEFM mutation shows synthetic lethality with STK17A. Effect size: -0.057 (p=0.0050). Tested in 7 mutant lines vs 2078 wild-type lines. Most dependent mutant line: DLD1 (Colorectal Adenocarcinoma): -0.1266"
  },
  {
    "mutation": "NEFM",
    "target_gene": "TBK1",
    "n_mutant_lines": 7,
    "n_wt_lines": 2078,
    "mutant_mean_score": -0.1112,
    "wt_mean_score": -0.0161,
    "effect_size": -0.095,
    "p_value": 0.161242515917434,
    "is_significant": true,
    "most_dependent_line": "HCT15 (Colorectal Adenocarcinoma): -0.3413",
    "mutant_lines_sample": [
      "DLD1",
      "DLD1",
      "HCT15 (UMF-815H (UMF-815H (UMF-815H (UMF-815H",
      "UMF-815K)",
      "UMF-815K)"
    ],
    "summary": "NEFM mutation shows synthetic lethality with TBK1. Effect size: -0.095 (p=0.1612). Tested in 7 mutant lines vs 2078 wild-type lines. Most dependent mutant line: HCT15 (Colorectal Adenocarcinoma): -0.3413"
  },
  {
    "mutation": "WRN",
    "target_gene": "STK17A",
    "n_mutant_lines": 7,
    "n_wt_lines": 2076,
    "mutant_mean_score": -0.0768,
    "wt_mean_score": -0.0351,
    "effect_size": -0.0417,
    "p_value": 0.0392057426655406,
    "is_significant": true,
    "most_dependent_line": "OCUM1 (Esophagogastric Adenocarcinoma): -0.1045",
    "mutant_lines_sample": [
      "OCUM1",
      "OCUM1",
      "OCUM1",
      "JHH1",
      "MEL270"
    ],
    "summary": "WRN mutation shows synthetic lethality with STK17A. Effect size: -0.042 (p=0.0392). Tested in 7 mutant lines vs 2076 wild-type lines. Most dependent mutant line: OCUM1 (Esophagogastric Adenocarcinoma): -0.1045"
  },
  {
    "mutation": "WRN",
    "target_gene": "MYLK4",
    "n_mutant_lines": 7,
    "n_wt_lines": 2076,
    "mutant_mean_score": -0.1618,
    "wt_mean_score": 0.0812,
    "effect_size": -0.243,
    "p_value": 0.0049732177573204,
    "is_significant": true,
    "most_dependent_line": "MEL270 (Ocular Melanoma): -0.3043",
    "mutant_lines_sample": [
      "OCUM1",
      "OCUM1",
      "OCUM1",
      "JHH1",
      "MEL270"
    ],
    "summary": "WRN mutation shows synthetic lethality with MYLK4. Effect size: -0.243 (p=0.0050). Tested in 7 mutant lines vs 2076 wild-type lines. Most dependent mutant line: MEL270 (Ocular Melanoma): -0.3043"
  },
  {
    "mutation": "WRN",
    "target_gene": "TBK1",
    "n_mutant_lines": 7,
    "n_wt_lines": 2076,
    "mutant_mean_score": -0.0597,
    "wt_mean_score": -0.0163,
    "effect_size": -0.0434,
    "p_value": 0.2763556711289319,
    "is_significant": true,
    "most_dependent_line": "JHH1 (Hepatocellular Carcinoma): -0.1586",
    "mutant_lines_sample": [
      "OCUM1",
      "OCUM1",
      "OCUM1",
      "JHH1",
      "MEL270"
    ],
    "summary": "WRN mutation shows synthetic lethality with TBK1. Effect size: -0.043 (p=0.2764). Tested in 7 mutant lines vs 2076 wild-type lines. Most dependent mutant line: JHH1 (Hepatocellular Carcinoma): -0.1586"
  },
  {
    "mutation": "WRN",
    "target_gene": "CLK4",
    "n_mutant_lines": 7,
    "n_wt_lines": 2076,
    "mutant_mean_score": -0.1349,
    "wt_mean_score": -0.0359,
    "effect_size": -0.099,
    "p_value": 0.1782816086467848,
    "is_significant": true,
    "most_dependent_line": "MEL270 (Ocular Melanoma): -0.5236",
    "mutant_lines_sample": [
      "OCUM1",
      "OCUM1",
      "OCUM1",
      "JHH1",
      "MEL270"
    ],
    "summary": "WRN mutation shows synthetic lethality with CLK4. Effect size: -0.099 (p=0.1783). Tested in 7 mutant lines vs 2076 wild-type lines. Most dependent mutant line: MEL270 (Ocular Melanoma): -0.5236"
  },
  {
    "mutation": "PREX2",
    "target_gene": "STK17A",
    "n_mutant_lines": 3,
    "n_wt_lines": 2082,
    "mutant_mean_score": -0.1348,
    "wt_mean_score": -0.0352,
    "effect_size": -0.0996,
    "p_value": 0.0534526067404254,
    "is_significant": true,
    "most_dependent_line": "HEPG2 (Hepatoblastoma): -0.1832",
    "mutant_lines_sample": [
      "IS076P",
      "IS076A",
      "HEPG2"
    ],
    "summary": "PREX2 mutation shows synthetic lethality with STK17A. Effect size: -0.100 (p=0.0535). Tested in 3 mutant lines vs 2082 wild-type lines. Most dependent mutant line: HEPG2 (Hepatoblastoma): -0.1832"
  },
  {
    "mutation": "PREX2",
    "target_gene": "MYLK4",
    "n_mutant_lines": 3,
    "n_wt_lines": 2082,
    "mutant_mean_score": 0.0479,
    "wt_mean_score": 0.0803,
    "effect_size": -0.0325,
    "p_value": 0.745562760817179,
    "is_significant": true,
    "most_dependent_line": "HEPG2 (Hepatoblastoma): -0.0824",
    "mutant_lines_sample": [
      "IS076P",
      "IS076A",
      "HEPG2"
    ],
    "summary": "PREX2 mutation shows synthetic lethality with MYLK4. Effect size: -0.033 (p=0.7456). Tested in 3 mutant lines vs 2082 wild-type lines. Most dependent mutant line: HEPG2 (Hepatoblastoma): -0.0824"
  },
  {
    "mutation": "PREX2",
    "target_gene": "TBK1",
    "n_mutant_lines": 3,
    "n_wt_lines": 2082,
    "mutant_mean_score": -0.0568,
    "wt_mean_score": -0.0164,
    "effect_size": -0.0404,
    "p_value": 0.4973211508416494,
    "is_significant": true,
    "most_dependent_line": "HEPG2 (Hepatoblastoma): -0.1313",
    "mutant_lines_sample": [
      "IS076P",
      "IS076A",
      "HEPG2"
    ],
    "summary": "PREX2 mutation shows synthetic lethality with TBK1. Effect size: -0.040 (p=0.4973). Tested in 3 mutant lines vs 2082 wild-type lines. Most dependent mutant line: HEPG2 (Hepatoblastoma): -0.1313"
  },
  {
    "mutation": "PREX2",
    "target_gene": "CLK4",
    "n_mutant_lines": 3,
    "n_wt_lines": 2082,
    "mutant_mean_score": -0.0895,
    "wt_mean_score": -0.0361,
    "effect_size": -0.0534,
    "p_value": 0.1868427313371905,
    "is_significant": true,
    "most_dependent_line": "IS076P (Esophagogastric Adenocarcinoma): -0.1227",
    "mutant_lines_sample": [
      "IS076P",
      "IS076A",
      "HEPG2"
    ],
    "summary": "PREX2 mutation shows synthetic lethality with CLK4. Effect size: -0.053 (p=0.1868). Tested in 3 mutant lines vs 2082 wild-type lines. Most dependent mutant line: IS076P (Esophagogastric Adenocarcinoma): -0.1227"
  },
  {
    "mutation": "ZFAND1",
    "target_gene": "STK17A",
    "n_mutant_lines": 4,
    "n_wt_lines": 2081,
    "mutant_mean_score": -0.0848,
    "wt_mean_score": -0.0353,
    "effect_size": -0.0495,
    "p_value": 0.2864646463677821,
    "is_significant": true,
    "most_dependent_line": "SNUC5 (Colorectal Adenocarcinoma): -0.1992",
    "mutant_lines_sample": [
      "HEYA8",
      "SNUC5",
      "SF539",
      "SF539"
    ],
    "summary": "ZFAND1 mutation shows synthetic lethality with STK17A. Effect size: -0.050 (p=0.2865). Tested in 4 mutant lines vs 2081 wild-type lines. Most dependent mutant line: SNUC5 (Colorectal Adenocarcinoma): -0.1992"
  },
  {
    "mutation": "ZFAND1",
    "target_gene": "MYLK4",
    "n_mutant_lines": 4,
    "n_wt_lines": 2081,
    "mutant_mean_score": 0.0427,
    "wt_mean_score": 0.0804,
    "effect_size": -0.0376,
    "p_value": 0.1237559669652645,
    "is_significant": true,
    "most_dependent_line": "HEYA8 (Ovarian Epithelial Tumor): -0.0061",
    "mutant_lines_sample": [
      "HEYA8",
      "SNUC5",
      "SF539",
      "SF539"
    ],
    "summary": "ZFAND1 mutation shows synthetic lethality with MYLK4. Effect size: -0.038 (p=0.1238). Tested in 4 mutant lines vs 2081 wild-type lines. Most dependent mutant line: HEYA8 (Ovarian Epithelial Tumor): -0.0061"
  },
  {
    "mutation": "CNBD1",
    "target_gene": "STK17A",
    "n_mutant_lines": 8,
    "n_wt_lines": 2077,
    "mutant_mean_score": -0.073,
    "wt_mean_score": -0.0352,
    "effect_size": -0.0378,
    "p_value": 0.4422538899806221,
    "is_significant": true,
    "most_dependent_line": "SW403 (Colorectal Adenocarcinoma): -0.2574",
    "mutant_lines_sample": [
      "SW403",
      "NCIN87",
      "NCIN87",
      "KP363T",
      "CCLFUPGI0005T"
    ],
    "summary": "CNBD1 mutation shows synthetic lethality with STK17A. Effect size: -0.038 (p=0.4423). Tested in 8 mutant lines vs 2077 wild-type lines. Most dependent mutant line: SW403 (Colorectal Adenocarcinoma): -0.2574"
  },
  {
    "mutation": "CNBD1",
    "target_gene": "MYLK4",
    "n_mutant_lines": 8,
    "n_wt_lines": 2077,
    "mutant_mean_score": 0.0592,
    "wt_mean_score": 0.0804,
    "effect_size": -0.0212,
    "p_value": 0.19081191269127,
    "is_significant": true,
    "most_dependent_line": "NCIN87 (Esophagogastric Adenocarcinoma): 0.0069",
    "mutant_lines_sample": [
      "SW403",
      "NCIN87",
      "NCIN87",
      "KP363T",
      "CCLFUPGI0005T"
    ],
    "summary": "CNBD1 mutation shows synthetic lethality with MYLK4. Effect size: -0.021 (p=0.1908). Tested in 8 mutant lines vs 2077 wild-type lines. Most dependent mutant line: NCIN87 (Esophagogastric Adenocarcinoma): 0.0069"
  },
  {
    "mutation": "CNBD1",
    "target_gene": "TBK1",
    "n_mutant_lines": 8,
    "n_wt_lines": 2077,
    "mutant_mean_score": -0.0577,
    "wt_mean_score": -0.0163,
    "effect_size": -0.0414,
    "p_value": 0.2444036693540788,
    "is_significant": true,
    "most_dependent_line": "WM88 (Melanoma): -0.1919",
    "mutant_lines_sample": [
      "SW403",
      "NCIN87",
      "NCIN87",
      "KP363T",
      "CCLFUPGI0005T"
    ],
    "summary": "CNBD1 mutation shows synthetic lethality with TBK1. Effect size: -0.041 (p=0.2444). Tested in 8 mutant lines vs 2077 wild-type lines. Most dependent mutant line: WM88 (Melanoma): -0.1919"
  },
  {
    "mutation": "NBN",
    "target_gene": "STK17A",
    "n_mutant_lines": 4,
    "n_wt_lines": 2081,
    "mutant_mean_score": -0.0409,
    "wt_mean_score": -0.0353,
    "effect_size": -0.0055,
    "p_value": 0.8057408184050889,
    "is_significant": true,
    "most_dependent_line": "KPL1 (Invasive Breast Carcinoma): -0.1022",
    "mutant_lines_sample": [
      "MCF7",
      "MCF7",
      "MCF7",
      "KPL1"
    ],
    "summary": "NBN mutation shows synthetic lethality with STK17A. Effect size: -0.005 (p=0.8057). Tested in 4 mutant lines vs 2081 wild-type lines. Most dependent mutant line: KPL1 (Invasive Breast Carcinoma): -0.1022"
  },
  {
    "mutation": "NBN",
    "target_gene": "MYLK4",
    "n_mutant_lines": 4,
    "n_wt_lines": 2081,
    "mutant_mean_score": 0.0722,
    "wt_mean_score": 0.0803,
    "effect_size": -0.0081,
    "p_value": 0.8460977987706607,
    "is_significant": true,
    "most_dependent_line": "MCF7 (Invasive Breast Carcinoma): 0.0339",
    "mutant_lines_sample": [
      "MCF7",
      "MCF7",
      "MCF7",
      "KPL1"
    ],
    "summary": "NBN mutation shows synthetic lethality with MYLK4. Effect size: -0.008 (p=0.8461). Tested in 4 mutant lines vs 2081 wild-type lines. Most dependent mutant line: MCF7 (Invasive Breast Carcinoma): 0.0339"
  },
  {
    "mutation": "NBN",
    "target_gene": "CLK4",
    "n_mutant_lines": 4,
    "n_wt_lines": 2081,
    "mutant_mean_score": -0.0894,
    "wt_mean_score": -0.036,
    "effect_size": -0.0534,
    "p_value": 0.1141738717988062,
    "is_significant": true,
    "most_dependent_line": "MCF7 (Invasive Breast Carcinoma): -0.1137",
    "mutant_lines_sample": [
      "MCF7",
      "MCF7",
      "MCF7",
      "KPL1"
    ],
    "summary": "NBN mutation shows synthetic lethality with CLK4. Effect size: -0.053 (p=0.1142). Tested in 4 mutant lines vs 2081 wild-type lines. Most dependent mutant line: MCF7 (Invasive Breast Carcinoma): -0.1137"
  },
  {
    "mutation": "CPQ",
    "target_gene": "STK17A",
    "n_mutant_lines": 4,
    "n_wt_lines": 2081,
    "mutant_mean_score": -0.0847,
    "wt_mean_score": -0.0353,
    "effect_size": -0.0494,
    "p_value": 0.1326863391183247,
    "is_significant": true,
    "most_dependent_line": "DLD1 (Colorectal Adenocarcinoma): -0.1266",
    "mutant_lines_sample": [
      "DLD1",
      "DLD1",
      "HCT15 (UMF-815H (UMF-815H (UMF-815H (UMF-815H",
      "UMF-815K)",
      "UMF-815K)"
    ],
    "summary": "CPQ mutation shows synthetic lethality with STK17A. Effect size: -0.049 (p=0.1327). Tested in 4 mutant lines vs 2081 wild-type lines. Most dependent mutant line: DLD1 (Colorectal Adenocarcinoma): -0.1266"
  },
  {
    "mutation": "CPQ",
    "target_gene": "TBK1",
    "n_mutant_lines": 4,
    "n_wt_lines": 2081,
    "mutant_mean_score": -0.1768,
    "wt_mean_score": -0.0161,
    "effect_size": -0.1607,
    "p_value": 0.1891502582049469,
    "is_significant": true,
    "most_dependent_line": "HCT15 (Colorectal Adenocarcinoma): -0.3413",
    "mutant_lines_sample": [
      "DLD1",
      "DLD1",
      "HCT15 (UMF-815H (UMF-815H (UMF-815H (UMF-815H",
      "UMF-815K)",
      "UMF-815K)"
    ],
    "summary": "CPQ mutation shows synthetic lethality with TBK1. Effect size: -0.161 (p=0.1892). Tested in 4 mutant lines vs 2081 wild-type lines. Most dependent mutant line: HCT15 (Colorectal Adenocarcinoma): -0.3413"
  },
  {
    "mutation": "FAM91A1",
    "target_gene": "STK17A",
    "n_mutant_lines": 3,
    "n_wt_lines": 2082,
    "mutant_mean_score": -0.065,
    "wt_mean_score": -0.0353,
    "effect_size": -0.0297,
    "p_value": 0.8348531980204025,
    "is_significant": true,
    "most_dependent_line": "CMLT1 (Myeloproliferative Neoplasms): -0.3156",
    "mutant_lines_sample": [
      "CMLT1",
      "HCT116",
      "HCT116"
    ],
    "summary": "FAM91A1 mutation shows synthetic lethality with STK17A. Effect size: -0.030 (p=0.8349). Tested in 3 mutant lines vs 2082 wild-type lines. Most dependent mutant line: CMLT1 (Myeloproliferative Neoplasms): -0.3156"
  },
  {
    "mutation": "FAM91A1",
    "target_gene": "TBK1",
    "n_mutant_lines": 3,
    "n_wt_lines": 2082,
    "mutant_mean_score": -0.1811,
    "wt_mean_score": -0.0162,
    "effect_size": -0.1649,
    "p_value": 0.0595841749850174,
    "is_significant": true,
    "most_dependent_line": "HCT116 (Colorectal Adenocarcinoma): -0.2235",
    "mutant_lines_sample": [
      "CMLT1",
      "HCT116",
      "HCT116"
    ],
    "summary": "FAM91A1 mutation shows synthetic lethality with TBK1. Effect size: -0.165 (p=0.0596). Tested in 3 mutant lines vs 2082 wild-type lines. Most dependent mutant line: HCT116 (Colorectal Adenocarcinoma): -0.2235"
  },
  {
    "mutation": "FAM91A1",
    "target_gene": "CLK4",
    "n_mutant_lines": 3,
    "n_wt_lines": 2082,
    "mutant_mean_score": -0.0748,
    "wt_mean_score": -0.0361,
    "effect_size": -0.0387,
    "p_value": 0.0057667811807001,
    "is_significant": true,
    "most_dependent_line": "CMLT1 (Myeloproliferative Neoplasms): -0.0851",
    "mutant_lines_sample": [
      "CMLT1",
      "HCT116",
      "HCT116"
    ],
    "summary": "FAM91A1 mutation shows synthetic lethality with CLK4. Effect size: -0.039 (p=0.0058). Tested in 3 mutant lines vs 2082 wild-type lines. Most dependent mutant line: CMLT1 (Myeloproliferative Neoplasms): -0.0851"
  },
  {
    "mutation": "MYC",
    "target_gene": "STK17A",
    "n_mutant_lines": 9,
    "n_wt_lines": 2076,
    "mutant_mean_score": -0.1148,
    "wt_mean_score": -0.035,
    "effect_size": -0.0798,
    "p_value": 0.0021788193642933,
    "is_significant": true,
    "most_dependent_line": "JM1 (B-Cell Acute Lymphoblastic Leukemia): -0.1686",
    "mutant_lines_sample": [
      "BL70",
      "BL70",
      "RAJI",
      "ROS50",
      "SKNO1"
    ],
    "summary": "MYC mutation shows synthetic lethality with STK17A. Effect size: -0.080 (p=0.0022). Tested in 9 mutant lines vs 2076 wild-type lines. Most dependent mutant line: JM1 (B-Cell Acute Lymphoblastic Leukemia): -0.1686"
  },
  {
    "mutation": "MYC",
    "target_gene": "MYLK4",
    "n_mutant_lines": 9,
    "n_wt_lines": 2076,
    "mutant_mean_score": 0.0669,
    "wt_mean_score": 0.0804,
    "effect_size": -0.0135,
    "p_value": 0.8554037370925538,
    "is_significant": true,
    "most_dependent_line": "ROS50 (Mature B-Cell Neoplasms): -0.4179",
    "mutant_lines_sample": [
      "BL70",
      "BL70",
      "RAJI",
      "ROS50",
      "SKNO1"
    ],
    "summary": "MYC mutation shows synthetic lethality with MYLK4. Effect size: -0.013 (p=0.8554). Tested in 9 mutant lines vs 2076 wild-type lines. Most dependent mutant line: ROS50 (Mature B-Cell Neoplasms): -0.4179"
  },
  {
    "mutation": "MYC",
    "target_gene": "TBK1",
    "n_mutant_lines": 9,
    "n_wt_lines": 2076,
    "mutant_mean_score": -0.0594,
    "wt_mean_score": -0.0163,
    "effect_size": -0.0431,
    "p_value": 0.1144382889463356,
    "is_significant": true,
    "most_dependent_line": "ROS50 (Mature B-Cell Neoplasms): -0.1785",
    "mutant_lines_sample": [
      "BL70",
      "BL70",
      "RAJI",
      "ROS50",
      "SKNO1"
    ],
    "summary": "MYC mutation shows synthetic lethality with TBK1. Effect size: -0.043 (p=0.1144). Tested in 9 mutant lines vs 2076 wild-type lines. Most dependent mutant line: ROS50 (Mature B-Cell Neoplasms): -0.1785"
  },
  {
    "mutation": "CDKN2A",
    "target_gene": "STK17A",
    "n_mutant_lines": 47,
    "n_wt_lines": 1959,
    "mutant_mean_score": -0.0386,
    "wt_mean_score": -0.0358,
    "effect_size": -0.0028,
    "p_value": 0.8768123904406838,
    "is_significant": true,
    "most_dependent_line": "MS751 (Cervical Squamous Cell Carcinoma): -0.2589",
    "mutant_lines_sample": [
      "NCIH1092",
      "PANC0403",
      "NCIH1792",
      "TE4",
      "IGROV1"
    ],
    "summary": "CDKN2A mutation shows synthetic lethality with STK17A. Effect size: -0.003 (p=0.8768). Tested in 47 mutant lines vs 1959 wild-type lines. Most dependent mutant line: MS751 (Cervical Squamous Cell Carcinoma): -0.2589"
  },
  {
    "mutation": "CDKN2A",
    "target_gene": "TBK1",
    "n_mutant_lines": 47,
    "n_wt_lines": 1959,
    "mutant_mean_score": -0.0322,
    "wt_mean_score": -0.0175,
    "effect_size": -0.0147,
    "p_value": 0.4580674932774422,
    "is_significant": true,
    "most_dependent_line": "JHH2 (Hepatocellular Carcinoma): -0.5756",
    "mutant_lines_sample": [
      "NCIH1092",
      "PANC0403",
      "NCIH1792",
      "TE4",
      "IGROV1"
    ],
    "summary": "CDKN2A mutation shows synthetic lethality with TBK1. Effect size: -0.015 (p=0.4581). Tested in 47 mutant lines vs 1959 wild-type lines. Most dependent mutant line: JHH2 (Hepatocellular Carcinoma): -0.5756"
  },
  {
    "mutation": "GNAQ",
    "target_gene": "TBK1",
    "n_mutant_lines": 3,
    "n_wt_lines": 2079,
    "mutant_mean_score": -0.0971,
    "wt_mean_score": -0.0163,
    "effect_size": -0.0808,
    "p_value": 0.0252760606418565,
    "is_significant": true,
    "most_dependent_line": "WM3772F (Ocular Melanoma): -0.1247",
    "mutant_lines_sample": [
      "MEL202",
      "UPMM3",
      "WM3772F"
    ],
    "summary": "GNAQ mutation shows synthetic lethality with TBK1. Effect size: -0.081 (p=0.0253). Tested in 3 mutant lines vs 2079 wild-type lines. Most dependent mutant line: WM3772F (Ocular Melanoma): -0.1247"
  },
  {
    "mutation": "GNAQ",
    "target_gene": "CLK4",
    "n_mutant_lines": 3,
    "n_wt_lines": 2079,
    "mutant_mean_score": -0.0903,
    "wt_mean_score": -0.0358,
    "effect_size": -0.0545,
    "p_value": 0.6225761166684057,
    "is_significant": true,
    "most_dependent_line": "WM3772F (Ocular Melanoma): -0.2676",
    "mutant_lines_sample": [
      "MEL202",
      "UPMM3",
      "WM3772F"
    ],
    "summary": "GNAQ mutation shows synthetic lethality with CLK4. Effect size: -0.054 (p=0.6226). Tested in 3 mutant lines vs 2079 wild-type lines. Most dependent mutant line: WM3772F (Ocular Melanoma): -0.2676"
  },
  {
    "mutation": "PTCH1",
    "target_gene": "TBK1",
    "n_mutant_lines": 14,
    "n_wt_lines": 2071,
    "mutant_mean_score": -0.0615,
    "wt_mean_score": -0.0162,
    "effect_size": -0.0454,
    "p_value": 0.148560311901392,
    "is_significant": true,
    "most_dependent_line": "DMS53 (Lung Neuroendocrine Tumor): -0.2295",
    "mutant_lines_sample": [
      "MELHO",
      "PA1",
      "MKN28",
      "COLO678",
      "NCIH1869"
    ],
    "summary": "PTCH1 mutation shows synthetic lethality with TBK1. Effect size: -0.045 (p=0.1486). Tested in 14 mutant lines vs 2071 wild-type lines. Most dependent mutant line: DMS53 (Lung Neuroendocrine Tumor): -0.2295"
  },
  {
    "mutation": "PTCH1",
    "target_gene": "CLK4",
    "n_mutant_lines": 14,
    "n_wt_lines": 2071,
    "mutant_mean_score": -0.0534,
    "wt_mean_score": -0.036,
    "effect_size": -0.0174,
    "p_value": 0.703674541895891,
    "is_significant": true,
    "most_dependent_line": "NCIH1573 (Non-Small Cell Lung Cancer): -0.4236",
    "mutant_lines_sample": [
      "MELHO",
      "PA1",
      "MKN28",
      "COLO678",
      "NCIH1869"
    ],
    "summary": "PTCH1 mutation shows synthetic lethality with CLK4. Effect size: -0.017 (p=0.7037). Tested in 14 mutant lines vs 2071 wild-type lines. Most dependent mutant line: NCIH1573 (Non-Small Cell Lung Cancer): -0.4236"
  },
  {
    "mutation": "ABCA1",
    "target_gene": "STK17A",
    "n_mutant_lines": 4,
    "n_wt_lines": 2081,
    "mutant_mean_score": -0.0526,
    "wt_mean_score": -0.0353,
    "effect_size": -0.0173,
    "p_value": 0.4532693619972774,
    "is_significant": true,
    "most_dependent_line": "SEMK2 (B-Cell Acute Lymphoblastic Leukemia): -0.0874",
    "mutant_lines_sample": [
      "SEM",
      "SEM",
      "SEMK2",
      "SEMK2"
    ],
    "summary": "ABCA1 mutation shows synthetic lethality with STK17A. Effect size: -0.017 (p=0.4533). Tested in 4 mutant lines vs 2081 wild-type lines. Most dependent mutant line: SEMK2 (B-Cell Acute Lymphoblastic Leukemia): -0.0874"
  },
  {
    "mutation": "COL5A1",
    "target_gene": "STK17A",
    "n_mutant_lines": 4,
    "n_wt_lines": 2081,
    "mutant_mean_score": -0.165,
    "wt_mean_score": -0.0351,
    "effect_size": -0.1299,
    "p_value": 0.147962659798052,
    "is_significant": true,
    "most_dependent_line": "SKMEL19 (Melanoma): -0.2811",
    "mutant_lines_sample": [
      "JMSU1",
      "JMSU1",
      "SKMEL19",
      "SKMEL19"
    ],
    "summary": "COL5A1 mutation shows synthetic lethality with STK17A. Effect size: -0.130 (p=0.1480). Tested in 4 mutant lines vs 2081 wild-type lines. Most dependent mutant line: SKMEL19 (Melanoma): -0.2811"
  },
  {
    "mutation": "COL5A1",
    "target_gene": "MYLK4",
    "n_mutant_lines": 4,
    "n_wt_lines": 2081,
    "mutant_mean_score": 0.0214,
    "wt_mean_score": 0.0804,
    "effect_size": -0.059,
    "p_value": 0.1177473493632349,
    "is_significant": true,
    "most_dependent_line": "SKMEL19 (Melanoma): -0.0257",
    "mutant_lines_sample": [
      "JMSU1",
      "JMSU1",
      "SKMEL19",
      "SKMEL19"
    ],
    "summary": "COL5A1 mutation shows synthetic lethality with MYLK4. Effect size: -0.059 (p=0.1177). Tested in 4 mutant lines vs 2081 wild-type lines. Most dependent mutant line: SKMEL19 (Melanoma): -0.0257"
  },
  {
    "mutation": "EIF1AX",
    "target_gene": "STK17A",
    "n_mutant_lines": 3,
    "n_wt_lines": 2080,
    "mutant_mean_score": -0.1474,
    "wt_mean_score": -0.0352,
    "effect_size": -0.1122,
    "p_value": 0.0197314440920007,
    "is_significant": true,
    "most_dependent_line": "L428 (Hodgkin Lymphoma): -0.1644",
    "mutant_lines_sample": [
      "NO10",
      "L428",
      "L428"
    ],
    "summary": "EIF1AX mutation shows synthetic lethality with STK17A. Effect size: -0.112 (p=0.0197). Tested in 3 mutant lines vs 2080 wild-type lines. Most dependent mutant line: L428 (Hodgkin Lymphoma): -0.1644"
  },
  {
    "mutation": "EIF1AX",
    "target_gene": "MYLK4",
    "n_mutant_lines": 3,
    "n_wt_lines": 2080,
    "mutant_mean_score": 0.0595,
    "wt_mean_score": 0.0803,
    "effect_size": -0.0208,
    "p_value": 0.7656588052611121,
    "is_significant": true,
    "most_dependent_line": "NO10 (Diffuse Glioma): -0.0625",
    "mutant_lines_sample": [
      "NO10",
      "L428",
      "L428"
    ],
    "summary": "EIF1AX mutation shows synthetic lethality with MYLK4. Effect size: -0.021 (p=0.7657). Tested in 3 mutant lines vs 2080 wild-type lines. Most dependent mutant line: NO10 (Diffuse Glioma): -0.0625"
  },
  {
    "mutation": "EIF1AX",
    "target_gene": "TBK1",
    "n_mutant_lines": 3,
    "n_wt_lines": 2080,
    "mutant_mean_score": -0.1585,
    "wt_mean_score": -0.0162,
    "effect_size": -0.1422,
    "p_value": 0.0049171765440753,
    "is_significant": true,
    "most_dependent_line": "NO10 (Diffuse Glioma): -0.1825",
    "mutant_lines_sample": [
      "NO10",
      "L428",
      "L428"
    ],
    "summary": "EIF1AX mutation shows synthetic lethality with TBK1. Effect size: -0.142 (p=0.0049). Tested in 3 mutant lines vs 2080 wild-type lines. Most dependent mutant line: NO10 (Diffuse Glioma): -0.1825"
  },
  {
    "mutation": "EIF1AX",
    "target_gene": "CLK4",
    "n_mutant_lines": 3,
    "n_wt_lines": 2080,
    "mutant_mean_score": -0.1028,
    "wt_mean_score": -0.0361,
    "effect_size": -0.0668,
    "p_value": 0.3203502328877194,
    "is_significant": true,
    "most_dependent_line": "L428 (Hodgkin Lymphoma): -0.1538",
    "mutant_lines_sample": [
      "NO10",
      "L428",
      "L428"
    ],
    "summary": "EIF1AX mutation shows synthetic lethality with CLK4. Effect size: -0.067 (p=0.3204). Tested in 3 mutant lines vs 2080 wild-type lines. Most dependent mutant line: L428 (Hodgkin Lymphoma): -0.1538"
  },
  {
    "mutation": "BCOR",
    "target_gene": "STK17A",
    "n_mutant_lines": 4,
    "n_wt_lines": 2080,
    "mutant_mean_score": -0.0511,
    "wt_mean_score": -0.0353,
    "effect_size": -0.0159,
    "p_value": 0.1743052244042366,
    "is_significant": true,
    "most_dependent_line": "TOV21G (Ovarian Epithelial Tumor): -0.0667",
    "mutant_lines_sample": [
      "TOV21G",
      "TOV21G",
      "CAL51",
      "CAL51"
    ],
    "summary": "BCOR mutation shows synthetic lethality with STK17A. Effect size: -0.016 (p=0.1743). Tested in 4 mutant lines vs 2080 wild-type lines. Most dependent mutant line: TOV21G (Ovarian Epithelial Tumor): -0.0667"
  },
  {
    "mutation": "BCOR",
    "target_gene": "MYLK4",
    "n_mutant_lines": 4,
    "n_wt_lines": 2080,
    "mutant_mean_score": -0.0243,
    "wt_mean_score": 0.0806,
    "effect_size": -0.1048,
    "p_value": 0.0053840983700214,
    "is_significant": true,
    "most_dependent_line": "TOV21G (Ovarian Epithelial Tumor): -0.0504",
    "mutant_lines_sample": [
      "TOV21G",
      "TOV21G",
      "CAL51",
      "CAL51"
    ],
    "summary": "BCOR mutation shows synthetic lethality with MYLK4. Effect size: -0.105 (p=0.0054). Tested in 4 mutant lines vs 2080 wild-type lines. Most dependent mutant line: TOV21G (Ovarian Epithelial Tumor): -0.0504"
  },
  {
    "mutation": "BCOR",
    "target_gene": "TBK1",
    "n_mutant_lines": 4,
    "n_wt_lines": 2080,
    "mutant_mean_score": -0.0417,
    "wt_mean_score": -0.0164,
    "effect_size": -0.0253,
    "p_value": 0.0205059989269525,
    "is_significant": true,
    "most_dependent_line": "CAL51 (Invasive Breast Carcinoma): -0.0528",
    "mutant_lines_sample": [
      "TOV21G",
      "TOV21G",
      "CAL51",
      "CAL51"
    ],
    "summary": "BCOR mutation shows synthetic lethality with TBK1. Effect size: -0.025 (p=0.0205). Tested in 4 mutant lines vs 2080 wild-type lines. Most dependent mutant line: CAL51 (Invasive Breast Carcinoma): -0.0528"
  },
  {
    "mutation": "IQSEC2",
    "target_gene": "STK17A",
    "n_mutant_lines": 4,
    "n_wt_lines": 2081,
    "mutant_mean_score": -0.0793,
    "wt_mean_score": -0.0353,
    "effect_size": -0.044,
    "p_value": 0.1471464098817058,
    "is_significant": true,
    "most_dependent_line": "HEC1 (Endometrial Carcinoma): -0.1186",
    "mutant_lines_sample": [
      "HEC1B",
      "HEC1B",
      "HEC1",
      "HEC1"
    ],
    "summary": "IQSEC2 mutation shows synthetic lethality with STK17A. Effect size: -0.044 (p=0.1471). Tested in 4 mutant lines vs 2081 wild-type lines. Most dependent mutant line: HEC1 (Endometrial Carcinoma): -0.1186"
  },
  {
    "mutation": "IQSEC2",
    "target_gene": "TBK1",
    "n_mutant_lines": 4,
    "n_wt_lines": 2081,
    "mutant_mean_score": -0.052,
    "wt_mean_score": -0.0164,
    "effect_size": -0.0357,
    "p_value": 0.1345592235076589,
    "is_significant": true,
    "most_dependent_line": "HEC1B (Endometrial Carcinoma): -0.0825",
    "mutant_lines_sample": [
      "HEC1B",
      "HEC1B",
      "HEC1",
      "HEC1"
    ],
    "summary": "IQSEC2 mutation shows synthetic lethality with TBK1. Effect size: -0.036 (p=0.1346). Tested in 4 mutant lines vs 2081 wild-type lines. Most dependent mutant line: HEC1B (Endometrial Carcinoma): -0.0825"
  }
]